<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Cystic fibrosis - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf12" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Cystic_fibrosis" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Cystic_fibrosis&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Cystic_fibrosis&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Cystic_fibrosis" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Cystic_fibrosis" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Cystic_fibrosis","wgTitle":"Cystic fibrosis","wgCurRevisionId":670677420,"wgRevisionId":670677420,"wgArticleId":50601,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","CS1 Spanish-language sources (es)","CS1 French-language sources (fr)","Articles with contributors link","Articles containing potentially dated statements from October 2011","All articles containing potentially dated statements","Commons category template with no category set","Commons category with page title same as on Wikidata","Articles with DMOZ links","Articles that use a Medicine navs subtemplate","Wikipedia articles with GND identifiers","Channelopathy","Autosomal recessive disorders","Pancreas disorders","Pediatrics","Lung disorders","Congenital disorders","Rare diseases","Steatorrhea-related diseases","Cystic fibrosis"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Cystic_fibrosis","wgRelevantArticleId":50601,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgULSAcceptLanguageList":["de","en-us","en"],"wgULSCurrentAutonym":"English","wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/ClubbingCF.JPG/100px-ClubbingCF.JPG","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q178194"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf12/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Cystic_fibrosis skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Cystic fibrosis</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Cystic fibrosis</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:ClubbingCF.JPG" class="image"><img alt="ClubbingCF.JPG" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/ClubbingCF.JPG/230px-ClubbingCF.JPG" width="230" height="172" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4e/ClubbingCF.JPG/345px-ClubbingCF.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4e/ClubbingCF.JPG/460px-ClubbingCF.JPG 2x" data-file-width="2331" data-file-height="1743" /></a>
<div><a href="/wiki/Nail_clubbing" title="Nail clubbing">Clubbing</a> in the fingers of a person with cystic fibrosis</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Medical_genetics" title="Medical genetics">Medical genetics</a>, <a href="/wiki/Pulmonology" title="Pulmonology">pulmonology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/E84">E84</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=277.0">277.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a rel="nofollow" class="external text" href="http://omim.org/entry/219700">219700</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb3347.htm">3347</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000107.htm">000107</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/1001602-overview">article/1001602</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Patient_UK" title="Patient UK">Patient UK</a></th>
<td><a rel="nofollow" class="external text" href="http://patient.info/doctor/cystic-fibrosis-pro">Cystic fibrosis</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D003550">D003550</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></th>
<td class="plainlist">
<ul>
<li><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/n/gene/NBK1250/">CFTR-Related Disorders</a></li>
</ul>
</td>
</tr>
</table>
<p><b>Cystic fibrosis</b> (<b>CF</b>), also known as <b>mucoviscidosis</b>, is a <a href="/wiki/Genetic_disorder" title="Genetic disorder">genetic disorder</a> that affects mostly the <a href="/wiki/Lungs" title="Lungs" class="mw-redirect">lungs</a> but also the <a href="/wiki/Pancreas" title="Pancreas">pancreas</a>, <a href="/wiki/Liver" title="Liver">liver</a>, <a href="/wiki/Kidneys" title="Kidneys" class="mw-redirect">kidneys</a> and <a href="/wiki/Intestine" title="Intestine" class="mw-redirect">intestine</a>.<sup id="cite_ref-O2009_1-0" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-CF2012_2-0" class="reference"><a href="#cite_note-CF2012-2"><span>[</span>2<span>]</span></a></sup> Long-term issues include <a href="/wiki/Shortness_of_breath" title="Shortness of breath" class="mw-redirect">difficulty breathing</a> and coughing up <a href="/wiki/Sputum" title="Sputum">sputum</a> as a result of frequent <a href="/wiki/Pneumonia" title="Pneumonia">lung infections</a>. Other <a href="/wiki/Symptom" title="Symptom">symptoms</a> include <a href="/wiki/Sinusitis" title="Sinusitis">sinus infections</a>, <a href="/wiki/Failure_to_thrive" title="Failure to thrive">poor growth</a>, <a href="/wiki/Fatty_stool" title="Fatty stool" class="mw-redirect">fatty stool</a>, <a href="/wiki/Nail_clubbing" title="Nail clubbing">clubbing</a> of the finger and toes, and <a href="/wiki/Infertility" title="Infertility">infertility</a> in males among others. Different people may have different degrees of symptoms.<sup id="cite_ref-O2009_1-1" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup></p>
<p>CF is an <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a> disorder. It is caused by the presence of mutations in both copies of the <a href="/wiki/Gene" title="Gene">gene</a> for the protein <a href="/wiki/Cystic_fibrosis_transmembrane_conductance_regulator" title="Cystic fibrosis transmembrane conductance regulator">cystic fibrosis transmembrane conductance regulator</a> (CFTR).<sup id="cite_ref-O2009_1-2" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup> Those with a single working copy are carriers and otherwise mostly normal.<sup id="cite_ref-Mas2013_3-0" class="reference"><a href="#cite_note-Mas2013-3"><span>[</span>3<span>]</span></a></sup> CFTR is involved in production of sweat, <a href="/wiki/Digestion" title="Digestion">digestive</a> fluids, and <a href="/wiki/Mucus" title="Mucus">mucus</a>.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> When CFTR is not functional, secretions which are usually thin instead become thick.<sup id="cite_ref-yankas_5-0" class="reference"><a href="#cite_note-yankas-5"><span>[</span>5<span>]</span></a></sup> The condition is diagnosed by a <a href="/wiki/Sweat_test" title="Sweat test">sweat test</a> and <a href="/wiki/Genetic_testing" title="Genetic testing">genetic testing</a>.<sup id="cite_ref-O2009_1-3" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup> Screening of infants at birth takes place in some areas of the world.<sup id="cite_ref-O2009_1-4" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup></p>
<p>There is no cure for cystic fibrosis.<sup id="cite_ref-Mas2013_3-1" class="reference"><a href="#cite_note-Mas2013-3"><span>[</span>3<span>]</span></a></sup> Lung infections are treated with <a href="/wiki/Antibiotics" title="Antibiotics">antibiotics</a> which may be given intravenously, inhaled, or by mouth. Sometimes the antibiotic <a href="/wiki/Azithromycin" title="Azithromycin">azithromycin</a> is used long term. Inhaled <a href="/wiki/Hypertonic_saline" title="Hypertonic saline" class="mw-redirect">hypertonic saline</a> and <a href="/wiki/Salbutamol" title="Salbutamol">salbutamol</a> may also be useful. <a href="/wiki/Lung_transplantation" title="Lung transplantation">Lung transplantation</a> may be an option if lung function continues to worsen. <a href="/wiki/Pancreatic_enzyme_replacement" title="Pancreatic enzyme replacement" class="mw-redirect">Pancreatic enzyme replacement</a> and <a href="/wiki/Fat_soluble_vitamin" title="Fat soluble vitamin" class="mw-redirect">fat soluble vitamin</a> supplementation are important, especially in the young. While not well supported by evidence, many people use <a href="/wiki/Airway_clearance_technique" title="Airway clearance technique">airway clearance techniques</a> such as <a href="/wiki/Chest_physiotherapy" title="Chest physiotherapy">chest physiotherapy</a>.<sup id="cite_ref-O2009_1-5" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup> The average life expectancy is between 37 and 50 years in the <a href="/wiki/Developed_world" title="Developed world" class="mw-redirect">developed world</a>.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6"><span>[</span>6<span>]</span></a></sup> Lung problems are responsible for death in 80% of people with cystic fibrosis.<sup id="cite_ref-O2009_1-6" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup></p>
<p>CF is most common among people of <a href="/wiki/Northern_European" title="Northern European" class="mw-redirect">Northern European</a> ancestry and affects about one out of every three thousand newborns.<sup id="cite_ref-O2009_1-7" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup> About one in twenty five are carriers.<sup id="cite_ref-Mas2013_3-2" class="reference"><a href="#cite_note-Mas2013-3"><span>[</span>3<span>]</span></a></sup> It is least common in Africans and Asians.<sup id="cite_ref-O2009_1-8" class="reference"><a href="#cite_note-O2009-1"><span>[</span>1<span>]</span></a></sup> It was first recognized as a specific disease by <a href="/wiki/Dorothy_Andersen" title="Dorothy Andersen" class="mw-redirect">Dorothy Andersen</a> in 1938, with descriptions that fit the condition occurring at least as far back as 1595.<sup id="cite_ref-CF2012_2-1" class="reference"><a href="#cite_note-CF2012-2"><span>[</span>2<span>]</span></a></sup> The name <i>cystic fibrosis</i> refers to the characteristic <a href="/wiki/Fibrosis" title="Fibrosis">fibrosis</a> and <a href="/wiki/Cyst" title="Cyst">cysts</a> that form within the <a href="/wiki/Pancreas" title="Pancreas">pancreas</a>.<sup id="cite_ref-CF2012_2-2" class="reference"><a href="#cite_note-CF2012-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-andersen_7-0" class="reference"><a href="#cite_note-andersen-7"><span>[</span>7<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Lungs_and_sinuses"><span class="tocnumber">1.1</span> <span class="toctext">Lungs and sinuses</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Gastrointestinal"><span class="tocnumber">1.2</span> <span class="toctext">Gastrointestinal</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Endocrine"><span class="tocnumber">1.3</span> <span class="toctext">Endocrine</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Infertility"><span class="tocnumber">1.4</span> <span class="toctext">Infertility</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Cause"><span class="tocnumber">2</span> <span class="toctext">Cause</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Chronic_infections"><span class="tocnumber">3.1</span> <span class="toctext">Chronic infections</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-9"><a href="#Diagnosis_and_monitoring"><span class="tocnumber">4</span> <span class="toctext">Diagnosis and monitoring</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Prenatal"><span class="tocnumber">4.1</span> <span class="toctext">Prenatal</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Management"><span class="tocnumber">5</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-12"><a href="#Antibiotics"><span class="tocnumber">5.1</span> <span class="toctext">Antibiotics</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Other_treatments_for_lung_disease"><span class="tocnumber">5.2</span> <span class="toctext">Other treatments for lung disease</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Transplantation"><span class="tocnumber">5.3</span> <span class="toctext">Transplantation</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Other_aspects"><span class="tocnumber">5.4</span> <span class="toctext">Other aspects</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Prognosis"><span class="tocnumber">6</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2 tocsection-17"><a href="#Quality_of_life"><span class="tocnumber">6.1</span> <span class="toctext">Quality of life</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-18"><a href="#Epidemiology"><span class="tocnumber">7</span> <span class="toctext">Epidemiology</span></a>
<ul>
<li class="toclevel-2 tocsection-19"><a href="#Evolution"><span class="tocnumber">7.1</span> <span class="toctext">Evolution</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#History"><span class="tocnumber">8</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#Research"><span class="tocnumber">9</span> <span class="toctext">Research</span></a>
<ul>
<li class="toclevel-2 tocsection-22"><a href="#Gene_therapy"><span class="tocnumber">9.1</span> <span class="toctext">Gene therapy</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Small_molecules"><span class="tocnumber">9.2</span> <span class="toctext">Small molecules</span></a></li>
<li class="toclevel-2 tocsection-24"><a href="#Other"><span class="tocnumber">9.3</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-25"><a href="#Society_and_culture"><span class="tocnumber">10</span> <span class="toctext">Society and culture</span></a></li>
<li class="toclevel-1 tocsection-26"><a href="#References"><span class="tocnumber">11</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-27"><a href="#External_links"><span class="tocnumber">12</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Blausen_0286_CysticFibrosis.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Blausen_0286_CysticFibrosis.png/220px-Blausen_0286_CysticFibrosis.png" width="220" height="293" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Blausen_0286_CysticFibrosis.png/330px-Blausen_0286_CysticFibrosis.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Blausen_0286_CysticFibrosis.png/440px-Blausen_0286_CysticFibrosis.png 2x" data-file-width="768" data-file-height="1024" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Blausen_0286_CysticFibrosis.png" class="internal" title="Enlarge"></a></div>
Health problems associated with cystic fibrosis</div>
</div>
</div>
<p>The main signs and symptoms of cystic fibrosis are salty-tasting <a href="/wiki/Skin" title="Skin">skin</a>,<sup id="cite_ref-pmid17557942_8-0" class="reference"><a href="#cite_note-pmid17557942-8"><span>[</span>8<span>]</span></a></sup> poor growth, and poor weight gain despite normal food intake,<sup id="cite_ref-pmid15339250_9-0" class="reference"><a href="#cite_note-pmid15339250-9"><span>[</span>9<span>]</span></a></sup> accumulation of thick, sticky mucus,<sup id="cite_ref-pmid19726878_10-0" class="reference"><a href="#cite_note-pmid19726878-10"><span>[</span>10<span>]</span></a></sup> frequent chest infections, and coughing or shortness of breath.<sup id="cite_ref-pmid19393108_11-0" class="reference"><a href="#cite_note-pmid19393108-11"><span>[</span>11<span>]</span></a></sup> Males can be <a href="/wiki/Infertility" title="Infertility">infertile</a> due to <a href="/wiki/Congenital_absence_of_the_vas_deferens" title="Congenital absence of the vas deferens">congenital absence of the vas deferens</a>.<sup id="cite_ref-pmid19535829_12-0" class="reference"><a href="#cite_note-pmid19535829-12"><span>[</span>12<span>]</span></a></sup> Symptoms often appear in infancy and childhood, such as <a href="/wiki/Bowel_obstruction" title="Bowel obstruction">bowel obstruction</a> due to <a href="/wiki/Meconium_ileus" title="Meconium ileus" class="mw-redirect">meconium ileus</a> in newborn babies.<sup id="cite_ref-pmid17030173_13-0" class="reference"><a href="#cite_note-pmid17030173-13"><span>[</span>13<span>]</span></a></sup> As the children grow, they must exercise to release mucus in the alveoli.<sup id="cite_ref-pmid19393104_14-0" class="reference"><a href="#cite_note-pmid19393104-14"><span>[</span>14<span>]</span></a></sup> <a href="/wiki/Cilium" title="Cilium">Ciliated</a> <a href="/wiki/Epithelium" title="Epithelium">epithelial cells</a> in the person have a mutated protein that leads to abnormally viscous mucus production.<sup id="cite_ref-pmid19726878_10-1" class="reference"><a href="#cite_note-pmid19726878-10"><span>[</span>10<span>]</span></a></sup> The poor growth in children typically presents as an inability to gain weight or height at the same rate as their peers and is occasionally not diagnosed until investigation is initiated for poor growth. The causes of growth failure are multifactorial and include chronic lung infection, poor absorption of nutrients through the gastrointestinal tract, and increased metabolic demand due to chronic illness.<sup id="cite_ref-pmid15339250_9-1" class="reference"><a href="#cite_note-pmid15339250-9"><span>[</span>9<span>]</span></a></sup></p>
<p>In rare cases, cystic fibrosis can manifest itself as a coagulation disorder. <a href="/wiki/Vitamin_K" title="Vitamin K">Vitamin K</a> is normally absorbed from breast milk, formula, and later, solid foods. This absorption is impaired in some cystic fibrosis patients. Young children are especially sensitive to <a href="/wiki/Vitamin_K" title="Vitamin K">vitamin K</a> malabsorptive disorders because only a very small amount of vitamin K crosses the placenta, leaving the child with very low reserves and limited ability to absorb vitamin K from dietary sources after birth. Because factors II, VII, IX, and X (clotting factors) are vitamin K–dependent, low levels of vitamin K can result in coagulation problems. Consequently, when a child presents with unexplained bruising, a coagulation evaluation may be warranted to determine whether there is an underlying disease.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15"><span>[</span>15<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Lungs_and_sinuses">Lungs and sinuses</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=2" title="Edit section: Lungs and sinuses">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Cystic_Fibrosis_Respiratory_Infections_by_Age.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Cystic_Fibrosis_Respiratory_Infections_by_Age.svg/220px-Cystic_Fibrosis_Respiratory_Infections_by_Age.svg.png" width="220" height="115" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Cystic_Fibrosis_Respiratory_Infections_by_Age.svg/330px-Cystic_Fibrosis_Respiratory_Infections_by_Age.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Cystic_Fibrosis_Respiratory_Infections_by_Age.svg/440px-Cystic_Fibrosis_Respiratory_Infections_by_Age.svg.png 2x" data-file-width="739" data-file-height="387" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Cystic_Fibrosis_Respiratory_Infections_by_Age.svg" class="internal" title="Enlarge"></a></div>
Respiratory infections in CF varies according to age.<br />
<br />
Green = <i><a href="/wiki/Pseudomonas_aeruginosa" title="Pseudomonas aeruginosa">Pseudomonas aeruginosa</a></i><br />
Brown = <i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a></i><br />
Blue = <i><a href="/wiki/Haemophilus_influenzae" title="Haemophilus influenzae">Haemophilus influenzae</a></i><br />
Red = <i><a href="/wiki/Burkholderia_cepacia" title="Burkholderia cepacia" class="mw-redirect">Burkholderia cepacia</a></i> complex</div>
</div>
</div>
<p>Lung disease results from clogging of the airways due to mucus build-up, decreased <a href="/wiki/Mucociliary_clearance" title="Mucociliary clearance">mucociliary clearance</a>, and resulting <a href="/wiki/Inflammation" title="Inflammation">inflammation</a>.<sup id="cite_ref-pmid20299528_16-0" class="reference"><a href="#cite_note-pmid20299528-16"><span>[</span>16<span>]</span></a></sup><sup id="cite_ref-kumar2007_17-0" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> Inflammation and infection cause injury and structural changes to the lungs, leading to a variety of symptoms. In the early stages, incessant coughing, copious <a href="/wiki/Phlegm" title="Phlegm">phlegm</a> production, and decreased ability to exercise are common. Many of these symptoms occur when <a href="/wiki/Bacteria" title="Bacteria">bacteria</a> that normally inhabit the thick mucus grow out of control and cause pneumonia. In later stages, changes in the architecture of the lung, such as pathology in the major airways (<a href="/wiki/Bronchiectasis" title="Bronchiectasis">bronchiectasis</a>), further exacerbate difficulties in breathing. Other symptoms include coughing up blood (<a href="/wiki/Hemoptysis" title="Hemoptysis">hemoptysis</a>), high <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a> in the lung (<a href="/wiki/Pulmonary_hypertension" title="Pulmonary hypertension">pulmonary hypertension</a>), <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>, difficulties getting enough <a href="/wiki/Oxygen" title="Oxygen">oxygen</a> to the body (<a href="/wiki/Hypoxia_(medical)" title="Hypoxia (medical)">hypoxia</a>), and respiratory failure requiring support with breathing masks, such as <a href="/wiki/Bilevel_positive_airway_pressure" title="Bilevel positive airway pressure">bilevel positive airway pressure</a> machines or <a href="/wiki/Mechanical_ventilation" title="Mechanical ventilation">ventilators</a>.<sup id="cite_ref-Rowe_18-0" class="reference"><a href="#cite_note-Rowe-18"><span>[</span>18<span>]</span></a></sup> <i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a></i>, <i><a href="/wiki/Haemophilus_influenzae" title="Haemophilus influenzae">Haemophilus influenzae</a></i>, and <i><a href="/wiki/Pseudomonas_aeruginosa" title="Pseudomonas aeruginosa">Pseudomonas aeruginosa</a></i> are the three most common organisms causing lung infections in CF patients.<sup id="cite_ref-kumar2007_17-1" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> In addition to typical bacterial infections, people with CF more commonly develop other types of lung disease. Among these is <a href="/wiki/Allergic_bronchopulmonary_aspergillosis" title="Allergic bronchopulmonary aspergillosis">allergic bronchopulmonary aspergillosis</a>, in which the body's response to the common <a href="/wiki/Fungus" title="Fungus">fungus</a> <i><a href="/wiki/Aspergillus_fumigatus" title="Aspergillus fumigatus">Aspergillus fumigatus</a></i> causes worsening of breathing problems. Another is infection with <i><a href="/wiki/Mycobacterium_avium_complex" title="Mycobacterium avium complex">Mycobacterium avium</a></i> complex (MAC), a group of bacteria related to <a href="/wiki/Tuberculosis" title="Tuberculosis">tuberculosis</a>, which can cause a lot of lung damage and does not respond to common antibiotics.<sup id="cite_ref-pmid16266669_19-0" class="reference"><a href="#cite_note-pmid16266669-19"><span>[</span>19<span>]</span></a></sup></p>
<p>Mucus in the <a href="/wiki/Paranasal_sinus" title="Paranasal sinus" class="mw-redirect">paranasal sinuses</a> is equally thick and may also cause blockage of the sinus passages, leading to infection. This may cause facial pain, fever, nasal drainage, and <a href="/wiki/Headache" title="Headache">headaches</a>. Individuals with CF may develop overgrowth of the nasal tissue (<a href="/wiki/Nasal_polyp" title="Nasal polyp">nasal polyps</a>) due to inflammation from chronic sinus infections.<sup id="cite_ref-pmid20209279_20-0" class="reference"><a href="#cite_note-pmid20209279-20"><span>[</span>20<span>]</span></a></sup> Recurrent sinonasal polyps can occur in as many as 10% to 25% of CF patients.<sup id="cite_ref-kumar2007_17-2" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> These polyps can block the nasal passages and increase breathing difficulties.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22"><span>[</span>22<span>]</span></a></sup></p>
<p>Cardiorespiratory complications are the most common cause of death (~80%) in patients at most CF centers in the United States.<sup id="cite_ref-kumar2007_17-3" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Gastrointestinal">Gastrointestinal</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=3" title="Edit section: Gastrointestinal">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Prior to prenatal and <a href="/wiki/Newborn_screening" title="Newborn screening">newborn screening</a>, cystic fibrosis was often diagnosed when a newborn infant failed to pass feces (<a href="/wiki/Meconium" title="Meconium">meconium</a>). Meconium may completely block the <a href="/wiki/Small_intestine" title="Small intestine">intestines</a> and cause serious illness. This condition, called <a href="/wiki/Meconium_ileus" title="Meconium ileus" class="mw-redirect">meconium ileus</a>, occurs in 5–10%<sup id="cite_ref-kumar2007_17-4" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup> of newborns with CF. In addition, protrusion of internal <a href="/wiki/Rectum" title="Rectum">rectal</a> membranes (<a href="/wiki/Rectal_prolapse" title="Rectal prolapse">rectal prolapse</a>) is more common, occurring in as many as 10% of children with CF,<sup id="cite_ref-kumar2007_17-5" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> and it is caused by increased fecal volume, <a href="/wiki/Malnutrition" title="Malnutrition">malnutrition</a>, and <a href="/wiki/Valsalva_maneuver" title="Valsalva maneuver">increased intra–abdominal pressure</a> due to coughing.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24"><span>[</span>24<span>]</span></a></sup></p>
<p>The thick mucus seen in the lungs has a counterpart in thickened secretions from the <a href="/wiki/Pancreas" title="Pancreas">pancreas</a>, an organ responsible for providing <a href="/wiki/Pancreatic_juice" title="Pancreatic juice">digestive juices</a> that help break down food. These secretions block the <a href="/wiki/Exocrine" title="Exocrine" class="mw-redirect">exocrine</a> movement of the digestive enzymes into the <a href="/wiki/Duodenum" title="Duodenum">duodenum</a> and result in irreversible damage to the pancreas, often with painful inflammation (<a href="/wiki/Pancreatitis" title="Pancreatitis">pancreatitis</a>).<sup id="cite_ref-25" class="reference"><a href="#cite_note-25"><span>[</span>25<span>]</span></a></sup> The <a href="/wiki/Pancreatic_duct" title="Pancreatic duct">pancreatic ducts</a> are totally plugged in more advanced cases, usually seen in older children or adolescents.<sup id="cite_ref-kumar2007_17-6" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> This causes atrophy of the exocrine glands and progressive fibrosis.<sup id="cite_ref-kumar2007_17-7" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup></p>
<p>The lack of digestive enzymes leads to difficulty absorbing nutrients with their subsequent excretion in the feces, a disorder known as <a href="/wiki/Malabsorption" title="Malabsorption">malabsorption</a>. Malabsorption leads to malnutrition and poor growth and development because of calorie loss. Resultant <a href="/wiki/Hypoproteinemia" title="Hypoproteinemia">hypoproteinemia</a> may be severe enough to cause generalized edema.<sup id="cite_ref-kumar2007_17-8" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> Individuals with CF also have difficulties absorbing the fat-soluble vitamins <a href="/wiki/Vitamin_A" title="Vitamin A">A</a>, <a href="/wiki/Vitamin_D" title="Vitamin D">D</a>, <a href="/wiki/Vitamin_E" title="Vitamin E">E</a>, and <a href="/wiki/Vitamin_K" title="Vitamin K">K</a>.</p>
<p>In addition to the pancreas problems, people with cystic fibrosis experience more <a href="/wiki/Gastroesophageal_reflux_disease" title="Gastroesophageal reflux disease">heartburn</a>, intestinal blockage by <a href="/wiki/Intussusception_(medical_disorder)" title="Intussusception (medical disorder)">intussusception</a>, and <a href="/wiki/Constipation" title="Constipation">constipation</a>.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup> Older individuals with CF may develop <a href="/wiki/Distal_intestinal_obstruction_syndrome" title="Distal intestinal obstruction syndrome">distal intestinal obstruction syndrome</a> when thickened feces cause intestinal blockage.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></p>
<p><a href="/wiki/Exocrine_pancreatic_insufficiency" title="Exocrine pancreatic insufficiency">Exocrine pancreatic insufficiency</a> occurs in the majority (85% to 90%) of patients with CF.<sup id="cite_ref-kumar2007_17-9" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> It is mainly associated with "severe" CFTR mutations, where both alleles are completely nonfunctional (e.g. ΔF508/ΔF508).<sup id="cite_ref-kumar2007_17-10" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> It occurs in 10% to 15% of patients with one "severe" and one "mild" CFTR mutation where there still is a little CFTR activity, or where there are two "mild" CFTR mutations.<sup id="cite_ref-kumar2007_17-11" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> In these milder cases, there is still sufficient pancreatic exocrine function so that enzyme supplementation is not required.<sup id="cite_ref-kumar2007_17-12" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> There are usually no other GI complications in pancreas-sufficient phenotypes, and in general, such individuals usually have excellent growth and development.<sup id="cite_ref-kumar2007_17-13" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> Despite this, idiopathic <a href="/wiki/Chronic_pancreatitis" title="Chronic pancreatitis">chronic pancreatitis</a> can occur in a subset of pancreas-sufficient individuals with CF, and is associated with recurrent abdominal pain and life-threatening complications.<sup id="cite_ref-kumar2007_17-14" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup></p>
<p>Thickened secretions also may cause liver problems in patients with CF. <a href="/wiki/Bile" title="Bile">Bile</a> secreted by the liver to aid in digestion may block the <a href="/wiki/Bile_duct" title="Bile duct">bile ducts</a>, leading to liver damage. Over time, this can lead to scarring and nodularity (<a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>). The liver fails to rid the blood of toxins and does not make important <a href="/wiki/Protein" title="Protein">proteins</a>, such as those responsible for <a href="/wiki/Coagulation" title="Coagulation">blood clotting</a>.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup><sup id="cite_ref-liver_29-0" class="reference"><a href="#cite_note-liver-29"><span>[</span>29<span>]</span></a></sup> Liver disease is the third most common cause of death associated with CF.<sup id="cite_ref-kumar2007_17-15" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Endocrine">Endocrine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=4" title="Edit section: Endocrine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/Pancreas" title="Pancreas">pancreas</a> contains the <a href="/wiki/Islets_of_Langerhans" title="Islets of Langerhans">islets of Langerhans</a>, which are responsible for making <a href="/wiki/Insulin" title="Insulin">insulin</a>, a hormone that helps regulate blood <a href="/wiki/Glucose" title="Glucose">glucose</a>. Damage of the pancreas can lead to loss of the islet <a href="/wiki/Cell_(biology)" title="Cell (biology)">cells</a>, leading to a type of diabetes that is unique to those with the disease.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> This <a href="/wiki/Cystic_fibrosis-related_diabetes" title="Cystic fibrosis-related diabetes">cystic fibrosis-related diabetes</a> (CFRD) shares characteristics that can be found in <a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">type 1</a> and <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2</a> diabetics, and is one of the principal nonpulmonary complications of CF.<sup id="cite_ref-Alves_31-0" class="reference"><a href="#cite_note-Alves-31"><span>[</span>31<span>]</span></a></sup> <a href="/wiki/Vitamin_D" title="Vitamin D">Vitamin D</a> is involved in <a href="/wiki/Calcium" title="Calcium">calcium</a> and <a href="/wiki/Phosphate" title="Phosphate">phosphate</a> regulation. Poor uptake of vitamin D from the diet because of malabsorption can lead to the bone disease <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> in which weakened bones are more susceptible to <a href="/wiki/Bone_fracture" title="Bone fracture">fractures</a>.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup> In addition, people with CF often develop <a href="/wiki/Nail_clubbing" title="Nail clubbing">clubbing</a> of their fingers and toes due to the effects of chronic illness and <a href="/wiki/Hypoxia_(medical)" title="Hypoxia (medical)">low oxygen</a> in their tissues.<sup id="cite_ref-pmid12806875_33-0" class="reference"><a href="#cite_note-pmid12806875-33"><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-pmid3488032_34-0" class="reference"><a href="#cite_note-pmid3488032-34"><span>[</span>34<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Infertility">Infertility</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=5" title="Edit section: Infertility">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Infertility" title="Infertility">Infertility</a> affects both men and women. At least 97% of men with cystic fibrosis are infertile, but not sterile and can have children with assisted reproductive techniques.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>35<span>]</span></a></sup> The main cause of infertility in men with cystic fibrosis is <a href="/wiki/Congenital_absence_of_the_vas_deferens" title="Congenital absence of the vas deferens">congenital absence of the vas deferens</a> (which normally connects the <a href="/wiki/Testicle" title="Testicle">testes</a> to the <a href="/wiki/Ejaculatory_duct" title="Ejaculatory duct">ejaculatory ducts</a> of the <a href="/wiki/Penis" title="Penis">penis</a>), but potentially also by other mechanisms such as causing <a href="/wiki/Azoospermia" title="Azoospermia">no sperm</a>, <a href="/wiki/Teratospermia" title="Teratospermia">teratospermia</a>, and <a href="/wiki/Oligoasthenospermia" title="Oligoasthenospermia" class="mw-redirect">few sperm with poor motility</a>.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36"><span>[</span>36<span>]</span></a></sup> Many men found to have congenital absence of the vas deferens during evaluation for infertility have a mild, previously undiagnosed form of CF.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup> Approximately 20% of women with CF have fertility difficulties due to thickened cervical mucus or malnutrition. In severe cases, malnutrition disrupts <a href="/wiki/Ovulation" title="Ovulation">ovulation</a> and causes <a href="/wiki/Amenorrhea" title="Amenorrhea" class="mw-redirect">amenorrhea</a>.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=6" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Autorecessive.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/220px-Autorecessive.svg.png" width="220" height="257" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/330px-Autorecessive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/3e/Autorecessive.svg/440px-Autorecessive.svg.png 2x" data-file-width="1350" data-file-height="1580" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Autorecessive.svg" class="internal" title="Enlarge"></a></div>
Cystic fibrosis has an autosomal recessive pattern of inheritance</div>
</div>
</div>
<p>CF is caused by a mutation in the <a href="/wiki/Gene" title="Gene">gene</a> <a href="/wiki/CFTR_(gene)" title="CFTR (gene)" class="mw-redirect">cystic fibrosis transmembrane conductance regulator</a> (CFTR). The most common mutation, <a href="/wiki/%CE%94F508" title="ΔF508">ΔF508</a>, is a deletion (<a href="/wiki/Delta_(letter)#Mathematics_and_the_Sciences" title="Delta (letter)">Δ</a> signifying deletion) of three nucleotides<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup> that results in a loss of the amino acid <a href="/wiki/Phenylalanine" title="Phenylalanine">phenylalanine</a> (F) at the 508th position on the protein. This mutation accounts for two-thirds (66–70%<sup id="cite_ref-kumar2007_17-16" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup>) of CF cases worldwide and 90% of cases in the <a href="/wiki/United_States" title="United States">United States</a>; however, there are over 1500 other mutations that can produce CF.<sup id="cite_ref-prevalence_40-0" class="reference"><a href="#cite_note-prevalence-40"><span>[</span>40<span>]</span></a></sup> Although most people have two working copies (alleles) of the CFTR gene, only one is needed to prevent cystic fibrosis. CF develops when neither allele can produce a functional CFTR protein. Thus, CF is considered an <a href="/wiki/Autosomal_recessive_disorder#Dominant_and_recessive_genetic_diseases_in_humans" title="Autosomal recessive disorder" class="mw-redirect">autosomal recessive disease</a>.</p>
<p>The <a href="/wiki/CFTR_(gene)" title="CFTR (gene)" class="mw-redirect">CFTR gene</a>, found at the q31.2 <a href="/wiki/Locus_(genetics)" title="Locus (genetics)">locus</a> of <a href="/wiki/Chromosome_7" title="Chromosome 7" class="mw-redirect">chromosome 7</a>, is 230,000 <a href="/wiki/Base_pair" title="Base pair">base pairs</a> long, and creates a protein that is 1,480 <a href="/wiki/Amino_acid" title="Amino acid">amino acids</a> long. More specifically the location is between base pair 117,120,016 to 117,308,718 on the long arm of chromosome 7, region 3, band 1, sub-band 2, represented as 7q31.2. Structurally, CFTR is a type of gene known as an <a href="/wiki/ATP-binding_cassette_transporter_genes" title="ATP-binding cassette transporter genes" class="mw-redirect">ABC gene</a>. The product of this gene (the CFTR) is a chloride ion channel important in creating <a href="/wiki/Perspiration" title="Perspiration">sweat</a>, <a href="/wiki/Digestion" title="Digestion">digestive</a> juices and <a href="/wiki/Mucus" title="Mucus">mucus</a>. This protein possesses two <a href="/wiki/ATP_hydrolysis" title="ATP hydrolysis">ATP-hydrolyzing</a> <a href="/wiki/Structural_domain" title="Structural domain" class="mw-redirect">domains</a>, which allows the protein to use <a href="/wiki/Energy" title="Energy">energy</a> in the form of <a href="/wiki/Adenosine_triphosphate" title="Adenosine triphosphate">ATP</a>. It also contains two domains comprising 6 <a href="/wiki/Alpha_helix" title="Alpha helix">alpha helices</a> apiece, which allow the protein to cross the cell membrane. A regulatory <a href="/wiki/Binding_site" title="Binding site">binding site</a> on the protein allows activation by <a href="/wiki/Phosphorylation" title="Phosphorylation">phosphorylation</a>, mainly by <a href="/wiki/CAMP-dependent_protein_kinase" title="CAMP-dependent protein kinase" class="mw-redirect">cAMP-dependent protein kinase</a>.<sup id="cite_ref-Rowe_18-1" class="reference"><a href="#cite_note-Rowe-18"><span>[</span>18<span>]</span></a></sup> The <a href="/wiki/C-terminal_end" title="C-terminal end" class="mw-redirect">carboxyl terminal</a> of the protein is anchored to the <a href="/wiki/Cytoskeleton" title="Cytoskeleton">cytoskeleton</a> by a <a href="/wiki/PDZ_(biology)" title="PDZ (biology)" class="mw-redirect">PDZ</a> domain interaction.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>41<span>]</span></a></sup></p>
<p>In addition, there is increasing evidence that genetic modifiers besides CFTR modulate the frequency and severity of the disease. One example is <a href="/wiki/Mannan-binding_lectin" title="Mannan-binding lectin">mannan-binding lectin</a>, which is involved in <a href="/wiki/Innate_immunity" title="Innate immunity" class="mw-redirect">innate immunity</a> by facilitating <a href="/wiki/Phagocytosis" title="Phagocytosis">phagocytosis</a> of microorganisms. <a href="/wiki/Polymorphism_(biology)" title="Polymorphism (biology)">Polymorphisms</a> in one or both mannan-binding lectin alleles that result in lower circulating levels of the protein are associated with a threefold higher risk of end-stage lung disease, as well as an increased burden of chronic bacterial infections.<sup id="cite_ref-kumar2007_17-17" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=7" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:CFTR_Protein_Panels.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/17/CFTR_Protein_Panels.svg/220px-CFTR_Protein_Panels.svg.png" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/17/CFTR_Protein_Panels.svg/330px-CFTR_Protein_Panels.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/17/CFTR_Protein_Panels.svg/440px-CFTR_Protein_Panels.svg.png 2x" data-file-width="512" data-file-height="384" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:CFTR_Protein_Panels.svg" class="internal" title="Enlarge"></a></div>
The CFTR protein is a channel protein that controls the flow of H<sub>2</sub>O and Cl- ions in and out of cells inside the lungs. When the CFTR protein is working correctly, as shown in Panel 1, ions freely flow in and out of the cells. However, when the CFTR protein is malfunctioning as in Panel 2, these ions cannot flow out of the cell due to a blocked channel. This causes cystic fibrosis, characterized by the buildup of thick mucus in the lungs.</div>
</div>
</div>
<p>There are several mutations in the <i>CFTR</i> gene, and different mutations cause different defects in the CFTR protein, sometimes causing a milder or more severe disease. These protein defects are also targets for drugs which can sometimes restore their function. <a href="/wiki/%CE%94F508" title="ΔF508">ΔF508-CFTR</a>, which occurs in &gt;90% of patients in the U.S., creates a protein that does not <a href="/wiki/Protein_folding" title="Protein folding">fold</a> normally and is degraded by the cell. Other mutations result in proteins that are too short (truncated) because <a href="/wiki/Translation_(genetics)" title="Translation (genetics)" class="mw-redirect">production</a> is ended prematurely. Other mutations produce proteins that: do not use energy normally, do not allow <a href="/wiki/Chloride" title="Chloride">chloride</a>, <a href="/wiki/Iodide" title="Iodide">iodide</a>, and <a href="/wiki/Thiocyanate" title="Thiocyanate">thiocyanate</a> to cross the membrane appropriately,<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup> degrade at a faster rate than normal. Mutations may also lead to fewer copies of the CFTR protein being produced.<sup id="cite_ref-Rowe_18-2" class="reference"><a href="#cite_note-Rowe-18"><span>[</span>18<span>]</span></a></sup></p>
<p>The protein created by this gene is anchored to the <a href="/wiki/Cell_membrane" title="Cell membrane">outer membrane</a> of <a href="/wiki/Cell_(biology)" title="Cell (biology)">cells</a> in the <a href="/wiki/Sweat_gland" title="Sweat gland">sweat glands</a>, lungs, pancreas, and all other remaining exocrine glands in the body. The protein spans this membrane and acts as a <a href="/wiki/Ion_channel" title="Ion channel">channel</a> connecting the inner part of the cell (<a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a>) to the <a href="/wiki/Extracellular_fluid" title="Extracellular fluid">surrounding fluid</a>. This channel is primarily responsible for controlling the movement of halogens from inside to outside of the cell; however, in the sweat ducts it facilitates the movement of chloride from the sweat duct into the cytoplasm. When the CFTR protein does not resorb ions in sweat ducts, chloride and thiocyanate<sup id="cite_ref-43" class="reference"><a href="#cite_note-43"><span>[</span>43<span>]</span></a></sup> released from sweat glands are trapped inside the ducts and pumped to the skin. Additionally <a href="/wiki/Hypothiocyanite" title="Hypothiocyanite">hypothiocyanite</a>, OSCN, cannot be produced by the immune defense system.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup><sup id="cite_ref-45" class="reference"><a href="#cite_note-45"><span>[</span>45<span>]</span></a></sup> Because chloride is <a href="/wiki/Electric_charge" title="Electric charge">negatively charged</a>, this creates a difference in the electrical potential inside and outside the cell causing <a href="/wiki/Cation" title="Cation" class="mw-redirect">cations</a> to cross into the cell. Sodium is the most common cation in the extracellular space. The excess chloride within sweat ducts prevents sodium resorption by epithelial sodium channels and the combination of sodium and chloride creates the <a href="/wiki/Sodium_chloride" title="Sodium chloride">salt</a>, which is lost in high amounts in the sweat of individuals with CF. This lost salt forms the basis for the sweat test.<sup id="cite_ref-Rowe_18-3" class="reference"><a href="#cite_note-Rowe-18"><span>[</span>18<span>]</span></a></sup></p>
<p>Most of the damage in CF is due to blockage of the narrow passages of affected organs with thickened secretions. These blockages lead to remodeling and infection in the lung, damage by accumulated digestive enzymes in the pancreas, blockage of the intestines by thick faeces, etc. There are several theories on how the defects in the protein and cellular function cause the clinical effects. The most current theory suggests that defective ion transport leads to dehydration in the airway epithelia, thickening mucus. In airway epithelial cells, the cilia exist in between the cell's apical surface and mucus in a layer known as Airway Surface Liquid (ASL). The flow of ions from the cell and into this layer is determined by ion channels like CFTR. CFTR not only allows Chloride ions to be drawn from the cell and into the ASL, but it also regulates another channel called ENac. ENac allows sodium ions to leave the ASL and enter the respiratory epithelium. CFTR normally inhibits this channel, but if the CFTR is defective, then sodium will flow freely from the ASL and into the cell. As water follows sodium, the depth of ASL will be depleted and the cilia will be left in the mucous layer.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46"><span>[</span>46<span>]</span></a></sup> As cilia cannot effectively move in a thick viscous environment, there is deficient mucociliary clearance and a build up of mucous, clogging small airways.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47"><span>[</span>47<span>]</span></a></sup> The accumulation of more viscous, nutrient-rich mucus in the lungs allows bacteria to hide from the body's <a href="/wiki/Immune_system" title="Immune system">immune system</a>, causing repeated respiratory infections. The presence of the same CFTR proteins in pancreatic duct and skin cells are what cause symptoms in these systems.</p>
<h3><span class="mw-headline" id="Chronic_infections">Chronic infections</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=8" title="Edit section: Chronic infections">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The lungs of individuals with cystic fibrosis are colonized and infected by bacteria from an early age. These bacteria, which often spread among individuals with CF, thrive in the altered mucus, which collects in the small airways of the lungs. This mucus leads to the formation of bacterial microenvironments known as <a href="/wiki/Biofilm" title="Biofilm">biofilms</a> that are difficult for immune cells and antibiotics to penetrate. Viscous secretions and persistent respiratory infections repeatedly damage the lung by gradually remodeling the airways, which makes infection even more difficult to eradicate.<sup id="cite_ref-Saiman_48-0" class="reference"><a href="#cite_note-Saiman-48"><span>[</span>48<span>]</span></a></sup></p>
<p>Over time, both the types of bacteria and their individual characteristics change in individuals with CF. In the initial stage, common bacteria such as <i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">Staphylococcus aureus</a></i> and <i><a href="/wiki/Haemophilus_influenzae" title="Haemophilus influenzae">Haemophilus influenzae</a></i> colonize and infect the lungs.<sup id="cite_ref-kumar2007_17-18" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> Eventually, <i><a href="/wiki/Pseudomonas_aeruginosa" title="Pseudomonas aeruginosa">Pseudomonas aeruginosa</a></i> (and sometimes <i><a href="/wiki/Burkholderia_cepacia_complex" title="Burkholderia cepacia complex">Burkholderia cepacia</a></i>) dominates. By 18 years of age, 80% of patients with classic CF harbor <i>P. aeruginosa</i>, and 3.5% harbor <i>B. cepacia</i>.<sup id="cite_ref-kumar2007_17-19" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> Once within the lungs, these bacteria adapt to the environment and develop <a href="/wiki/Antibiotic_resistance" title="Antibiotic resistance" class="mw-redirect">resistance</a> to commonly used antibiotics. <i>Pseudomonas</i> can develop special characteristics that allow the formation of large colonies, known as "mucoid" <i>Pseudomonas</i>, which are rarely seen in people that do not have CF.<sup id="cite_ref-Saiman_48-1" class="reference"><a href="#cite_note-Saiman-48"><span>[</span>48<span>]</span></a></sup></p>
<p>One way infection spreads is by passing between different individuals with CF.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49"><span>[</span>49<span>]</span></a></sup> In the past, people with CF often participated in summer "CF Camps" and other recreational gatherings.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50"><span>[</span>50<span>]</span></a></sup><sup id="cite_ref-51" class="reference"><a href="#cite_note-51"><span>[</span>51<span>]</span></a></sup> Hospitals grouped patients with CF into common areas and routine equipment (such as <a href="/wiki/Nebulizer" title="Nebulizer">nebulizers</a>)<sup id="cite_ref-52" class="reference"><a href="#cite_note-52"><span>[</span>52<span>]</span></a></sup> was not sterilized between individual patients.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53"><span>[</span>53<span>]</span></a></sup> This led to transmission of more dangerous strains of bacteria among groups of patients. As a result, individuals with CF are now routinely isolated from one another in the healthcare setting, and healthcare providers are encouraged to wear gowns and gloves when examining patients with CF to limit the spread of virulent bacterial strains.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54"><span>[</span>54<span>]</span></a></sup></p>
<p>CF patients may also have their airways chronically colonized by filamentous fungi (such as <i>Aspergillus fumigatus</i>, <i><a href="/wiki/Scedosporium_apiospermum" title="Scedosporium apiospermum" class="mw-redirect">Scedosporium apiospermum</a></i>, <i><a href="/wiki/Aspergillus_terreus" title="Aspergillus terreus">Aspergillus terreus</a></i>) and/or yeasts (such as <i><a href="/wiki/Candida_albicans" title="Candida albicans">Candida albicans</a></i>); other filamentous fungi less commonly isolated include <i><a href="/wiki/Aspergillus_flavus" title="Aspergillus flavus">Aspergillus flavus</a></i> and <i><a href="/wiki/Aspergillus_nidulans" title="Aspergillus nidulans">Aspergillus nidulans</a></i> (occur transiently in CF respiratory secretions) and <i><a href="/wiki/Exophiala_dermatitidis" title="Exophiala dermatitidis">Exophiala dermatitidis</a></i> and <i><a href="/wiki/Scedosporium_prolificans" title="Scedosporium prolificans">Scedosporium prolificans</a></i> (chronic airway-colonizers); some filamentous fungi like <i>Penicillium emersonii</i> and <i><a href="/wiki/Acrophialophora_fusispora" title="Acrophialophora fusispora">Acrophialophora fusispora</a></i> are encountered in patients almost exclusively in the context of CF.<sup id="cite_ref-Pihet_55-0" class="reference"><a href="#cite_note-Pihet-55"><span>[</span>55<span>]</span></a></sup> Defective mucociliary clearance characterizing CF is associated with local immunological disorders. In addition, the prolonged therapy with antibiotics and the use of corticosteroid treatments may also facilitate fungal growth. Although the clinical relevance of the fungal airway colonization is still a matter of debate, filamentous fungi may contribute to the local inflammatory response and therefore to the progressive deterioration of the lung function, as often happens with allergic broncho-pulmonary aspergillosis (ABPA) – the most common fungal disease in the context of CF, involving a Th2-driven immune response to Aspergillus.<sup id="cite_ref-Pihet_55-1" class="reference"><a href="#cite_note-Pihet-55"><span>[</span>55<span>]</span></a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56"><span>[</span>56<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis_and_monitoring">Diagnosis and monitoring</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=9" title="Edit section: Diagnosis and monitoring">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:82px;"><a href="/wiki/File:CFTR_gene_on_chromosome_7.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/CFTR_gene_on_chromosome_7.svg/80px-CFTR_gene_on_chromosome_7.svg.png" width="80" height="519" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/18/CFTR_gene_on_chromosome_7.svg/120px-CFTR_gene_on_chromosome_7.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/18/CFTR_gene_on_chromosome_7.svg/160px-CFTR_gene_on_chromosome_7.svg.png 2x" data-file-width="75" data-file-height="487" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:CFTR_gene_on_chromosome_7.svg" class="internal" title="Enlarge"></a></div>
The location of the CFTR gene on chromosome 7</div>
</div>
</div>
<p>Cystic fibrosis may be diagnosed by many different methods including <a href="/wiki/Newborn_screening" title="Newborn screening">newborn screening</a>, <a href="/wiki/Sweat_test" title="Sweat test">sweat testing</a>, and <a href="/wiki/Genetic_testing" title="Genetic testing">genetic testing</a>.<sup id="cite_ref-pmid16648884_57-0" class="reference"><a href="#cite_note-pmid16648884-57"><span>[</span>57<span>]</span></a></sup> As of 2006 in the United States, 10 percent of cases are diagnosed shortly after birth as part of newborn screening programs. The newborn screen initially measures for raised blood concentration of <a href="/wiki/Immunoreactive_trypsinogen" title="Immunoreactive trypsinogen">immunoreactive trypsinogen</a>.<sup id="cite_ref-Davies_58-0" class="reference"><a href="#cite_note-Davies-58"><span>[</span>58<span>]</span></a></sup> Infants with an abnormal newborn screen need a sweat test to confirm the CF diagnosis. In many cases, a parent makes the diagnosis because the infant tastes salty.<sup id="cite_ref-kumar2007_17-20" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup> <a href="/wiki/Trypsinogen" title="Trypsinogen">Trypsinogen</a> levels can be increased in individuals who have a single mutated copy of the <i>CFTR</i> gene (carriers) or, in rare instances, in individuals with two normal copies of the <i>CFTR</i> gene. Due to these <a href="/wiki/False_positive" title="False positive" class="mw-redirect">false positives</a>, CF screening in newborns can be controversial.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59"><span>[</span>59<span>]</span></a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60"><span>[</span>60<span>]</span></a></sup> Most states and countries do not screen for CF routinely at birth. Therefore, most individuals are diagnosed after symptoms (e.g. sinopulmonary disease and GI manifestations<sup id="cite_ref-kumar2007_17-21" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup>) prompt an evaluation for cystic fibrosis. The most commonly used form of testing is the sweat test. Sweat-testing involves application of a medication that stimulates sweating (<a href="/wiki/Pilocarpine" title="Pilocarpine">pilocarpine</a>). To deliver the medication through the skin, <a href="/wiki/Iontophoresis" title="Iontophoresis">iontophoresis</a> is used to, whereby one <a href="/wiki/Electrode" title="Electrode">electrode</a> is placed onto the applied medication and an <a href="/wiki/Electric_current" title="Electric current">electric current</a> is passed to a separate electrode on the skin. The resultant sweat is then collected on filter paper or in a capillary tube and analyzed for abnormal amounts of <a href="/wiki/Sodium" title="Sodium">sodium</a> and <a href="/wiki/Chloride" title="Chloride">chloride</a>. People with CF have increased amounts of sodium and chloride in their sweat. In contrast, people with CF have less thiocyanate and <a href="/wiki/Hypothiocyanite" title="Hypothiocyanite">hypothiocyanite</a> in their saliva<sup id="cite_ref-61" class="reference"><a href="#cite_note-61"><span>[</span>61<span>]</span></a></sup> and mucus (Banfi et al.). CF can also be diagnosed by identification of mutations in the CFTR gene.<sup id="cite_ref-62" class="reference"><a href="#cite_note-62"><span>[</span>62<span>]</span></a></sup></p>
<p>People with CF may be listed in a <a href="/wiki/Disease_registry" title="Disease registry">disease registry</a> that allows researchers and doctors to track health results and identify candidates for <a href="/wiki/Clinical_trial" title="Clinical trial">clinical trials</a>.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63"><span>[</span>63<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Prenatal">Prenatal</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=10" title="Edit section: Prenatal">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Couples who are pregnant or planning a pregnancy can have themselves tested for the CFTR gene mutations to determine the risk that their child will be born with cystic fibrosis. Testing is typically performed first on one or both parents and, if the risk of CF is high, testing on the <a href="/wiki/Fetus" title="Fetus">fetus</a> is performed. The <a href="/wiki/American_College_of_Obstetricians_and_Gynecologists" title="American College of Obstetricians and Gynecologists" class="mw-redirect">American College of Obstetricians and Gynecologists</a> (ACOG) recommends testing for couples who have a personal or close family history of CF, and they recommend that carrier testing be offered to all Caucasian couples and be made available to couples of other ethnic backgrounds.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64"><span>[</span>64<span>]</span></a></sup></p>
<p>Because development of CF in the fetus requires each parent to pass on a mutated copy of the CFTR gene and because CF testing is expensive, testing is often performed initially on one parent. If testing shows that parent is a CFTR gene mutation carrier, the other parent is tested to calculate the risk that their children will have CF. CF can result from more than a thousand different mutations, and as of 2006 it is not possible to test for each one. Testing analyzes the blood for the most common mutations such as ΔF508—most commercially available tests look for 32 or fewer different mutations. If a family has a known uncommon mutation, specific screening for that mutation can be performed. Because not all known mutations are found on current tests, a negative screen does not guarantee that a child will not have CF.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65"><span>[</span>65<span>]</span></a></sup></p>
<p>During pregnancy, testing can be performed on the <a href="/wiki/Placenta" title="Placenta">placenta</a> (<a href="/wiki/Chorionic_villus_sampling" title="Chorionic villus sampling">chorionic villus sampling</a>) or the fluid around the fetus (<a href="/wiki/Amniocentesis" title="Amniocentesis">amniocentesis</a>). However, <a href="/wiki/Chorionic_villus_sampling" title="Chorionic villus sampling">chorionic villus sampling</a> has a risk of fetal death of 1 in 100 and amniocentesis of 1 in 200;<sup id="cite_ref-66" class="reference"><a href="#cite_note-66"><span>[</span>66<span>]</span></a></sup> a recent study has indicated this may be much lower, approximately 1 in 1,600.<sup id="cite_ref-67" class="reference"><a href="#cite_note-67"><span>[</span>67<span>]</span></a></sup></p>
<p>Economically, for carrier couples of cystic fibrosis, when comparing preimplantation genetic diagnosis (PGD) with natural conception (NC) followed by prenatal testing and abortion of affected pregnancies, PGD provides net economic benefits up to a maternal age of approximately 40 years, after which NC, prenatal testing and abortion has higher economic benefit.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68"><span>[</span>68<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=11" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>While there are no cures for cystic fibrosis, there are several treatment methods. The management of cystic fibrosis has improved significantly over the past 70 years. While infants born with cystic fibrosis 70 years ago would have been unlikely to live beyond their first year, infants today are likely to live well into adulthood. Recent advances in the treatment of cystic fibrosis have meant that an individual with cystic fibrosis can live a fuller life less encumbered by their condition. The cornerstones of management are proactive treatment of <a href="/wiki/Respiratory_tract_infection" title="Respiratory tract infection">airway infection</a>, and encouragement of good nutrition and an active lifestyle. <a href="/wiki/Pulmonary_rehabilitation" title="Pulmonary rehabilitation">Pulmonary rehabilitation</a> as a management of cystic fibrosis continues throughout a person's life, and is aimed at maximizing organ function, and therefore quality of life. At best, current treatments delay the decline in organ function. Because of the wide variation in disease symptoms, treatment typically occurs at specialist multidisciplinary centers, and is tailored to the individual. Targets for therapy are the <a href="/wiki/Lungs" title="Lungs" class="mw-redirect">lungs</a>, <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract" class="mw-redirect">gastrointestinal tract</a> (including pancreatic enzyme supplements), the <a href="/wiki/Reproductive_organs" title="Reproductive organs" class="mw-redirect">reproductive organs</a> (including <a href="/wiki/Assisted_reproductive_technology" title="Assisted reproductive technology">assisted reproductive technology</a> (ART)) and psychological support.<sup id="cite_ref-Davies_58-1" class="reference"><a href="#cite_note-Davies-58"><span>[</span>58<span>]</span></a></sup></p>
<p>The most consistent aspect of therapy in cystic fibrosis is limiting and treating the lung damage caused by thick mucus and infection, with the goal of maintaining <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a>. <a href="/wiki/Intravenous_therapy" title="Intravenous therapy">Intravenous</a>, <a href="/wiki/Inhalation" title="Inhalation">inhaled</a>, and oral antibiotics are used to treat chronic and acute infections. Mechanical devices and inhalation medications are used to alter and clear the thickened mucus. These therapies, while effective, can be extremely time-consuming.</p>
<h3><span class="mw-headline" id="Antibiotics">Antibiotics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=12" title="Edit section: Antibiotics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Many people with CF are on one or more <a href="/wiki/Antibiotics" title="Antibiotics">antibiotics</a> at all times, even when healthy, to <a href="/wiki/Prophylactic" title="Prophylactic" class="mw-redirect">prophylactically</a> suppress infection. Antibiotics are absolutely necessary whenever pneumonia is suspected or there has been a noticeable decline in lung function, and are usually chosen based on the results of a sputum analysis and the person's past response. This prolonged therapy often necessitates hospitalization and insertion of a more permanent <a href="/wiki/Heparin_lock" title="Heparin lock" class="mw-redirect">IV</a> such as a <a href="/wiki/Peripherally_inserted_central_catheter" title="Peripherally inserted central catheter">peripherally inserted central catheter</a> (PICC line) or <a href="/wiki/Port-a-Cath" title="Port-a-Cath" class="mw-redirect">Port-a-Cath</a>. Inhaled therapy with antibiotics such as <a href="/wiki/Tobramycin" title="Tobramycin">tobramycin</a>, <a href="/wiki/Colistin" title="Colistin">colistin</a>, and <a href="/wiki/Aztreonam" title="Aztreonam">aztreonam</a> is often given for months at a time to improve lung function by impeding the growth of colonized bacteria.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69"><span>[</span>69<span>]</span></a></sup><sup id="cite_ref-70" class="reference"><a href="#cite_note-70"><span>[</span>70<span>]</span></a></sup><sup id="cite_ref-71" class="reference"><a href="#cite_note-71"><span>[</span>71<span>]</span></a></sup> Inhaled antibiotic therapy helps lung function by fighting infection, but also has significant drawbacks like development of antibiotic resistance, tinnitus and changes in the voice.<sup id="cite_ref-pmid21412868_72-0" class="reference"><a href="#cite_note-pmid21412868-72"><span>[</span>72<span>]</span></a></sup> Oral antibiotics such as ciprofloxacin or <a href="/wiki/Azithromycin" title="Azithromycin">azithromycin</a> are given to help prevent infection or to control ongoing infection.<sup id="cite_ref-73" class="reference"><a href="#cite_note-73"><span>[</span>73<span>]</span></a></sup> The <a href="/wiki/Aminoglycoside" title="Aminoglycoside">aminoglycoside</a> antibiotics (e.g. tobramycin) used can cause <a href="/wiki/Ototoxicity" title="Ototoxicity">hearing loss</a>, damage to the <a href="/wiki/Vestibular_system" title="Vestibular system">balance system</a> in the <a href="/wiki/Inner_ear" title="Inner ear">inner ear</a> or <a href="/wiki/Renal_failure" title="Renal failure">kidney problems</a> with long-term use.<sup id="cite_ref-74" class="reference"><a href="#cite_note-74"><span>[</span>74<span>]</span></a></sup> To prevent these <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">side-effects</a>, the amount of antibiotics in the blood is routinely measured and adjusted accordingly.</p>
<h3><span class="mw-headline" id="Other_treatments_for_lung_disease">Other treatments for lung disease</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=13" title="Edit section: Other treatments for lung disease">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Several mechanical techniques are used to dislodge sputum and encourage its expectoration. In the hospital setting, <a href="/wiki/Pulmonary_hygiene#Conventional_Chest_physiotherapy" title="Pulmonary hygiene">chest physiotherapy (CPT)</a> is utilized; a respiratory therapist percusses an individual's chest with his or her hands several times a day, to loosen up secretions. Devices that recreate this percussive therapy include the <a href="/wiki/ThAIRapy_Vest" title="ThAIRapy Vest" class="mw-redirect">ThAIRapy Vest</a> and the <a href="/wiki/Intrapulmonary_percussive_ventilator" title="Intrapulmonary percussive ventilator">intrapulmonary percussive ventilator</a> (IPV). Newer methods such as <a href="/wiki/Biphasic_Cuirass_Ventilation" title="Biphasic Cuirass Ventilation" class="mw-redirect">Biphasic Cuirass Ventilation</a>, and associated clearance mode available in such devices, integrate a cough assistance phase, as well as a vibration phase for dislodging secretions. These are portable and adapted for home use.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75"><span>[</span>75<span>]</span></a></sup></p>
<p><a href="/wiki/Ivacaftor" title="Ivacaftor">Ivacaftor</a> is an oral medication for the treatment of cystic fibrosis due to a number of specific mutations.<sup id="cite_ref-Whit2014_76-0" class="reference"><a href="#cite_note-Whit2014-76"><span>[</span>76<span>]</span></a></sup><sup id="cite_ref-77" class="reference"><a href="#cite_note-77"><span>[</span>77<span>]</span></a></sup> It improves lung function by about 10%; however, as of 2014 is expensive.<sup id="cite_ref-Whit2014_76-1" class="reference"><a href="#cite_note-Whit2014-76"><span>[</span>76<span>]</span></a></sup></p>
<p>Aerosolized medications that help loosen secretions include <a href="/wiki/Dornase_alfa" title="Dornase alfa">dornase alfa</a> and <a href="/wiki/Hypertonicity" title="Hypertonicity" class="mw-redirect">hypertonic</a> <a href="/wiki/Saline_(medicine)" title="Saline (medicine)">saline</a>.<sup id="cite_ref-78" class="reference"><a href="#cite_note-78"><span>[</span>78<span>]</span></a></sup> Dornase is a <a href="/wiki/Recombinant_DNA" title="Recombinant DNA">recombinant</a> human <a href="/wiki/Deoxyribonuclease" title="Deoxyribonuclease">deoxyribonuclease</a>, which breaks down DNA in the <a href="/wiki/Sputum" title="Sputum">sputum</a>, thus decreasing its <a href="/wiki/Viscosity" title="Viscosity">viscosity</a>.<sup id="cite_ref-79" class="reference"><a href="#cite_note-79"><span>[</span>79<span>]</span></a></sup> <a href="/wiki/Denufosol" title="Denufosol">Denufosol</a> is an investigational drug that opens an alternative chloride channel, helping to liquefy mucus.<sup id="cite_ref-pmid18276176_80-0" class="reference"><a href="#cite_note-pmid18276176-80"><span>[</span>80<span>]</span></a></sup> It is unclear if <a href="/wiki/Inhaled_corticosteroids" title="Inhaled corticosteroids" class="mw-redirect">inhaled corticosteroids</a> are useful.<sup id="cite_ref-81" class="reference"><a href="#cite_note-81"><span>[</span>81<span>]</span></a></sup></p>
<p>As lung disease worsens, mechanical breathing support may become necessary. Individuals with CF may need to wear special masks at night that help push air into their lungs. These machines, known as <a href="/wiki/Bilevel_positive_airway_pressure" title="Bilevel positive airway pressure">bilevel positive airway pressure</a> (BiPAP) ventilators, help prevent low blood oxygen levels during sleep. BiPAP may also be used during physical therapy to improve sputum clearance.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82"><span>[</span>82<span>]</span></a></sup> During severe illness, a <a href="/wiki/Intubation" title="Intubation">tube</a> may be placed in the throat (a procedure known as a <a href="/wiki/Tracheostomy" title="Tracheostomy" class="mw-redirect">tracheostomy</a>) to enable breathing supported by a <a href="/wiki/Ventilator" title="Ventilator" class="mw-redirect">ventilator</a>.</p>
<p>For children, preliminary studies show massage therapy may help people and their families quality of life.<sup id="cite_ref-pmid16229132_83-0" class="reference"><a href="#cite_note-pmid16229132-83"><span>[</span>83<span>]</span></a></sup> It is unclear what effect <a href="/wiki/Pneumococcal_vaccination" title="Pneumococcal vaccination" class="mw-redirect">pneumococcal vaccination</a> has as it has not been studied as of 2014.<sup id="cite_ref-84" class="reference"><a href="#cite_note-84"><span>[</span>84<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Transplantation">Transplantation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=14" title="Edit section: Transplantation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Lung_transplantation" title="Lung transplantation">Lung transplantation</a> often becomes necessary for individuals with cystic fibrosis as lung function and <a href="/wiki/Exercise_intolerance" title="Exercise intolerance">exercise tolerance</a> decline. Although single lung transplantation is possible in other diseases, individuals with CF must have both lungs replaced because the remaining lung might contain bacteria that could infect the transplanted lung. A pancreatic or liver transplant may be performed at the same time in order to alleviate liver disease and/or diabetes.<sup id="cite_ref-85" class="reference"><a href="#cite_note-85"><span>[</span>85<span>]</span></a></sup> Lung transplantation is considered when lung function declines to the point where assistance from mechanical devices is required or someone's survival is threatened.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86"><span>[</span>86<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other_aspects">Other aspects</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=15" title="Edit section: Other aspects">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Icsi.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Icsi.JPG/220px-Icsi.JPG" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/79/Icsi.JPG/330px-Icsi.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/79/Icsi.JPG/440px-Icsi.JPG 2x" data-file-width="800" data-file-height="600" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Icsi.JPG" class="internal" title="Enlarge"></a></div>
Intracytoplasmic sperm injection can be used to provide fertility for men with cystic fibrosis</div>
</div>
</div>
<p>Newborns with intestinal obstruction typically require surgery, whereas adults with <a href="/wiki/Anatomical_terms_of_location#Proximal_and_distal" title="Anatomical terms of location">distal</a> intestinal obstruction syndrome typically do not. Treatment of pancreatic insufficiency by replacement of missing digestive enzymes allows the duodenum to properly absorb nutrients and vitamins that would otherwise be lost in the feces. However, the best dosage and form of pancreatic enzyme replacement is unclear, as are the risks and long-term effectiveness of this treatment.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87"><span>[</span>87<span>]</span></a></sup></p>
<p>So far, no large-scale research involving the incidence of <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a> and <a href="/wiki/Coronary_heart_disease" title="Coronary heart disease" class="mw-redirect">coronary heart disease</a> in adults with cystic fibrosis has been conducted. This is likely due to the fact that the vast majority of people with cystic fibrosis do not live long enough to develop clinically significant atherosclerosis or coronary heart disease.</p>
<p><a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">Diabetes</a> is the most common non-pulmonary complication of CF. It mixes features of <a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">type 1</a> and <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2</a> diabetes, and is recognized as a distinct entity, <a href="/wiki/Cystic_fibrosis-related_diabetes" title="Cystic fibrosis-related diabetes">cystic fibrosis-related diabetes</a> (CFRD).<sup id="cite_ref-Alves_31-1" class="reference"><a href="#cite_note-Alves-31"><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-Zirbes_88-0" class="reference"><a href="#cite_note-Zirbes-88"><span>[</span>88<span>]</span></a></sup> While oral <a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug" class="mw-redirect">anti-diabetic drugs</a> are sometimes used, the only recommended treatment is the use of <a href="/wiki/Insulin" title="Insulin">insulin</a> injections or an <a href="/wiki/Insulin_pump" title="Insulin pump">insulin pump</a>,<sup id="cite_ref-89" class="reference"><a href="#cite_note-89"><span>[</span>89<span>]</span></a></sup> and, unlike in type 1 and 2 diabetes, dietary restrictions are not recommended.<sup id="cite_ref-Alves_31-2" class="reference"><a href="#cite_note-Alves-31"><span>[</span>31<span>]</span></a></sup></p>
<p>Development of <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> can be prevented by increased intake of vitamin D and <a href="/wiki/Calcium" title="Calcium">calcium</a>, and can be treated by <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonates</a>, although <a href="/wiki/Adverse_drug_reaction" title="Adverse drug reaction">adverse effects</a> can be an issue.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90"><span>[</span>90<span>]</span></a></sup> Poor growth may be avoided by insertion of a <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a> for increasing <a href="/wiki/Calorie" title="Calorie">calories</a> through supplemental feeds or by administration of injected <a href="/wiki/Growth_hormone" title="Growth hormone">growth hormone</a>.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91"><span>[</span>91<span>]</span></a></sup></p>
<p>Sinus infections are treated by prolonged courses of antibiotics. The development of nasal polyps or other chronic changes within the nasal passages may severely limit airflow through the nose, and over time reduce the person's sense of smell. Sinus surgery is often used to alleviate nasal obstruction and to limit further infections. Nasal steroids such as <a href="/wiki/Fluticasone" title="Fluticasone">fluticasone</a> are used to decrease nasal inflammation.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92"><span>[</span>92<span>]</span></a></sup></p>
<p>Female infertility may be overcome by <a href="/wiki/In_vitro_fertilisation" title="In vitro fertilisation">assisted reproduction</a> technology, particularly <a href="/wiki/Embryo_transfer" title="Embryo transfer">embryo transfer</a> techniques. Male infertility caused by absence of the <a href="/wiki/Vas_deferens" title="Vas deferens">vas deferens</a> may be overcome with <a href="/wiki/Testicular_sperm_extraction" title="Testicular sperm extraction">testicular sperm extraction</a> (TESE), collecting sperm cells directly from the testicles. If the collected sample contains too few sperm cells to likely have a spontaneous <a href="/wiki/Fertilization" title="Fertilization" class="mw-redirect">fertilization</a>, <a href="/wiki/Intracytoplasmic_sperm_injection" title="Intracytoplasmic sperm injection">intracytoplasmic sperm injection</a> can be performed.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93"><span>[</span>93<span>]</span></a></sup> <a href="/wiki/Embryo_transfer#Third_party_reproduction" title="Embryo transfer">Third party reproduction</a> is also a possibility for women with CF. It is unclear if taking <a href="/wiki/Antioxidant" title="Antioxidant">antioxidants</a> affects outcomes.<sup id="cite_ref-94" class="reference"><a href="#cite_note-94"><span>[</span>94<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=16" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The prognosis for cystic fibrosis has improved due to earlier diagnosis through screening, better treatment and access to health care. In 1959, the median age of survival of children with cystic fibrosis in the United States was six months.<sup id="cite_ref-median_95-0" class="reference"><a href="#cite_note-median-95"><span>[</span>95<span>]</span></a></sup> In 2010, survival is estimated to be 37 years for women and 40 for men.<sup id="cite_ref-Mac2014_96-0" class="reference"><a href="#cite_note-Mac2014-96"><span>[</span>96<span>]</span></a></sup> In Canada, median survival increased from 24 years in 1982 to 47.7 in 2007.<sup id="cite_ref-97" class="reference"><a href="#cite_note-97"><span>[</span>97<span>]</span></a></sup></p>
<p>Of those with cystic fibrosis who are more than 18 years old as of 2009, 92% had graduated from <a href="/wiki/High_school" title="High school">high school</a>, 67% had at least some college education, 15% were disabled and 9% were unemployed, 56% were single and 39% were married or living with a partner.<sup id="cite_ref-98" class="reference"><a href="#cite_note-98"><span>[</span>98<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Quality_of_life">Quality of life</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=17" title="Edit section: Quality of life">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Chronic illnesses can be very difficult to manage. Cystic fibrosis (CF) is a chronic illness that affects the "digestive and respiratory tracts resulting in generalized malnutrition and chronic respiratory infections".<sup id="cite_ref-99" class="reference"><a href="#cite_note-99"><span>[</span>99<span>]</span></a></sup> The thick secretions clog the airways in the lungs, which often cause inflammation and severe lung infections.<sup id="cite_ref-Ratjen03_100-0" class="reference"><a href="#cite_note-Ratjen03-100"><span>[</span>100<span>]</span></a></sup><sup id="cite_ref-101" class="reference"><a href="#cite_note-101"><span>[</span>101<span>]</span></a></sup> If it is compromised, it affects the quality of life of someone with CF and their ability to complete such tasks as everyday chores. It is important for CF patients to understand the detrimental relationship that chronic illnesses place on the quality of life. According to Schmitz and Goldbeck (2006), the fact that cystic fibrosis significantly increases emotional stress on both the individual and the family, "and the necessary time-consuming daily treatment routine may have further negative effects on quality of life (QOL)".<sup id="cite_ref-102" class="reference"><a href="#cite_note-102"><span>[</span>102<span>]</span></a></sup> However, Havermans and colleagues (2006) have shown that young outpatients with CF who have participated in the CFQ-R (Cystic Fibrosis Questionnaire-Revised) "rated some QOL domains higher than did their parents".<sup id="cite_ref-103" class="reference"><a href="#cite_note-103"><span>[</span>103<span>]</span></a></sup> Consequently, outpatients with CF have a more positive outlook for themselves. Furthermore, there are many ways to improve the QOL in CF patients. Exercise is promoted to increase lung function. Integrating an exercise regimen into the CF patient’s daily routine can significantly improve the quality of life.<sup id="cite_ref-104" class="reference"><a href="#cite_note-104"><span>[</span>104<span>]</span></a></sup> There is no definitive cure for cystic fibrosis. However, there are diverse medications used, such as mucolytics, bronchodilators, steroids, and antibiotics, that have the purpose of loosening mucus, expanding airways, decreasing inflammation, and fighting lung infections.<sup id="cite_ref-105" class="reference"><a href="#cite_note-105"><span>[</span>105<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=18" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="wikitable floatright">
<tr>
<th>Mutation</th>
<th>Frequency<br />
worldwide<sup id="cite_ref-table_106-0" class="reference"><a href="#cite_note-table-106"><span>[</span>106<span>]</span></a></sup></th>
</tr>
<tr>
<td>ΔF508</td>
<td>66%–70%<sup id="cite_ref-kumar2007_17-22" class="reference"><a href="#cite_note-kumar2007-17"><span>[</span>17<span>]</span></a></sup></td>
</tr>
<tr>
<td>G542X</td>
<td>2.4%</td>
</tr>
<tr>
<td>G551D</td>
<td>1.6%</td>
</tr>
<tr>
<td>N1303K</td>
<td>1.3%</td>
</tr>
<tr>
<td>W1282X</td>
<td>1.2%</td>
</tr>
<tr>
<td>All others</td>
<td>27.5%</td>
</tr>
</table>
<p>Cystic fibrosis is the most common life-limiting autosomal recessive disease among people of <a href="/wiki/Ethnic_groups_in_Europe" title="Ethnic groups in Europe">European</a> heritage.<sup id="cite_ref-107" class="reference"><a href="#cite_note-107"><span>[</span>107<span>]</span></a></sup> In the United States, approximately 30,000 individuals have CF; most are diagnosed by six months of age. In <a href="/wiki/Canada" title="Canada">Canada</a>, there are approximately 4,000 people with CF.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108"><span>[</span>108<span>]</span></a></sup> Approximately 1 in 25 people of European descent, and one in 30 of Caucasian Americans,<sup id="cite_ref-109" class="reference"><a href="#cite_note-109"><span>[</span>109<span>]</span></a></sup> is a carrier of a cystic fibrosis mutation. Although CF is less common in these groups, approximately 1 in 46 <a href="/wiki/Hispanic" title="Hispanic">Hispanics</a>, 1 in 65 <a href="/wiki/Africa#Demographics" title="Africa">Africans</a> and 1 in 90 <a href="/wiki/Asian_people" title="Asian people">Asians</a> carry at least one abnormal CFTR gene.<sup id="cite_ref-110" class="reference"><a href="#cite_note-110"><span>[</span>110<span>]</span></a></sup><sup id="cite_ref-111" class="reference"><a href="#cite_note-111"><span>[</span>111<span>]</span></a></sup> Ireland has the world's highest prevalence of cystic fibrosis, at 1:1353.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112"><span>[</span>112<span>]</span></a></sup></p>
<p>Although technically a <a href="/wiki/Rare_disease" title="Rare disease">rare disease</a>, cystic fibrosis is ranked as one of the most widespread life-shortening genetic diseases. It is most common among nations in the Western world. An exception is <a href="/wiki/Finland" title="Finland">Finland</a>, where only one in 80 people carry a CF mutation.<sup id="cite_ref-pmid11813900_113-0" class="reference"><a href="#cite_note-pmid11813900-113"><span>[</span>113<span>]</span></a></sup> The <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> states that "In the European Union, 1 in 2000–3000 newborns is found to be affected by CF".<sup id="cite_ref-WHO_.7C_Genes_and_human_disease_114-0" class="reference"><a href="#cite_note-WHO_.7C_Genes_and_human_disease-114"><span>[</span>114<span>]</span></a></sup> In the United States, 1 in 3,500 children are born with CF.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115"><span>[</span>115<span>]</span></a></sup> In 1997, about 1 in 3,300 caucasian children in the United States was born with cystic fibrosis. In contrast, only 1 in 15,000 African American children suffered from cystic fibrosis, and in Asian Americans the rate was even lower at 1 in 32,000.<sup id="cite_ref-116" class="reference"><a href="#cite_note-116"><span>[</span>116<span>]</span></a></sup></p>
<p>Cystic fibrosis is diagnosed in males and females equally. For reasons that remain unclear, data has shown that males tend to have a longer <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> than females,<sup id="cite_ref-117" class="reference"><a href="#cite_note-117"><span>[</span>117<span>]</span></a></sup><sup id="cite_ref-118" class="reference"><a href="#cite_note-118"><span>[</span>118<span>]</span></a></sup> however recent studies suggest this gender gap may no longer exist perhaps due to improvements in health care facilities,<sup id="cite_ref-119" class="reference"><a href="#cite_note-119"><span>[</span>119<span>]</span></a></sup><sup id="cite_ref-120" class="reference"><a href="#cite_note-120"><span>[</span>120<span>]</span></a></sup> while a recent study from Ireland identified a link between the female hormone estrogen and worse outcomes in CF.<sup id="cite_ref-121" class="reference"><a href="#cite_note-121"><span>[</span>121<span>]</span></a></sup></p>
<p>The distribution of CF alleles varies among populations. The frequency of ΔF508 carriers has been estimated at 1:200 in northern Sweden, 1:143 in Lithuanians, and 1:38 in Denmark. No ΔF508 carriers were found among 171 <a href="/wiki/Finns" title="Finns">Finns</a> and 151 <a href="/wiki/Saami_people" title="Saami people" class="mw-redirect">Saami people</a>.<sup id="cite_ref-pmid8039801_122-0" class="reference"><a href="#cite_note-pmid8039801-122"><span>[</span>122<span>]</span></a></sup> ΔF508 does occur in Finland, but it is a minority allele there. Cystic fibrosis is known to occur in only 20 families (pedigrees) in Finland.<sup id="cite_ref-pmid2210753_123-0" class="reference"><a href="#cite_note-pmid2210753-123"><span>[</span>123<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Evolution">Evolution</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=19" title="Edit section: Evolution">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The <a href="/wiki/%CE%94F508" title="ΔF508">ΔF508</a> mutation is estimated to be up to 52,000 years old.<sup id="cite_ref-124" class="reference"><a href="#cite_note-124"><span>[</span>124<span>]</span></a></sup> Numerous hypotheses have been advanced as to why such a lethal mutation has persisted and spread in the human population. Other common autosomal recessive diseases such as <a href="/wiki/Sickle-cell_anemia" title="Sickle-cell anemia" class="mw-redirect">sickle-cell anemia</a> have been found to protect carriers from other diseases, a concept known as <a href="/wiki/Heterozygote_advantage" title="Heterozygote advantage">heterozygote advantage</a>. Resistance to the following have all been proposed as possible sources of heterozygote advantage:</p>
<ul>
<li>Cholera: With the discovery that <a href="/wiki/Cholera_toxin" title="Cholera toxin">cholera toxin</a> requires normal host CFTR proteins to function properly, it was hypothesized that carriers of mutant CFTR genes benefited from resistance to cholera and other causes of diarrhea.<sup id="cite_ref-125" class="reference"><a href="#cite_note-125"><span>[</span>125<span>]</span></a></sup> Further studies have not confirmed this hypothesis.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126"><span>[</span>126<span>]</span></a></sup><sup id="cite_ref-127" class="reference"><a href="#cite_note-127"><span>[</span>127<span>]</span></a></sup></li>
<li>Typhoid: Normal CFTR proteins are also essential for the entry of <a href="/wiki/Salmonella_Typhi" title="Salmonella Typhi" class="mw-redirect"><i>Salmonella</i> Typhi</a> into cells,<sup id="cite_ref-128" class="reference"><a href="#cite_note-128"><span>[</span>128<span>]</span></a></sup> suggesting that carriers of mutant CFTR genes might be resistant to <a href="/wiki/Typhoid_fever" title="Typhoid fever">typhoid fever</a>. No <i>in vivo</i> study has yet confirmed this. In both cases, the low level of cystic fibrosis outside of Europe, in places where both cholera and typhoid fever are <a href="/wiki/Endemic_(epidemiology)" title="Endemic (epidemiology)">endemic</a>, is not immediately explicable.</li>
<li><a href="/wiki/Diarrhea" title="Diarrhea">Diarrhea</a>: It has also been hypothesized that the prevalence of CF in Europe might be connected with the development of cattle domestication. In this hypothesis, carriers of a single mutant CFTR chromosome had some protection from diarrhea caused by <a href="/wiki/Lactose_intolerance" title="Lactose intolerance">lactose intolerance</a>, prior to the appearance of the mutations that created lactose tolerance.<sup id="cite_ref-129" class="reference"><a href="#cite_note-129"><span>[</span>129<span>]</span></a></sup></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis</a>: Another possible explanation is that carriers of the gene could have some resistance to TB.<sup id="cite_ref-130" class="reference"><a href="#cite_note-130"><span>[</span>130<span>]</span></a></sup><sup id="cite_ref-131" class="reference"><a href="#cite_note-131"><span>[</span>131<span>]</span></a></sup></li>
</ul>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=20" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tleft">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Dorothy_Hansine_Andersen.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/72/Dorothy_Hansine_Andersen.jpg/220px-Dorothy_Hansine_Andersen.jpg" width="220" height="300" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/7/72/Dorothy_Hansine_Andersen.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/7/72/Dorothy_Hansine_Andersen.jpg 2x" data-file-width="307" data-file-height="418" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Dorothy_Hansine_Andersen.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Dorothy_Hansine_Andersen" title="Dorothy Hansine Andersen">Dorothy Hansine Andersen</a> who first described cystic fibrosis in 1938 (Photo at <a href="/wiki/National_Library_of_Medicine" title="National Library of Medicine" class="mw-redirect">National Library of Medicine</a>).</div>
</div>
</div>
<div class="hatnote">See also: <a href="/wiki/List_of_people_diagnosed_with_cystic_fibrosis" title="List of people diagnosed with cystic fibrosis">List of people diagnosed with cystic fibrosis</a></div>
<p>It is supposed that CF appeared about 3,000 BC because of migration of peoples, gene mutations, and new conditions in nourishment.<sup id="cite_ref-Bosch_132-0" class="reference"><a href="#cite_note-Bosch-132"><span>[</span>132<span>]</span></a></sup> Although the entire clinical spectrum of CF was not recognized until the 1930s, certain aspects of CF were identified much earlier. Indeed, literature from Germany and Switzerland in the 18th century warned <i>Wehe dem Kind, das beim Kuß auf die Stirn salzig schmekt, er ist verhext und muss bald sterbe</i> or "Woe to the child who tastes salty from a kiss on the brow, for he is cursed and soon must die," recognizing the association between the salt loss in CF and illness.<sup id="cite_ref-Bosch_132-1" class="reference"><a href="#cite_note-Bosch-132"><span>[</span>132<span>]</span></a></sup></p>
<p>In the 19th century, <a href="/wiki/Carl_von_Rokitansky" title="Carl von Rokitansky">Carl von Rokitansky</a> described a case of fetal death with <a href="/wiki/Meconium_peritonitis" title="Meconium peritonitis">meconium peritonitis</a>, a complication of meconium ileus associated with cystic fibrosis. Meconium ileus was first described in 1905 by <a href="/wiki/Karl_Landsteiner" title="Karl Landsteiner">Karl Landsteiner</a>.<sup id="cite_ref-Bosch_132-2" class="reference"><a href="#cite_note-Bosch-132"><span>[</span>132<span>]</span></a></sup> In 1936, <a href="/wiki/Guido_Fanconi" title="Guido Fanconi">Guido Fanconi</a> published a paper describing a connection between <a href="/wiki/Celiac_disease" title="Celiac disease" class="mw-redirect">celiac disease</a>, cystic fibrosis of the pancreas, and <a href="/wiki/Bronchiectasis" title="Bronchiectasis">bronchiectasis</a>.<sup id="cite_ref-133" class="reference"><a href="#cite_note-133"><span>[</span>133<span>]</span></a></sup></p>
<p>In 1938 <a href="/wiki/Dorothy_Hansine_Andersen" title="Dorothy Hansine Andersen">Dorothy Hansine Andersen</a> published an article, "Cystic Fibrosis of the Pancreas and Its Relation to Celiac Disease: a Clinical and Pathological Study," in the <i>American Journal of Diseases of Children</i>. She was the first to describe the characteristic cystic fibrosis of the pancreas and to correlate it with the lung and intestinal disease prominent in CF.<sup id="cite_ref-andersen_7-1" class="reference"><a href="#cite_note-andersen-7"><span>[</span>7<span>]</span></a></sup> She also first hypothesized that CF was a recessive disease and first used pancreatic enzyme replacement to treat affected children. In 1952 Paul di Sant' Agnese discovered abnormalities in <a href="/wiki/Sweat" title="Sweat" class="mw-redirect">sweat</a> <a href="/wiki/Electrolyte" title="Electrolyte">electrolytes</a>; a <a href="/wiki/Sweat_test" title="Sweat test">sweat test</a> was developed and improved over the next decade.<sup id="cite_ref-134" class="reference"><a href="#cite_note-134"><span>[</span>134<span>]</span></a></sup></p>
<p>The first linkage between CF and another marker (Paroxonase) was found in 1985 by <a href="/wiki/Hans_Eiberg" title="Hans Eiberg">Hans Eiberg</a>, indicating that only one locus exists for CF. In 1988 the first mutation for CF, <a href="/wiki/Delta-F508" title="Delta-F508" class="mw-redirect">ΔF508</a> was discovered by <a href="/wiki/Francis_Collins_(geneticist)" title="Francis Collins (geneticist)" class="mw-redirect">Francis Collins</a>, <a href="/wiki/Lap-Chee_Tsui" title="Lap-Chee Tsui">Lap-Chee Tsui</a> and <a href="/wiki/John_R._Riordan" title="John R. Riordan">John R. Riordan</a> on the seventh chromosome. Subsequent research has found over 1,000 different mutations that cause CF.</p>
<p>Because mutations in the CFTR gene are typically small, <a href="/wiki/Classical_genetics" title="Classical genetics">classical genetics</a> techniques had been unable to accurately pinpoint the mutated gene.<sup id="cite_ref-135" class="reference"><a href="#cite_note-135"><span>[</span>135<span>]</span></a></sup> Using protein markers, <a href="/wiki/Gene_linkage" title="Gene linkage" class="mw-redirect">gene-linkage</a> studies were able to map the mutation to chromosome 7. <a href="/wiki/Chromosome_walking" title="Chromosome walking" class="mw-redirect">Chromosome-walking</a> and <a href="/wiki/Chromosome_jumping" title="Chromosome jumping">-jumping</a> techniques were then used to identify and <a href="/wiki/DNA_sequencing" title="DNA sequencing">sequence</a> the gene.<sup id="cite_ref-136" class="reference"><a href="#cite_note-136"><span>[</span>136<span>]</span></a></sup> In 1989 Lap-Chee Tsui led a team of researchers at the <a href="/wiki/Hospital_for_Sick_Children" title="Hospital for Sick Children" class="mw-redirect">Hospital for Sick Children</a> in <a href="/wiki/Toronto" title="Toronto">Toronto</a> that discovered the gene responsible for CF. Cystic fibrosis represents a classic example of how a human genetic disorder was elucidated strictly by the process of <a href="/wiki/Forward_genetics" title="Forward genetics">forward genetics</a>.</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=21" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Gene_therapy">Gene therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=22" title="Edit section: Gene therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Gene_therapy" title="Gene therapy">Gene therapy</a> has been explored as a potential cure for cystic fibrosis. Results from trials have shown limited success as of 2013.<sup id="cite_ref-137" class="reference"><a href="#cite_note-137"><span>[</span>137<span>]</span></a></sup> A small study published in 2015 found a small benefit.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138"><span>[</span>138<span>]</span></a></sup></p>
<p>The focus of much cystic fibrosis gene therapy research is aimed at trying to place a normal copy of the <a href="/wiki/CFTR_(gene)" title="CFTR (gene)" class="mw-redirect">CFTR gene</a> into affected cells. Transferring the normal CFTR gene into the affected epithelium cells would result in the production of functional CFTR in all target cells, without adverse reactions or an inflammation response. Studies have shown that to prevent the lung manifestations of cystic fibrosis, only 5–10% the normal amount of CFTR <a href="/wiki/Gene_expression" title="Gene expression">gene expression</a> is needed.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139"><span>[</span>139<span>]</span></a></sup> Multiple approaches have been tested for gene transfer, such as liposomes and viral vectors in animal models and clinical trials. However, both methods were found to be relatively inefficient treatment options.<sup id="cite_ref-140" class="reference"><a href="#cite_note-140"><span>[</span>140<span>]</span></a></sup> The main reason is that very few cells take up the vector and express the gene, so the treatment has little effect. Additionally, problems have been noted in cDNA recombination, such that the gene introduced by the treatment is rendered unusable.<sup id="cite_ref-141" class="reference"><a href="#cite_note-141"><span>[</span>141<span>]</span></a></sup> There has been a functional repair in culture of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients.<sup id="cite_ref-142" class="reference"><a href="#cite_note-142"><span>[</span>142<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Small_molecules">Small molecules</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=23" title="Edit section: Small molecules">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>A number of <a href="/wiki/Small_molecule" title="Small molecule">small molecules</a> that aim at compensating various mutations of the CFTR gene are under development. One approach is to develop drugs that get the ribosome to overcome the <a href="/wiki/Stop_codon" title="Stop codon">stop codon</a> and synthesize a full-length CFTR protein. About 10% of CF result from a premature stop codon in the DNA, leading to early termination of protein synthesis and truncated proteins. These drugs target <a href="/wiki/Nonsense_mutation" title="Nonsense mutation">nonsense mutations</a> such as G542X, which consists of the amino acid <a href="/wiki/Glycine" title="Glycine">glycine</a> in position 542 being replaced by a stop codon. Aminoglycoside antibiotics interfere with protein synthesis and error-correction. In some cases, they can cause the cell to overcome a premature stop codon by inserting a random amino acid, thereby allowing expression of a full-length protein.<sup id="cite_ref-143" class="reference"><a href="#cite_note-143"><span>[</span>143<span>]</span></a></sup> The aminoglycoside <a href="/wiki/Gentamicin" title="Gentamicin">gentamicin</a> has been used to treat lung cells from CF patients in the laboratory to induce the cells to grow full-length proteins.<sup id="cite_ref-144" class="reference"><a href="#cite_note-144"><span>[</span>144<span>]</span></a></sup> Another drug targeting nonsense mutations is <a href="/wiki/Ataluren" title="Ataluren">ataluren</a>, which is undergoing Phase III clinical trials as of October 2011<sup class="plainlinks noprint asof-tag update" style="display:none;"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Cystic_fibrosis&amp;action=edit">[update]</a></sup>.<sup id="cite_ref-145" class="reference"><a href="#cite_note-145"><span>[</span>145<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=24" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>It is unclear as of 2014 if <a href="/wiki/Ursodeoxycholic_acid" title="Ursodeoxycholic acid">ursodeoxycholic acid</a> is useful for those with cystic fibrosis-related liver disease.<sup id="cite_ref-146" class="reference"><a href="#cite_note-146"><span>[</span>146<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=25" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a href="/wiki/Sick:_The_Life_and_Death_of_Bob_Flanagan,_Supermasochist" title="Sick: The Life and Death of Bob Flanagan, Supermasochist">Sick: The Life and Death of Bob Flanagan, Supermasochist</a></li>
<li><i><a href="/wiki/65_Redroses" title="65 Redroses">65_Redroses</a></i></li>
<li><i><a href="/wiki/Breathing_for_a_Living" title="Breathing for a Living">Breathing for a Living</a></i>, a memoir by <a href="/wiki/Laura_Rothenberg" title="Laura Rothenberg">Laura Rothenberg</a></li>
</ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=26" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-O2009-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-O2009_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-O2009_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-O2009_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-O2009_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-O2009_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-O2009_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-O2009_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-O2009_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-O2009_1-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">O'Sullivan, BP; Freedman, SD (30 May 2009). "Cystic fibrosis.". <i>Lancet</i> <b>373</b> (9678): 1891–904. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fs0140-6736%2809%2960327-5">10.1016/s0140-6736(09)60327-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19403164">19403164</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis.&amp;rft.aufirst=BP&amp;rft.au=Freedman%2C+SD&amp;rft.aulast=O%27Sullivan&amp;rft.au=O%27Sullivan%2C+BP&amp;rft.date=30+May+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2809%2960327-5&amp;rft_id=info%3Apmid%2F19403164&amp;rft.issue=9678&amp;rft.jtitle=Lancet&amp;rft.pages=1891-904&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=373" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CF2012-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-CF2012_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CF2012_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-CF2012_2-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Hodson, Margaret; Geddes, Duncan; Bush, Andrew, eds. (2012). <a rel="nofollow" class="external text" href="https://books.google.ca/books?id=9x_cBQAAQBAJ&amp;pg=PA3"><i>Cystic fibrosis</i></a> (3rd ed.). London: Hodder Arnold. p.&#160;3. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-4441-1369-3" title="Special:BookSources/978-1-4441-1369-3">978-1-4441-1369-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=Cystic+fibrosis&amp;rft.date=2012&amp;rft.edition=3rd&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3D9x_cBQAAQBAJ%26pg%3DPA3&amp;rft.isbn=978-1-4441-1369-3&amp;rft.pages=3&amp;rft.place=London&amp;rft.pub=Hodder+Arnold&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mas2013-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mas2013_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mas2013_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Mas2013_3-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Massie, J; Delatycki, MB (December 2013). "Cystic fibrosis carrier screening.". <i>Paediatric respiratory reviews</i> <b>14</b> (4): 270–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.prrv.2012.12.002">10.1016/j.prrv.2012.12.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23466339">23466339</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+carrier+screening.&amp;rft.au=Delatycki%2C+MB&amp;rft.aufirst=J&amp;rft.aulast=Massie&amp;rft.au=Massie%2C+J&amp;rft.date=December+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prrv.2012.12.002&amp;rft_id=info%3Apmid%2F23466339&amp;rft.issue=4&amp;rft.jtitle=Paediatric+respiratory+reviews&amp;rft.pages=270-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation book">Buckingham, Lela (2012). <a rel="nofollow" class="external text" href="https://books.google.ca/books?id=1cTZAAAAQBAJ&amp;pg=PA351"><i>Molecular diagnostics fundamentals, methods, and clinical applications</i></a> (2nd ed.). Philadelphia: F.A. Davis Co. p.&#160;351. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-8036-2975-2" title="Special:BookSources/978-0-8036-2975-2">978-0-8036-2975-2</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.au=Buckingham%2C+Lela&amp;rft.aufirst=Lela&amp;rft.aulast=Buckingham&amp;rft.btitle=Molecular+diagnostics+fundamentals%2C+methods%2C+and+clinical+applications&amp;rft.date=2012&amp;rft.edition=2nd&amp;rft.genre=book&amp;rft_id=https%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3D1cTZAAAAQBAJ%26pg%3DPA351&amp;rft.isbn=978-0-8036-2975-2&amp;rft.pages=351&amp;rft.place=Philadelphia&amp;rft.pub=F.A.+Davis+Co.&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-yankas-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-yankas_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D (2004). <a rel="nofollow" class="external text" href="http://chestjournal.chestpubs.org/content/125/1_suppl/1S.long">"Cystic fibrosis adult care consensus conference report"</a>. <i>Chest</i> <b>125</b> (90010): 1–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.125.1_suppl.1S">10.1378/chest.125.1_suppl.1S</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14734689">14734689</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+adult+care+consensus+conference+report&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fchestjournal.chestpubs.org%2Fcontent%2F125%2F1_suppl%2F1S.long&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.125.1_suppl.1S&amp;rft_id=info%3Apmid%2F14734689&amp;rft.issue=90010&amp;rft.jtitle=Chest&amp;rft.pages=1-39&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=125" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><span class="citation journal">Davies, JC; Ebdon, AM; Orchard, C (November 2014). "Recent advances in the management of cystic fibrosis.". <i>Archives of Disease in Childhood</i> <b>99</b> (11): 1033–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Farchdischild-2013-304400">10.1136/archdischild-2013-304400</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24996790">24996790</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Recent+advances+in+the+management+of+cystic+fibrosis.&amp;rft.au=Davies%2C+JC&amp;rft.au=Ebdon%2C+AM&amp;rft.aufirst=JC&amp;rft.aulast=Davies&amp;rft.au=Orchard%2C+C&amp;rft.date=November+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Farchdischild-2013-304400&amp;rft_id=info%3Apmid%2F24996790&amp;rft.issue=11&amp;rft.jtitle=Archives+of+Disease+in+Childhood&amp;rft.pages=1033-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=99" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-andersen-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-andersen_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-andersen_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Andersen DH (1938). "Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathological study". <i>Am J Dis Child</i> <b>56</b>: 344–399. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchpedi.1938.01980140114013">10.1001/archpedi.1938.01980140114013</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+of+the+pancreas+and+its+relation+to+celiac+disease%3A+a+clinical+and+pathological+study&amp;rft.au=Andersen+DH&amp;rft.aulast=Andersen+DH&amp;rft.date=1938&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Farchpedi.1938.01980140114013&amp;rft.jtitle=Am+J+Dis+Child&amp;rft.pages=344-399&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=56" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17557942-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17557942_8-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Quinton PM (June 2007). <a rel="nofollow" class="external text" href="http://nips.physiology.org/cgi/pmidlookup?view=long&amp;pmid=17557942">"Cystic fibrosis: lessons from the sweat gland"</a>. <i>Physiology (Bethesda)</i> <b>22</b> (3): 212–25. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1152%2Fphysiol.00041.2006">10.1152/physiol.00041.2006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17557942">17557942</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis%3A+lessons+from+the+sweat+gland&amp;rft.aulast=Quinton+PM&amp;rft.au=Quinton+PM&amp;rft.date=June+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fnips.physiology.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D17557942&amp;rft_id=info%3Adoi%2F10.1152%2Fphysiol.00041.2006&amp;rft_id=info%3Apmid%2F17557942&amp;rft.issue=3&amp;rft.jtitle=Physiology+%28Bethesda%29&amp;rft.pages=212-25&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15339250-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15339250_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15339250_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hardin DS (August 2004). <a rel="nofollow" class="external text" href="http://eje-online.org/cgi/pmidlookup?view=long&amp;pmid=15339250">"GH improves growth and clinical status in children with cystic fibrosis – a review of published studies"</a>. <i>Eur. J. Endocrinol.</i> <b>151</b> (Suppl 1): S81–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1530%2Feje.0.151S081">10.1530/eje.0.151S081</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15339250">15339250</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=GH+improves+growth+and+clinical+status+in+children+with+cystic+fibrosis+%E2%80%93+a+review+of+published+studies&amp;rft.au=Hardin+DS&amp;rft.aulast=Hardin+DS&amp;rft.date=August+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Feje-online.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D15339250&amp;rft_id=info%3Adoi%2F10.1530%2Feje.0.151S081&amp;rft_id=info%3Apmid%2F15339250&amp;rft.issue=Suppl+1&amp;rft.jtitle=Eur.+J.+Endocrinol.&amp;rft.pages=S81-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=151" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19726878-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19726878_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19726878_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">De Lisle RC (September 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2735941">"Pass the bicarb: the importance of HCO3- for mucin release"</a>. <i>J. Clin. Invest.</i> <b>119</b> (9): 2535–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI40598">10.1172/JCI40598</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2735941">2735941</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19726878">19726878</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Pass+the+bicarb%3A+the+importance+of+HCO3-+for+mucin+release&amp;rft.au=De+Lisle+RC&amp;rft.aulast=De+Lisle+RC&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2735941&amp;rft_id=info%3Adoi%2F10.1172%2FJCI40598&amp;rft_id=info%3Apmc%2F2735941&amp;rft_id=info%3Apmid%2F19726878&amp;rft.issue=9&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.pages=2535-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=119" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19393108-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19393108_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">O'Malley CA (May 2009). <a rel="nofollow" class="external text" href="http://www.rcjournal.com/contents/05.09/05.09.0641.pdf">"Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist"</a> <span style="font-size:85%;">(PDF)</span>. <i>Respir Care</i> <b>54</b> (5): 641–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4187%2Faarc0446">10.4187/aarc0446</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19393108">19393108</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Infection+control+in+cystic+fibrosis%3A+cohorting%2C+cross-contamination%2C+and+the+respiratory+therapist&amp;rft.aulast=O%27Malley+CA&amp;rft.au=O%27Malley+CA&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.rcjournal.com%2Fcontents%2F05.09%2F05.09.0641.pdf&amp;rft_id=info%3Adoi%2F10.4187%2Faarc0446&amp;rft_id=info%3Apmid%2F19393108&amp;rft.issue=5&amp;rft.jtitle=Respir+Care&amp;rft.pages=641-57&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19535829-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19535829_12-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Makker K, Agarwal A, Sharma R (April 2009). <a rel="nofollow" class="external text" href="http://www.icmr.nic.in/ijmr/2009/april/0403.pdf">"Oxidative stress &amp; male infertility"</a> <span style="font-size:85%;">(PDF)</span>. <i>Indian J. Med. Res.</i> <b>129</b> (4): 357–67. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19535829">19535829</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Oxidative+stress+%26+male+infertility&amp;rft.aulast=Makker+K%2C+Agarwal+A%2C+Sharma+R&amp;rft.au=Makker+K%2C+Agarwal+A%2C+Sharma+R&amp;rft.date=April+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.icmr.nic.in%2Fijmr%2F2009%2Fapril%2F0403.pdf&amp;rft_id=info%3Apmid%2F19535829&amp;rft.issue=4&amp;rft.jtitle=Indian+J.+Med.+Res.&amp;rft.pages=357-67&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=129" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17030173-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17030173_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Blackman SM, Deering-Brose R, McWilliams R, Naughton K, Coleman B, Lai T, Algire M, Beck S, Hoover-Fong J, Hamosh A, Fallin MD, West K, Arking DE, Chakravarti A, Cutler DJ, Cutting GR (October 2006). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0016-5085(06)01659-3">"Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis"</a>. <i>Gastroenterology</i> <b>131</b> (4): 1030–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fj.gastro.2006.07.016">10.1053/j.gastro.2006.07.016</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1764617">1764617</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17030173">17030173</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Relative+contribution+of+genetic+and+nongenetic+modifiers+to+intestinal+obstruction+in+cystic+fibrosis&amp;rft.au=Blackman+SM%2C+Deering-Brose+R%2C+McWilliams+R%2C+Naughton+K%2C+Coleman+B%2C+Lai+T%2C+Algire+M%2C+Beck+S%2C+Hoover-Fong+J%2C+Hamosh+A%2C+Fallin+MD%2C+West+K%2C+Arking+DE%2C+Chakravarti+A%2C+Cutler+DJ%2C+Cutting+GR&amp;rft.aulast=Blackman+SM%2C+Deering-Brose+R%2C+McWilliams+R%2C+Naughton+K%2C+Coleman+B%2C+Lai+T%2C+Algire+M%2C+Beck+S%2C+Hoover-Fong+J%2C+Hamosh+A%2C+Fallin+MD%2C+West+K%2C+Arking+DE%2C+Chakravarti+A%2C+Cutler+DJ%2C+Cutting+GR&amp;rft.date=October+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0016-5085%2806%2901659-3&amp;rft_id=info%3Adoi%2F10.1053%2Fj.gastro.2006.07.016&amp;rft_id=info%3Apmc%2F1764617&amp;rft_id=info%3Apmid%2F17030173&amp;rft.issue=4&amp;rft.jtitle=Gastroenterology&amp;rft.pages=1030-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=131" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid19393104-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19393104_14-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ratjen FA (May 2009). <a rel="nofollow" class="external text" href="http://www.rcjournal.com/contents/05.09/05.09.0595.pdf">"Cystic fibrosis: pathogenesis and future treatment strategies"</a> <span style="font-size:85%;">(PDF)</span>. <i>Respir Care</i> <b>54</b> (5): 595–605. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.4187%2Faarc0427">10.4187/aarc0427</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19393104">19393104</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis%3A+pathogenesis+and+future+treatment+strategies&amp;rft.aulast=Ratjen+FA&amp;rft.au=Ratjen+FA&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.rcjournal.com%2Fcontents%2F05.09%2F05.09.0595.pdf&amp;rft_id=info%3Adoi%2F10.4187%2Faarc0427&amp;rft_id=info%3Apmid%2F19393104&amp;rft.issue=5&amp;rft.jtitle=Respir+Care&amp;rft.pages=595-605&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><span class="citation journal">Reaves J, Wallace G (2010). <a rel="nofollow" class="external text" href="http://www.consultantlive.com/pediatrics/display/article/10162/1583642">"Unexplained bruising: weighing the pros and cons of possible causes"</a>. <i>Consultant for Pediatricians</i> <b>9</b>: 201–2.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Unexplained+bruising%3A+weighing+the+pros+and+cons+of+possible+causes&amp;rft.aulast=Reaves+J%2C+Wallace+G&amp;rft.au=Reaves+J%2C+Wallace+G&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.consultantlive.com%2Fpediatrics%2Fdisplay%2Farticle%2F10162%2F1583642&amp;rft.jtitle=Consultant+for+Pediatricians&amp;rft.pages=201-2&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20299528-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20299528_16-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Flume PA, Mogayzel Jr PJ, Robinson KA et al. (March 2010). "Cystic Fibrosis Pulmonary Guidelines: Pulmonary Complications: Hemoptysis and Pneumothorax". <i>Am J Respir Crit Care Med</i> <b>182</b> (3): 298–306. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.201002-0157OC">10.1164/rccm.201002-0157OC</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20299528">20299528</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+Fibrosis+Pulmonary+Guidelines%3A+Pulmonary+Complications%3A+Hemoptysis+and+Pneumothorax&amp;rft.au=Flume+PA%2C+Mogayzel+Jr+PJ%2C+Robinson+KA&amp;rft.aulast=Flume+PA%2C+Mogayzel+Jr+PJ%2C+Robinson+KA&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.201002-0157OC&amp;rft_id=info%3Apmid%2F20299528&amp;rft.issue=3&amp;rft.jtitle=Am+J+Respir+Crit+Care+Med&amp;rft.pages=298-306&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=182" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-kumar2007-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-kumar2007_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-kumar2007_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-kumar2007_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-kumar2007_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-kumar2007_17-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-kumar2007_17-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-kumar2007_17-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-kumar2007_17-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-kumar2007_17-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-kumar2007_17-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-kumar2007_17-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-kumar2007_17-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-kumar2007_17-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-kumar2007_17-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-kumar2007_17-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-kumar2007_17-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-kumar2007_17-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-kumar2007_17-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-kumar2007_17-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-kumar2007_17-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-kumar2007_17-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-kumar2007_17-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-kumar2007_17-22"><sup><i><b>w</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Mitchell, Richard Sheppard; Kumar, Vinay; Robbins, Stanley L.; Abbas, Abul K.; Fausto, Nelson (2007). <i>Robbins basic pathology</i>. Saunders/Elsevier. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-4160-2973-7" title="Special:BookSources/1-4160-2973-7">1-4160-2973-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.aulast=Mitchell%2C+Richard+Sheppard%3B+Kumar%2C+Vinay%3B+Robbins%2C+Stanley+L.%3B+Abbas%2C+Abul+K.%3B+Fausto%2C+Nelson&amp;rft.au=Mitchell%2C+Richard+Sheppard%3B+Kumar%2C+Vinay%3B+Robbins%2C+Stanley+L.%3B+Abbas%2C+Abul+K.%3B+Fausto%2C+Nelson&amp;rft.btitle=Robbins+basic+pathology&amp;rft.date=2007&amp;rft.genre=book&amp;rft.isbn=1-4160-2973-7&amp;rft.pub=Saunders%2FElsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rowe-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rowe_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rowe_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rowe_18-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Rowe_18-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Rowe SM, Miller S, Sorscher EJ (May 2005). "Cystic fibrosis". <i>The New England Journal of Medicine</i> <b>352</b> (19): 1992–2001. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra043184">10.1056/NEJMra043184</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15888700">15888700</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis&amp;rft.aulast=Rowe+SM%2C+Miller+S%2C+Sorscher+EJ&amp;rft.au=Rowe+SM%2C+Miller+S%2C+Sorscher+EJ&amp;rft.date=May+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra043184&amp;rft_id=info%3Apmid%2F15888700&amp;rft.issue=19&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.pages=1992-2001&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=352" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16266669-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16266669_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Girón RM, Domingo D, Buendía B, Antón E, Ruiz-Velasco LM, Ancochea J (October 2005). <a rel="nofollow" class="external text" href="http://www.elsevier.es/revistas/0300-2896/41/560">"Nontuberculous mycobacteria in patients with cystic fibrosis"</a>. <i>Arch. Bronconeumol.</i> (in Spanish) <b>41</b> (10): 560–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1579-2129%2806%2960283-8">10.1016/S1579-2129(06)60283-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16266669">16266669</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Nontuberculous+mycobacteria+in+patients+with+cystic+fibrosis&amp;rft.au=Gir%C3%B3n+RM%2C+Domingo+D%2C+Buend%C3%ADa+B%2C+Ant%C3%B3n+E%2C+Ruiz-Velasco+LM%2C+Ancochea+J&amp;rft.aulast=Gir%C3%B3n+RM%2C+Domingo+D%2C+Buend%C3%ADa+B%2C+Ant%C3%B3n+E%2C+Ruiz-Velasco+LM%2C+Ancochea+J&amp;rft.date=October+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.elsevier.es%2Frevistas%2F0300-2896%2F41%2F560&amp;rft_id=info%3Adoi%2F10.1016%2FS1579-2129%2806%2960283-8&amp;rft_id=info%3Apmid%2F16266669&amp;rft.issue=10&amp;rft.jtitle=Arch.+Bronconeumol.&amp;rft.pages=560-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20209279-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20209279_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Franco LP, Camargos PA, Becker HM, Guimarães RE (December 2009). <a rel="nofollow" class="external text" href="http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S1808-86942009000600006&amp;lng=en&amp;nrm=iso&amp;tlng=en">"Nasal endoscopic evaluation of children and adolescents with cystic fibrosis"</a>. <i>Braz J Otorhinolaryngol</i> <b>75</b> (6): 806–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1590%2FS1808-86942009000600006">10.1590/S1808-86942009000600006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20209279">20209279</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Nasal+endoscopic+evaluation+of+children+and+adolescents+with+cystic+fibrosis&amp;rft.au=Franco+LP%2C+Camargos+PA%2C+Becker+HM%2C+Guimar%C3%A3es+RE&amp;rft.aulast=Franco+LP%2C+Camargos+PA%2C+Becker+HM%2C+Guimar%C3%A3es+RE&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.scielo.br%2Fscielo.php%3Fscript%3Dsci_arttext%26pid%3DS1808-86942009000600006%26lng%3Den%26nrm%3Diso%26tlng%3Den&amp;rft_id=info%3Adoi%2F10.1590%2FS1808-86942009000600006&amp;rft_id=info%3Apmid%2F20209279&amp;rft.issue=6&amp;rft.jtitle=Braz+J+Otorhinolaryngol&amp;rft.pages=806-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=75" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation journal">Maldonado M, Martínez A, Alobid I, Mullol J (December 2004). "The antrochoanal polyp". <i>Rhinology</i> <b>42</b> (4): 178–82. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15626248">15626248</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+antrochoanal+polyp&amp;rft.aulast=Maldonado+M%2C+Mart%C3%ADnez+A%2C+Alobid+I%2C+Mullol+J&amp;rft.au=Maldonado+M%2C+Mart%C3%ADnez+A%2C+Alobid+I%2C+Mullol+J&amp;rft.date=December+2004&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F15626248&amp;rft.issue=4&amp;rft.jtitle=Rhinology&amp;rft.pages=178-82&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=42" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><span class="citation journal">Ramsey B, Richardson MA (September 1992). "Impact of sinusitis in cystic fibrosis". <i>J. Allergy Clin. Immunol.</i> <b>90</b> (3 Pt 2): 547–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0091-6749%2892%2990183-3">10.1016/0091-6749(92)90183-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1527348">1527348</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Impact+of+sinusitis+in+cystic+fibrosis&amp;rft.aulast=Ramsey+B%2C+Richardson+MA&amp;rft.au=Ramsey+B%2C+Richardson+MA&amp;rft.date=September+1992&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0091-6749%2892%2990183-3&amp;rft_id=info%3Apmid%2F1527348&amp;rft.issue=3+Pt+2&amp;rft.jtitle=J.+Allergy+Clin.+Immunol.&amp;rft.pages=547-52&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=90" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Eggermont E, De Boeck K (October 1991). "Small-intestinal abnormalities in cystic fibrosis patients". <i>Eur. J. Pediatr.</i> <b>150</b> (12): 824–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2FBF01954999">10.1007/BF01954999</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1743211">1743211</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Small-intestinal+abnormalities+in+cystic+fibrosis+patients&amp;rft.au=Eggermont+E%2C+De+Boeck+K&amp;rft.aulast=Eggermont+E%2C+De+Boeck+K&amp;rft.date=October+1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF01954999&amp;rft_id=info%3Apmid%2F1743211&amp;rft.issue=12&amp;rft.jtitle=Eur.+J.+Pediatr.&amp;rft.pages=824-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=150" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><span class="citation journal">Kulczycki LL, Shwachman H (August 1958). "Studies in cystic fibrosis of the pancreas; occurrence of rectal prolapse". <i>N. Engl. J. Med.</i> <b>259</b> (9): 409–12. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM195808282590901">10.1056/NEJM195808282590901</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13578072">13578072</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Studies+in+cystic+fibrosis+of+the+pancreas%3B+occurrence+of+rectal+prolapse&amp;rft.au=Kulczycki+LL%2C+Shwachman+H&amp;rft.aulast=Kulczycki+LL%2C+Shwachman+H&amp;rft.date=August+1958&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM195808282590901&amp;rft_id=info%3Apmid%2F13578072&amp;rft.issue=9&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=409-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=259" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><span class="citation journal">Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS (September 1998). "Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis". <i>N. Engl. J. Med.</i> <b>339</b> (10): 653–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199809033391002">10.1056/NEJM199809033391002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9725922">9725922</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Relation+between+mutations+of+the+cystic+fibrosis+gene+and+idiopathic+pancreatitis&amp;rft.au=Cohn+JA%2C+Friedman+KJ%2C+Noone+PG%2C+Knowles+MR%2C+Silverman+LM%2C+Jowell+PS&amp;rft.aulast=Cohn+JA%2C+Friedman+KJ%2C+Noone+PG%2C+Knowles+MR%2C+Silverman+LM%2C+Jowell+PS&amp;rft.date=September+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199809033391002&amp;rft_id=info%3Apmid%2F9725922&amp;rft.issue=10&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=653-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=339" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation journal">Malfroot A, Dab I (November 1991). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1793275">"New insights on gastro-esophageal reflux in cystic fibrosis by longitudinal follow up"</a>. <i>Arch. Dis. Child.</i> <b>66</b> (11): 1339–45. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fadc.66.11.1339">10.1136/adc.66.11.1339</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1793275">1793275</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1755649">1755649</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=New+insights+on+gastro-esophageal+reflux+in+cystic+fibrosis+by+longitudinal+follow+up&amp;rft.aulast=Malfroot+A%2C+Dab+I&amp;rft.au=Malfroot+A%2C+Dab+I&amp;rft.date=November+1991&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1793275&amp;rft_id=info%3Adoi%2F10.1136%2Fadc.66.11.1339&amp;rft_id=info%3Apmc%2F1793275&amp;rft_id=info%3Apmid%2F1755649&amp;rft.issue=11&amp;rft.jtitle=Arch.+Dis.+Child.&amp;rft.pages=1339-45&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=66" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Khoshoo V, Udall JN (February 1994). "Meconium ileus equivalent in children and adults". <i>Am. J. Gastroenterol.</i> <b>89</b> (2): 153–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8304294">8304294</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Meconium+ileus+equivalent+in+children+and+adults&amp;rft.au=Khoshoo+V%2C+Udall+JN&amp;rft.aulast=Khoshoo+V%2C+Udall+JN&amp;rft.date=February+1994&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8304294&amp;rft.issue=2&amp;rft.jtitle=Am.+J.+Gastroenterol.&amp;rft.pages=153-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=89" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Williams SG, Westaby D, Tanner MS, Mowat AP (October 1992). "Liver and biliary problems in cystic fibrosis". <i>Br. Med. Bull.</i> <b>48</b> (4): 877–92. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1458306">1458306</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Liver+and+biliary+problems+in+cystic+fibrosis&amp;rft.aulast=Williams+SG%2C+Westaby+D%2C+Tanner+MS%2C+Mowat+AP&amp;rft.au=Williams+SG%2C+Westaby+D%2C+Tanner+MS%2C+Mowat+AP&amp;rft.date=October+1992&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1458306&amp;rft.issue=4&amp;rft.jtitle=Br.+Med.+Bull.&amp;rft.pages=877-92&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=48" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-liver-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-liver_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Colombo C, Russo MC, Zazzeron L, Romano G (July 2006). "Liver disease in cystic fibrosis". <i>J. Pediatr. Gastroenterol. Nutr.</i> <b>43</b> (Suppl 1): S49–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.mpg.0000226390.02355.52">10.1097/01.mpg.0000226390.02355.52</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16819402">16819402</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Liver+disease+in+cystic+fibrosis&amp;rft.au=Colombo+C%2C+Russo+MC%2C+Zazzeron+L%2C+Romano+G&amp;rft.aulast=Colombo+C%2C+Russo+MC%2C+Zazzeron+L%2C+Romano+G&amp;rft.date=July+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.mpg.0000226390.02355.52&amp;rft_id=info%3Apmid%2F16819402&amp;rft.issue=Suppl+1&amp;rft.jtitle=J.+Pediatr.+Gastroenterol.+Nutr.&amp;rft.pages=S49-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER (August 1994). "Insulin sensitivity in cystic fibrosis". <i>Diabetes</i> <b>43</b> (8): 1020–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2337%2Fdiabetes.43.8.1020">10.2337/diabetes.43.8.1020</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8039595">8039595</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Insulin+sensitivity+in+cystic+fibrosis&amp;rft.aulast=Moran+A%2C+Pyzdrowski+KL%2C+Weinreb+J%2C+Kahn+BB%2C+Smith+SA%2C+Adams+KS%2C+Seaquist+ER&amp;rft.au=Moran+A%2C+Pyzdrowski+KL%2C+Weinreb+J%2C+Kahn+BB%2C+Smith+SA%2C+Adams+KS%2C+Seaquist+ER&amp;rft.date=August+1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2337%2Fdiabetes.43.8.1020&amp;rft_id=info%3Apmid%2F8039595&amp;rft.issue=8&amp;rft.jtitle=Diabetes&amp;rft.pages=1020-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=43" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Alves-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Alves_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Alves_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Alves_31-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Alves Cde A, Aguiar RA, Alves AC, Santana MA (April 2007). "Diabetes mellitus in patients with cystic fibrosis". <i>J Bras Pneumol</i> <b>33</b> (2): 213–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1590%2FS1806-37132007000200017">10.1590/S1806-37132007000200017</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17724542">17724542</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Diabetes+mellitus+in+patients+with+cystic+fibrosis&amp;rft.au=Alves+Cde+A%2C+Aguiar+RA%2C+Alves+AC%2C+Santana+MA&amp;rft.aulast=Alves+Cde+A%2C+Aguiar+RA%2C+Alves+AC%2C+Santana+MA&amp;rft.date=April+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1590%2FS1806-37132007000200017&amp;rft_id=info%3Apmid%2F17724542&amp;rft.issue=2&amp;rft.jtitle=J+Bras+Pneumol&amp;rft.pages=213-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=33" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Haworth CS, Selby PL, Webb AK, Dodd ME, Musson H, McL Niven R, Economou G, Horrocks AW, Freemont AJ, Mawer EB, Adams JE (November 1999). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1745400">"Low bone mineral density in adults with cystic fibrosis"</a>. <i>Thorax</i> <b>54</b> (11): 961–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fthx.54.11.961">10.1136/thx.54.11.961</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1745400">1745400</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10525552">10525552</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Low+bone+mineral+density+in+adults+with+cystic+fibrosis&amp;rft.au=Haworth+CS%2C+Selby+PL%2C+Webb+AK%2C+Dodd+ME%2C+Musson+H%2C+McL+Niven+R%2C+Economou+G%2C+Horrocks+AW%2C+Freemont+AJ%2C+Mawer+EB%2C+Adams+JE&amp;rft.aulast=Haworth+CS%2C+Selby+PL%2C+Webb+AK%2C+Dodd+ME%2C+Musson+H%2C+McL+Niven+R%2C+Economou+G%2C+Horrocks+AW%2C+Freemont+AJ%2C+Mawer+EB%2C+Adams+JE&amp;rft.date=November+1999&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1745400&amp;rft_id=info%3Adoi%2F10.1136%2Fthx.54.11.961&amp;rft_id=info%3Apmc%2F1745400&amp;rft_id=info%3Apmid%2F10525552&amp;rft.issue=11&amp;rft.jtitle=Thorax&amp;rft.pages=961-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=54" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid12806875-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12806875_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vandemergel X, Decaux G (April 2003). "[Review on hypertrophic osteoarthropathy and digital clubbing]". <i><a href="/wiki/Revue_M%C3%A9dicale_de_Bruxelles" title="Revue Médicale de Bruxelles">Revue Médicale de Bruxelles</a></i> (in French) <b>24</b> (2): 88–94. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12806875">12806875</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=%5BReview+on+hypertrophic+osteoarthropathy+and+digital+clubbing%5D&amp;rft.aulast=Vandemergel+X%2C+Decaux+G&amp;rft.au=Vandemergel+X%2C+Decaux+G&amp;rft.date=April+2003&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F12806875&amp;rft.issue=2&amp;rft.jtitle=Revue+M%C3%A9dicale+de+Bruxelles&amp;rft.pages=88-94&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=24" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid3488032-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3488032_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pitts-Tucker TJ, Miller MG, Littlewood JM (June 1986). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1777828">"Finger clubbing in cystic fibrosis"</a>. <i>Arch. Dis. Child.</i> <b>61</b> (6): 576–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fadc.61.6.576">10.1136/adc.61.6.576</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1777828">1777828</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3488032">3488032</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Finger+clubbing+in+cystic+fibrosis&amp;rft.aulast=Pitts-Tucker+TJ%2C+Miller+MG%2C+Littlewood+JM&amp;rft.au=Pitts-Tucker+TJ%2C+Miller+MG%2C+Littlewood+JM&amp;rft.date=June+1986&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1777828&amp;rft_id=info%3Adoi%2F10.1136%2Fadc.61.6.576&amp;rft_id=info%3Apmc%2F1777828&amp;rft_id=info%3Apmid%2F3488032&amp;rft.issue=6&amp;rft.jtitle=Arch.+Dis.+Child.&amp;rft.pages=576-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=61" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><span class="citation journal">McCallum TJ, Milunsky JM, Cunningham DL, Harris DH, Maher TA, Oates RD (October 2000). "Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes". <i>Chest</i> <b>118</b> (4): 1059–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.118.4.1059">10.1378/chest.118.4.1059</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11035677">11035677</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Fertility+in+men+with+cystic+fibrosis%3A+an+update+on+current+surgical+practices+and+outcomes&amp;rft.aulast=McCallum+TJ%2C+Milunsky+JM%2C+Cunningham+DL%2C+Harris+DH%2C+Maher+TA%2C+Oates+RD&amp;rft.au=McCallum+TJ%2C+Milunsky+JM%2C+Cunningham+DL%2C+Harris+DH%2C+Maher+TA%2C+Oates+RD&amp;rft.date=October+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.118.4.1059&amp;rft_id=info%3Apmid%2F11035677&amp;rft.issue=4&amp;rft.jtitle=Chest&amp;rft.pages=1059-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=118" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><span class="citation journal">Chen H, Ruan YC, Xu WM, Chen J, Chan HC (2012). "Regulation of male fertility by CFTR and implications in male infertility". <i>Human Reproduction Update</i> <b>18</b> (6): 703–713. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhumupd%2Fdms027">10.1093/humupd/dms027</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22709980">22709980</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Regulation+of+male+fertility+by+CFTR+and+implications+in+male+infertility&amp;rft.au=Chen+H%2C+Ruan+YC%2C+Xu+WM%2C+Chen+J%2C+Chan+HC&amp;rft.aulast=Chen+H%2C+Ruan+YC%2C+Xu+WM%2C+Chen+J%2C+Chan+HC&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhumupd%2Fdms027&amp;rft_id=info%3Apmid%2F22709980&amp;rft.issue=6&amp;rft.jtitle=Human+Reproduction+Update&amp;rft.pages=703-713&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation journal">Augarten A, Yahav Y, Kerem BS, Halle D, Laufer J, Szeinberg A, Dor J, Mashiach S, Gazit E, Madgar I (November 1994). "Congenital bilateral absence of vas deferens in the absence of cystic fibrosis". <i>Lancet</i> <b>344</b> (8935): 1473–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2894%2990292-5">10.1016/S0140-6736(94)90292-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7968122">7968122</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Congenital+bilateral+absence+of+vas+deferens+in+the+absence+of+cystic+fibrosis&amp;rft.au=Augarten+A%2C+Yahav+Y%2C+Kerem+BS%2C+Halle+D%2C+Laufer+J%2C+Szeinberg+A%2C+Dor+J%2C+Mashiach+S%2C+Gazit+E%2C+Madgar+I&amp;rft.aulast=Augarten+A%2C+Yahav+Y%2C+Kerem+BS%2C+Halle+D%2C+Laufer+J%2C+Szeinberg+A%2C+Dor+J%2C+Mashiach+S%2C+Gazit+E%2C+Madgar+I&amp;rft.date=November+1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2894%2990292-5&amp;rft_id=info%3Apmid%2F7968122&amp;rft.issue=8935&amp;rft.jtitle=Lancet&amp;rft.pages=1473-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=344" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation journal">Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE (July 2000). "Pregnancy in cystic fibrosis. Fetal and maternal outcome". <i>Chest</i> <b>118</b> (1): 85–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.118.1.85">10.1378/chest.118.1.85</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10893364">10893364</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Pregnancy+in+cystic+fibrosis.+Fetal+and+maternal+outcome&amp;rft.au=Gilljam+M%2C+Antoniou+M%2C+Shin+J%2C+Dupuis+A%2C+Corey+M%2C+Tullis+DE&amp;rft.aulast=Gilljam+M%2C+Antoniou+M%2C+Shin+J%2C+Dupuis+A%2C+Corey+M%2C+Tullis+DE&amp;rft.date=July+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.118.1.85&amp;rft_id=info%3Apmid%2F10893364&amp;rft.issue=1&amp;rft.jtitle=Chest&amp;rft.pages=85-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=118" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.science.ca/scientists/scientistprofile.php?pID=19">"Profile&#160;: Lap-Chee Tsui"</a>. Science.ca. 1989-05-09<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-01-23</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=Profile+%3A+Lap-Chee+Tsui&amp;rft.date=1989-05-09&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.science.ca%2Fscientists%2Fscientistprofile.php%3FpID%3D19&amp;rft.pub=Science.ca&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-prevalence-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-prevalence_40-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bobadilla JL, Macek M, Fine JP, Farrell PM (June 2002). "Cystic fibrosis: a worldwide analysis of CFTR mutations—correlation with incidence data and application to screening". <i>Hum. Mutat.</i> <b>19</b> (6): 575–606. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhumu.10041">10.1002/humu.10041</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12007216">12007216</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis%3A+a+worldwide+analysis+of+CFTR+mutations%E2%80%94correlation+with+incidence+data+and+application+to+screening&amp;rft.au=Bobadilla+JL%2C+Macek+M%2C+Fine+JP%2C+Farrell+PM&amp;rft.aulast=Bobadilla+JL%2C+Macek+M%2C+Fine+JP%2C+Farrell+PM&amp;rft.date=June+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.10041&amp;rft_id=info%3Apmid%2F12007216&amp;rft.issue=6&amp;rft.jtitle=Hum.+Mutat.&amp;rft.pages=575-606&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><span class="citation journal">Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, Stutts MJ, Milgram SL (July 1998). "An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton". <i>J. Biol. Chem.</i> <b>273</b> (31): 19797–801. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1074%2Fjbc.273.31.19797">10.1074/jbc.273.31.19797</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9677412">9677412</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=An+apical+PDZ+protein+anchors+the+cystic+fibrosis+transmembrane+conductance+regulator+to+the+cytoskeleton&amp;rft.aulast=Short+DB%2C+Trotter+KW%2C+Reczek+D%2C+Kreda+SM%2C+Bretscher+A%2C+Boucher+RC%2C+Stutts+MJ%2C+Milgram+SL&amp;rft.au=Short+DB%2C+Trotter+KW%2C+Reczek+D%2C+Kreda+SM%2C+Bretscher+A%2C+Boucher+RC%2C+Stutts+MJ%2C+Milgram+SL&amp;rft.date=July+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1074%2Fjbc.273.31.19797&amp;rft_id=info%3Apmid%2F9677412&amp;rft.issue=31&amp;rft.jtitle=J.+Biol.+Chem.&amp;rft.pages=19797-801&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=273" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><a href="#CITEREFChildersEckelHimmel2007">Childers, Eckel &amp; Himmel 2007</a></span></li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><a href="#CITEREFXuSz.C3.A9pLu2009">Xu, Szép &amp; Lu 2009</a></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><a href="#CITEREFMoskwaLorentzenExcoffon2007">Moskwa, Lorentzen &amp; Excoffon 2007</a></span></li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><a href="#CITEREFConnerWijkstrom-FreiRandell2007">Conner, Wijkstrom-Frei &amp; Randell 2007</a></span></li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text">Verkman AS, Song Y, Thiagarajah JR. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am J Physiol Cell Physiol. 2003;284(1):C2–C15</span></li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text">Marieb &amp; Hoehn, (2014) Human Antomy and Physiology, Chapter 22: The Respiratory System, pg 906, Pearson Education</span></li>
<li id="cite_note-Saiman-48"><span class="mw-cite-backlink">^ <a href="#cite_ref-Saiman_48-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Saiman_48-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Saiman L (2004). "Microbiology of early CF lung disease". <i>Paediatric Respiratory Reviews</i> <b>5</b> (Suppl A): S367–69. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS1526-0542%2804%2990065-6">10.1016/S1526-0542(04)90065-6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14980298">14980298</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Microbiology+of+early+CF+lung+disease&amp;rft.aulast=Saiman+L&amp;rft.au=Saiman+L&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS1526-0542%2804%2990065-6&amp;rft_id=info%3Apmid%2F14980298&amp;rft.issue=Suppl+A&amp;rft.jtitle=Paediatric+Respiratory+Reviews&amp;rft.pages=S367-69&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><span class="citation journal">Tümmler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H (June 1991). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC271975">"Nosocomial acquisition of <i>Pseudomonas aeruginosa</i> by cystic fibrosis patients"</a>. <i>J. Clin. Microbiol.</i> <b>29</b> (6): 1265–7. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1991JPoSA..29.1265A">1991JPoSA..29.1265A</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fpola.1991.080290905">10.1002/pola.1991.080290905</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC271975">271975</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1907611">1907611</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Nosocomial+acquisition+of+Pseudomonas+aeruginosa+by+cystic+fibrosis+patients&amp;rft.aulast=T%C3%BCmmler+B%2C+Koopmann+U%2C+Grothues+D%2C+Weissbrodt+H%2C+Steinkamp+G%2C+von+der+Hardt+H&amp;rft.au=T%C3%BCmmler+B%2C+Koopmann+U%2C+Grothues+D%2C+Weissbrodt+H%2C+Steinkamp+G%2C+von+der+Hardt+H&amp;rft.date=June+1991&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC271975&amp;rft_id=info%3Abibcode%2F1991JPoSA..29.1265A&amp;rft_id=info%3Adoi%2F10.1002%2Fpola.1991.080290905&amp;rft_id=info%3Apmc%2F271975&amp;rft_id=info%3Apmid%2F1907611&amp;rft.issue=6&amp;rft.jtitle=J.+Clin.+Microbiol.&amp;rft.pages=1265-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><span class="citation journal">"<i>Pseudomonas cepacia</i> at summer camps for persons with cystic fibrosis". <i>MMWR Morb. Mortal. Wkly. Rep.</i> <b>42</b> (23): 456–9. June 1993. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7684813">7684813</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Pseudomonas+cepacia+at+summer+camps+for+persons+with+cystic+fibrosis&amp;rft.date=June+1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F7684813&amp;rft.issue=23&amp;rft.jtitle=MMWR+Morb.+Mortal.+Wkly.+Rep.&amp;rft.pages=456-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=42" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><span class="citation journal">Pegues DA, Carson LA, Tablan OC, FitzSimmons SC, Roman SB, Miller JM, Jarvis WR (May 1994). "Acquisition of <i>Pseudomonas cepacia</i> at summer camps for patients with cystic fibrosis. Summer Camp Study Group". <i>J. Pediatr.</i> <b>124</b> (5 Pt 1): 694–702. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-3476%2805%2981357-5">10.1016/S0022-3476(05)81357-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7513755">7513755</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Acquisition+of+Pseudomonas+cepacia+at+summer+camps+for+patients+with+cystic+fibrosis.+Summer+Camp+Study+Group&amp;rft.aulast=Pegues+DA%2C+Carson+LA%2C+Tablan+OC%2C+FitzSimmons+SC%2C+Roman+SB%2C+Miller+JM%2C+Jarvis+WR&amp;rft.au=Pegues+DA%2C+Carson+LA%2C+Tablan+OC%2C+FitzSimmons+SC%2C+Roman+SB%2C+Miller+JM%2C+Jarvis+WR&amp;rft.date=May+1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-3476%2805%2981357-5&amp;rft_id=info%3Apmid%2F7513755&amp;rft.issue=5+Pt+1&amp;rft.jtitle=J.+Pediatr.&amp;rft.pages=694-702&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=124" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><span class="citation journal">Pankhurst CL, Philpott-Howard J (April 1996). "The environmental risk factors associated with medical and dental equipment in the transmission of <i>Burkholderia (Pseudomonas) cepacia</i> in cystic fibrosis patients". <i>J. Hosp. Infect.</i> <b>32</b> (4): 249–55. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0195-6701%2896%2990035-3">10.1016/S0195-6701(96)90035-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8744509">8744509</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+environmental+risk+factors+associated+with+medical+and+dental+equipment+in+the+transmission+of+Burkholderia+%28Pseudomonas%29+cepacia+in+cystic+fibrosis+patients&amp;rft.aulast=Pankhurst+CL%2C+Philpott-Howard+J&amp;rft.au=Pankhurst+CL%2C+Philpott-Howard+J&amp;rft.date=April+1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0195-6701%2896%2990035-3&amp;rft_id=info%3Apmid%2F8744509&amp;rft.issue=4&amp;rft.jtitle=J.+Hosp.+Infect.&amp;rft.pages=249-55&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><span class="citation journal">Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK (June 2003). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1746694">"Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak"</a>. <i>Thorax</i> <b>58</b> (6): 525–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fthorax.58.6.525">10.1136/thorax.58.6.525</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1746694">1746694</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12775867">12775867</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Identification+of+airborne+dissemination+of+epidemic+multiresistant+strains+of+Pseudomonas+aeruginosa+at+a+CF+centre+during+a+cross+infection+outbreak&amp;rft.au=Jones+AM%2C+Govan+JR%2C+Doherty+CJ%2C+Dodd+ME%2C+Isalska+BJ%2C+Stanbridge+TN%2C+Webb+AK&amp;rft.aulast=Jones+AM%2C+Govan+JR%2C+Doherty+CJ%2C+Dodd+ME%2C+Isalska+BJ%2C+Stanbridge+TN%2C+Webb+AK&amp;rft.date=June+2003&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1746694&amp;rft_id=info%3Adoi%2F10.1136%2Fthorax.58.6.525&amp;rft_id=info%3Apmc%2F1746694&amp;rft_id=info%3Apmid%2F12775867&amp;rft.issue=6&amp;rft.jtitle=Thorax&amp;rft.pages=525-27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=58" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><span class="citation journal">Høiby N (June 1995). "Isolation and treatment of cystic fibrosis patients with lung infections caused by <i>Pseudomonas (Burkholderia) cepacia</i> and multiresistant <i>Pseudomonas aeruginosa</i>". <i>Neth J Med</i> <b>46</b> (6): 280–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0300-2977%2895%2900020-N">10.1016/0300-2977(95)00020-N</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7643943">7643943</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Isolation+and+treatment+of+cystic+fibrosis+patients+with+lung+infections+caused+by+Pseudomonas+%28Burkholderia%29+cepacia+and+multiresistant+Pseudomonas+aeruginosa&amp;rft.au=H%C3%B8iby+N&amp;rft.aulast=H%C3%B8iby+N&amp;rft.date=June+1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0300-2977%2895%2900020-N&amp;rft_id=info%3Apmid%2F7643943&amp;rft.issue=6&amp;rft.jtitle=Neth+J+Med&amp;rft.pages=280-87&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Pihet-55"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pihet_55-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pihet_55-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Pihet M, Carrere J, Cimon B, Chabasse D, Delhaes L, Symoens F, Bouchara JP (June 2009). "Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis—a review". <i>Med Mycol.</i> <b>47</b> (4): 387–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F13693780802609604">10.1080/13693780802609604</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19107638">19107638</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Occurrence+and+relevance+of+filamentous+fungi+in+respiratory+secretions+of+patients+with+cystic+fibrosis%E2%80%94a+review&amp;rft.aulast=Pihet+M%2C+Carrere+J%2C+Cimon+B%2C+Chabasse+D%2C+Delhaes+L%2C+Symoens+F%2C+Bouchara+JP&amp;rft.au=Pihet+M%2C+Carrere+J%2C+Cimon+B%2C+Chabasse+D%2C+Delhaes+L%2C+Symoens+F%2C+Bouchara+JP&amp;rft.date=June+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1080%2F13693780802609604&amp;rft_id=info%3Apmid%2F19107638&amp;rft.issue=4&amp;rft.jtitle=Med+Mycol.&amp;rft.pages=387-97&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><span class="citation journal">Rapaka RR, Kolls JK (2009). "Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions". <i>Med Mycol.</i> <b>47</b> (Suppl 1): S331–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F13693780802266777">10.1080/13693780802266777</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18668399">18668399</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Pathogenesis+of+allergic+bronchopulmonary+aspergillosis+in+cystic+fibrosis%3A+current+understanding+and+future+directions&amp;rft.aulast=Rapaka+RR%2C+Kolls+JK&amp;rft.au=Rapaka+RR%2C+Kolls+JK&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1080%2F13693780802266777&amp;rft_id=info%3Apmid%2F18668399&amp;rft.issue=Suppl+1&amp;rft.jtitle=Med+Mycol.&amp;rft.pages=S331-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=47" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16648884-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16648884_57-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Mishra A, Greaves R, Massie J (November 2005). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1320177">"The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era."</a>. <i>The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists</i> <b>26</b> (4): 135–53. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1320177">1320177</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16648884">16648884</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+relevance+of+sweat+testing+for+the+diagnosis+of+cystic+fibrosis+in+the+genomic+era.&amp;rft.aulast=Mishra+A%2C+Greaves+R%2C+Massie+J&amp;rft.au=Mishra+A%2C+Greaves+R%2C+Massie+J&amp;rft.date=November+2005&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1320177&amp;rft_id=info%3Apmc%2F1320177&amp;rft_id=info%3Apmid%2F16648884&amp;rft.issue=4&amp;rft.jtitle=The+Clinical+biochemist.+Reviews+%2F+Australian+Association+of+Clinical+Biochemists&amp;rft.pages=135-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Davies-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-Davies_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Davies_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Davies JC, Alton EW, Bush A (December 2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2137053">"Cystic fibrosis"</a>. <i>BMJ</i> <b>335</b> (7632): 1255–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.39391.713229.AD">10.1136/bmj.39391.713229.AD</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2137053">2137053</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18079549">18079549</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis&amp;rft.au=Davies+JC%2C+Alton+EW%2C+Bush+A&amp;rft.aulast=Davies+JC%2C+Alton+EW%2C+Bush+A&amp;rft.date=December+2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2137053&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39391.713229.AD&amp;rft_id=info%3Apmc%2F2137053&amp;rft_id=info%3Apmid%2F18079549&amp;rft.issue=7632&amp;rft.jtitle=BMJ&amp;rft.pages=1255-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=335" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><span class="citation journal">Ross LF (September 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2569148">"Newborn screening for cystic fibrosis: a lesson in public health disparities"</a>. <i>The Journal of Pediatrics</i> <b>153</b> (3): 308–13. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jpeds.2008.04.061">10.1016/j.jpeds.2008.04.061</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2569148">2569148</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18718257">18718257</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Newborn+screening+for+cystic+fibrosis%3A+a+lesson+in+public+health+disparities&amp;rft.aulast=Ross+LF&amp;rft.au=Ross+LF&amp;rft.date=September+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2569148&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jpeds.2008.04.061&amp;rft_id=info%3Apmc%2F2569148&amp;rft_id=info%3Apmid%2F18718257&amp;rft.issue=3&amp;rft.jtitle=The+Journal+of+Pediatrics&amp;rft.pages=308-13&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=153" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><span class="citation journal">Assael BM, Castellani C, Ocampo MB, Iansa P, Callegaro A, Valsecchi MG (September 2002). <a rel="nofollow" class="external text" href="http://aje.oxfordjournals.org/cgi/reprint/156/5/397">"Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years"</a>. <i>American Journal of Epidemiology</i> <b>156</b> (5): 397–401. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Faje%2Fkwf064">10.1093/aje/kwf064</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12196308">12196308</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Epidemiology+and+survival+analysis+of+cystic+fibrosis+in+an+area+of+intense+neonatal+screening+over+30+years&amp;rft.au=Assael+BM%2C+Castellani+C%2C+Ocampo+MB%2C+Iansa+P%2C+Callegaro+A%2C+Valsecchi+MG&amp;rft.aulast=Assael+BM%2C+Castellani+C%2C+Ocampo+MB%2C+Iansa+P%2C+Callegaro+A%2C+Valsecchi+MG&amp;rft.date=September+2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Faje.oxfordjournals.org%2Fcgi%2Freprint%2F156%2F5%2F397&amp;rft_id=info%3Adoi%2F10.1093%2Faje%2Fkwf064&amp;rft_id=info%3Apmid%2F12196308&amp;rft.issue=5&amp;rft.jtitle=American+Journal+of+Epidemiology&amp;rft.pages=397-401&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=156" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><a href="#CITEREFMinarowskiSandsMinarowska2008">Minarowski, Sands &amp; Minarowska 2008</a></span></li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><span class="citation journal">Stern RC (February 1997). "The diagnosis of cystic fibrosis". <i>N. Engl. J. Med.</i> <b>336</b> (7): 487–91. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199702133360707">10.1056/NEJM199702133360707</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9017943">9017943</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+diagnosis+of+cystic+fibrosis&amp;rft.aulast=Stern+RC&amp;rft.au=Stern+RC&amp;rft.date=February+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199702133360707&amp;rft_id=info%3Apmid%2F9017943&amp;rft.issue=7&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=487-91&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=336" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><span class="citation news">Freudenheim, Milt (2009-12-22). <a rel="nofollow" class="external text" href="http://www.nytimes.com/2009/12/22/health/22cyst.html?8dpc=&amp;pagewanted=all">"Tool in Cystic Fibrosis Fight: A Registry"</a>. <i><a href="/wiki/New_York_Times" title="New York Times" class="mw-redirect">New York Times</a></i>. pp.&#160;D1<span class="reference-accessdate">. Retrieved <span class="nowrap">2009-12-21</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Tool+in+Cystic+Fibrosis+Fight%3A+A+Registry&amp;rft.aufirst=Milt&amp;rft.au=Freudenheim%2C+Milt&amp;rft.aulast=Freudenheim&amp;rft.date=2009-12-22&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nytimes.com%2F2009%2F12%2F22%2Fhealth%2F22cyst.html%3F8dpc%3D%26pagewanted%3Dall&amp;rft.jtitle=New+York+Times&amp;rft.pages=D1&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><span class="citation book">American College of Obstetricians and Gynecologists; American College of Medical Genetics (2001). <i>Preconception and prenatal carrier screening for cystic fibrosis. Clinical and laboratory guidelines</i>. Washington DC: American College of Obstetricians and Gynecologists. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-915473-74-7" title="Special:BookSources/0-915473-74-7">0-915473-74-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.au=American+College+of+Medical+Genetics&amp;rft.au=American+College+of+Obstetricians+and+Gynecologists&amp;rft.aulast=American+College+of+Obstetricians+and+Gynecologists&amp;rft.btitle=Preconception+and+prenatal+carrier+screening+for+cystic+fibrosis.+Clinical+and+laboratory+guidelines&amp;rft.date=2001&amp;rft.genre=book&amp;rft.isbn=0-915473-74-7&amp;rft.place=Washington+DC&amp;rft.pub=American+College+of+Obstetricians+and+Gynecologists&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><span class="citation journal">Elias S, Annas GJ, Simpson JL (April 1991). "Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice". <i>Am. J. Obstet. Gynecol.</i> <b>164</b> (4): 1077–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2F0002-9378%2891%2990589-j">10.1016/0002-9378(91)90589-j</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2014829">2014829</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Carrier+screening+for+cystic+fibrosis%3A+implications+for+obstetric+and+gynecologic+practice&amp;rft.au=Elias+S%2C+Annas+GJ%2C+Simpson+JL&amp;rft.aulast=Elias+S%2C+Annas+GJ%2C+Simpson+JL&amp;rft.date=April+1991&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2F0002-9378%2891%2990589-j&amp;rft_id=info%3Apmid%2F2014829&amp;rft.issue=4&amp;rft.jtitle=Am.+J.+Obstet.+Gynecol.&amp;rft.pages=1077-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=164" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><span class="citation journal">Tabor A, Philip J, Madsen M, Bang J, Obel EB, Nørgaard-Pedersen B (June 1986). "Randomised controlled trial of genetic amniocentesis in 4606 low-risk women". <i>Lancet</i> <b>1</b> (8493): 1287–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2886%2991218-3">10.1016/S0140-6736(86)91218-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2423826">2423826</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Randomised+controlled+trial+of+genetic+amniocentesis+in+4606+low-risk+women&amp;rft.aulast=Tabor+A%2C+Philip+J%2C+Madsen+M%2C+Bang+J%2C+Obel+EB%2C+N%C3%B8rgaard-Pedersen+B&amp;rft.au=Tabor+A%2C+Philip+J%2C+Madsen+M%2C+Bang+J%2C+Obel+EB%2C+N%C3%B8rgaard-Pedersen+B&amp;rft.date=June+1986&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2886%2991218-3&amp;rft_id=info%3Apmid%2F2423826&amp;rft.issue=8493&amp;rft.jtitle=Lancet&amp;rft.pages=1287-93&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><span class="citation journal">Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Porter TF, Luthy DA, Comstock CH, Saade GR, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME (November 2006). "Pregnancy loss rates after midtrimester amniocentesis". <i>Obstet Gynecol</i> <b>108</b> (5): 1067–72. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2F01.AOG.0000240135.13594.07">10.1097/01.AOG.0000240135.13594.07</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17077226">17077226</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Pregnancy+loss+rates+after+midtrimester+amniocentesis&amp;rft.au=Eddleman+KA%2C+Malone+FD%2C+Sullivan+L%2C+Dukes+K%2C+Berkowitz+RL%2C+Kharbutli+Y%2C+Porter+TF%2C+Luthy+DA%2C+Comstock+CH%2C+Saade+GR%2C+Klugman+S%2C+Dugoff+L%2C+Craigo+SD%2C+Timor-Tritsch+IE%2C+Carr+SR%2C+Wolfe+HM%2C+D%27Alton+ME&amp;rft.aulast=Eddleman+KA%2C+Malone+FD%2C+Sullivan+L%2C+Dukes+K%2C+Berkowitz+RL%2C+Kharbutli+Y%2C+Porter+TF%2C+Luthy+DA%2C+Comstock+CH%2C+Saade+GR%2C+Klugman+S%2C+Dugoff+L%2C+Craigo+SD%2C+Timor-Tritsch+IE%2C+Carr+SR%2C+Wolfe+HM%2C+D%27Alton+ME&amp;rft.date=November+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F01.AOG.0000240135.13594.07&amp;rft_id=info%3Apmid%2F17077226&amp;rft.issue=5&amp;rft.jtitle=Obstet+Gynecol&amp;rft.pages=1067-72&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=108" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><span class="citation journal">Davis LB, Champion SJ, Fair SO, Baker VL, Garber AM (April 2010). "A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis". <i>Fertil. Sterol.</i> <b>93</b> (6): 1793–804. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.fertnstert.2008.12.053">10.1016/j.fertnstert.2008.12.053</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19439290">19439290</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=A+cost-benefit+analysis+of+preimplantation+genetic+diagnosis+for+carrier+couples+of+cystic+fibrosis&amp;rft.au=Davis+LB%2C+Champion+SJ%2C+Fair+SO%2C+Baker+VL%2C+Garber+AM&amp;rft.aulast=Davis+LB%2C+Champion+SJ%2C+Fair+SO%2C+Baker+VL%2C+Garber+AM&amp;rft.date=April+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.fertnstert.2008.12.053&amp;rft_id=info%3Apmid%2F19439290&amp;rft.issue=6&amp;rft.jtitle=Fertil.+Sterol.&amp;rft.pages=1793-804&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=93" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><span class="citation journal">Pai VB, Nahata MC (October 2001). "Efficacy and safety of aerosolized tobramycin in cystic fibrosis". <i>Pediatr. Pulmonol.</i> <b>32</b> (4): 314–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fppul.1125">10.1002/ppul.1125</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11568993">11568993</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Efficacy+and+safety+of+aerosolized+tobramycin+in+cystic+fibrosis&amp;rft.aulast=Pai+VB%2C+Nahata+MC&amp;rft.au=Pai+VB%2C+Nahata+MC&amp;rft.date=October+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fppul.1125&amp;rft_id=info%3Apmid%2F11568993&amp;rft.issue=4&amp;rft.jtitle=Pediatr.+Pulmonol.&amp;rft.pages=314-27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><span class="citation journal">Westerman EM, Le Brun PP, Touw DJ, Frijlink HW, Heijerman HG (March 2004). "Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study". <i>J. Cyst. Fibros.</i> <b>3</b> (1): 23–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jcf.2003.12.005">10.1016/j.jcf.2003.12.005</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15463883">15463883</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Effect+of+nebulized+colistin+sulphate+and+colistin+sulphomethate+on+lung+function+in+patients+with+cystic+fibrosis%3A+a+pilot+study&amp;rft.aulast=Westerman+EM%2C+Le+Brun+PP%2C+Touw+DJ%2C+Frijlink+HW%2C+Heijerman+HG&amp;rft.au=Westerman+EM%2C+Le+Brun+PP%2C+Touw+DJ%2C+Frijlink+HW%2C+Heijerman+HG&amp;rft.date=March+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jcf.2003.12.005&amp;rft_id=info%3Apmid%2F15463883&amp;rft.issue=1&amp;rft.jtitle=J.+Cyst.+Fibros.&amp;rft.pages=23-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><span class="citation journal">McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB (November 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2577727">"Inhaled aztreonam lysine for chronic airway <i>Pseudomonas aeruginosa</i> in cystic fibrosis"</a>. <i>Am. J. Respir. Crit. Care Med.</i> <b>178</b> (9): 921–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200712-1804OC">10.1164/rccm.200712-1804OC</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2577727">2577727</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18658109">18658109</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Inhaled+aztreonam+lysine+for+chronic+airway+Pseudomonas+aeruginosa+in+cystic+fibrosis&amp;rft.aulast=McCoy+KS%2C+Quittner+AL%2C+Oermann+CM%2C+Gibson+RL%2C+Retsch-Bogart+GZ%2C+Montgomery+AB&amp;rft.au=McCoy+KS%2C+Quittner+AL%2C+Oermann+CM%2C+Gibson+RL%2C+Retsch-Bogart+GZ%2C+Montgomery+AB&amp;rft.date=November+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2577727&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200712-1804OC&amp;rft_id=info%3Apmc%2F2577727&amp;rft_id=info%3Apmid%2F18658109&amp;rft.issue=9&amp;rft.jtitle=Am.+J.+Respir.+Crit.+Care+Med.&amp;rft.pages=921-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=178" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid21412868-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid21412868_72-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ryan G, Singh M, Dwan K (2011). "Inhaled antibiotics for long-term therapy in cystic fibrosis". <i>The Cochrane Database of Systematic Reviews</i> (3): CD001021. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD001021.pub2">10.1002/14651858.CD001021.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21412868">21412868</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Inhaled+antibiotics+for+long-term+therapy+in+cystic+fibrosis&amp;rft.aulast=Ryan+G%2C+Singh+M%2C+Dwan+K&amp;rft.au=Ryan+G%2C+Singh+M%2C+Dwan+K&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001021.pub2&amp;rft_id=info%3Apmid%2F21412868&amp;rft.issue=3&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.pages=CD001021&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-73">^</a></b></span> <span class="reference-text"><span class="citation journal">Hansen CR, Pressler T, Koch C, Høiby N (March 2005). "Long-term azitromycin treatment of cystic fibrosis patients with chronic <i>Pseudomonas aeruginosa</i> infection; an observational cohort study". <i>J. Cyst. Fibros.</i> <b>4</b> (1): 35–40. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jcf.2004.09.001">10.1016/j.jcf.2004.09.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15752679">15752679</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Long-term+azitromycin+treatment+of+cystic+fibrosis+patients+with+chronic+Pseudomonas+aeruginosa+infection%3B+an+observational+cohort+study&amp;rft.au=Hansen+CR%2C+Pressler+T%2C+Koch+C%2C+H%C3%B8iby+N&amp;rft.aulast=Hansen+CR%2C+Pressler+T%2C+Koch+C%2C+H%C3%B8iby+N&amp;rft.date=March+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jcf.2004.09.001&amp;rft_id=info%3Apmid%2F15752679&amp;rft.issue=1&amp;rft.jtitle=J.+Cyst.+Fibros.&amp;rft.pages=35-40&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-74">^</a></b></span> <span class="reference-text"><span class="citation journal">Tan KH, Mulheran M, Knox AJ, Smyth AR (March 2003). <a rel="nofollow" class="external text" href="http://ajrccm.atsjournals.org/cgi/pmidlookup?view=long&amp;pmid=12623858">"Aminoglycoside prescribing and surveillance in cystic fibrosis"</a>. <i>Am. J. Respir. Crit. Care Med.</i> <b>167</b> (6): 819–23. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200109-012CC">10.1164/rccm.200109-012CC</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12623858">12623858</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Aminoglycoside+prescribing+and+surveillance+in+cystic+fibrosis&amp;rft.aulast=Tan+KH%2C+Mulheran+M%2C+Knox+AJ%2C+Smyth+AR&amp;rft.au=Tan+KH%2C+Mulheran+M%2C+Knox+AJ%2C+Smyth+AR&amp;rft.date=March+2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fajrccm.atsjournals.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D12623858&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200109-012CC&amp;rft_id=info%3Apmid%2F12623858&amp;rft.issue=6&amp;rft.jtitle=Am.+J.+Respir.+Crit.+Care+Med.&amp;rft.pages=819-23&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=167" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><span class="citation journal">van der Schans C, Prasad A, Main E (2000). Van Der Schans, Cees P, ed. "Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis". <i>Cochrane Database Syst Rev</i> (2): CD001401. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD001401">10.1002/14651858.CD001401</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10796781">10796781</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Chest+physiotherapy+compared+to+no+chest+physiotherapy+for+cystic+fibrosis&amp;rft.aulast=van+der+Schans+C%2C+Prasad+A%2C+Main+E&amp;rft.au=van+der+Schans+C%2C+Prasad+A%2C+Main+E&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001401&amp;rft_id=info%3Apmid%2F10796781&amp;rft.issue=2&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD001401&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Whit2014-76"><span class="mw-cite-backlink">^ <a href="#cite_ref-Whit2014_76-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Whit2014_76-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Whiting, P; Al, M; Burgers, L; Westwood, M; Ryder, S; Hoogendoorn, M; Armstrong, N; Allen, A; Severens, H; Kleijnen, J (March 2014). "Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis.". <i>Health technology assessment (Winchester, England)</i> <b>18</b> (18): 1–106. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24656117">24656117</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Ivacaftor+for+the+treatment+of+patients+with+cystic+fibrosis+and+the+G551D+mutation%3A+a+systematic+review+and+cost-effectiveness+analysis.&amp;rft.au=Al%2C+M&amp;rft.au=Allen%2C+A&amp;rft.au=Armstrong%2C+N&amp;rft.au=Burgers%2C+L&amp;rft.aufirst=P&amp;rft.au=Hoogendoorn%2C+M&amp;rft.au=Kleijnen%2C+J&amp;rft.aulast=Whiting&amp;rft.au=Ryder%2C+S&amp;rft.au=Severens%2C+H&amp;rft.au=Westwood%2C+M&amp;rft.au=Whiting%2C+P&amp;rft.date=March+2014&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F24656117&amp;rft.issue=18&amp;rft.jtitle=Health+technology+assessment+%28Winchester%2C+England%29&amp;rft.pages=1-106&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><span class="citation journal">Wainwright, CE (October 2014). "Ivacaftor for patients with cystic fibrosis.". <i>Expert review of respiratory medicine</i> <b>8</b> (5): 533–8. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25148205">25148205</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Ivacaftor+for+patients+with+cystic+fibrosis.&amp;rft.aufirst=CE&amp;rft.aulast=Wainwright&amp;rft.au=Wainwright%2C+CE&amp;rft.date=October+2014&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F25148205&amp;rft.issue=5&amp;rft.jtitle=Expert+review+of+respiratory+medicine&amp;rft.pages=533-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><span class="citation journal">Kuver R, Lee SP (April 2006). "Hypertonic saline for cystic fibrosis". <i>N. Engl. J. Med.</i> <b>354</b> (17): 1848–51; author reply 1848–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMc060351">10.1056/NEJMc060351</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16642591">16642591</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Hypertonic+saline+for+cystic+fibrosis&amp;rft.au=Kuver+R%2C+Lee+SP&amp;rft.aulast=Kuver+R%2C+Lee+SP&amp;rft.date=April+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMc060351&amp;rft_id=info%3Apmid%2F16642591&amp;rft.issue=17&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1848-51%3B+author+reply+1848-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=354" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-79">^</a></b></span> <span class="reference-text"><span class="citation journal">Lieberman J (July 1968). "Dornase aerosol effect on sputum viscosity in cases of cystic fibrosis". <i>JAMA</i> <b>205</b> (5): 312–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Fjama.205.5.312">10.1001/jama.205.5.312</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/5694947">5694947</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Dornase+aerosol+effect+on+sputum+viscosity+in+cases+of+cystic+fibrosis&amp;rft.aulast=Lieberman+J&amp;rft.au=Lieberman+J&amp;rft.date=July+1968&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.205.5.312&amp;rft_id=info%3Apmid%2F5694947&amp;rft.issue=5&amp;rft.jtitle=JAMA&amp;rft.pages=312-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=205" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid18276176-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18276176_80-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kellerman D, Rossi Mospan A, Engels J, Schaberg A, Gorden J, Smiley L (2008). "Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3". <i>Pulmonary Pharmacology &amp; Therapeutics</i> <b>21</b> (4): 600–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.pupt.2007.12.003">10.1016/j.pupt.2007.12.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18276176">18276176</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Denufosol%3A+a+review+of+studies+with+inhaled+P2Y%282%29+agonists+that+led+to+Phase+3&amp;rft.au=Kellerman+D%2C+Rossi+Mospan+A%2C+Engels+J%2C+Schaberg+A%2C+Gorden+J%2C+Smiley+L&amp;rft.aulast=Kellerman+D%2C+Rossi+Mospan+A%2C+Engels+J%2C+Schaberg+A%2C+Gorden+J%2C+Smiley+L&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pupt.2007.12.003&amp;rft_id=info%3Apmid%2F18276176&amp;rft.issue=4&amp;rft.jtitle=Pulmonary+Pharmacology+%26+Therapeutics&amp;rft.pages=600-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=21" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><span class="citation journal">Balfour-Lynn, IM; Welch, K (Oct 9, 2014). "Inhaled corticosteroids for cystic fibrosis.". <i>The Cochrane database of systematic reviews</i> <b>10</b>: CD001915. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD001915.pub4">10.1002/14651858.CD001915.pub4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25300165">25300165</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Inhaled+corticosteroids+for+cystic+fibrosis.&amp;rft.au=Balfour-Lynn%2C+IM&amp;rft.aufirst=IM&amp;rft.aulast=Balfour-Lynn&amp;rft.au=Welch%2C+K&amp;rft.date=Oct+9%2C+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD001915.pub4&amp;rft_id=info%3Apmid%2F25300165&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD001915&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><span class="citation journal">Moran F, Bradley JM, Piper AJ (2009). Moran, Fidelma, ed. "Non-invasive ventilation for cystic fibrosis". <i>Cochrane Database Syst Rev</i> (1): CD002769. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD002769.pub3">10.1002/14651858.CD002769.pub3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19160211">19160211</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Non-invasive+ventilation+for+cystic+fibrosis&amp;rft.aulast=Moran+F%2C+Bradley+JM%2C+Piper+AJ&amp;rft.au=Moran+F%2C+Bradley+JM%2C+Piper+AJ&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002769.pub3&amp;rft_id=info%3Apmid%2F19160211&amp;rft.issue=1&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD002769&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16229132-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16229132_83-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Huth MM, Zink KA, Van Horn NR (2005). "The effects of massage therapy in improving outcomes for youth with cystic fibrosis: an evidence review". <i>Pediatr Nurs</i> <b>31</b> (4): 328–32. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16229132">16229132</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+effects+of+massage+therapy+in+improving+outcomes+for+youth+with+cystic+fibrosis%3A+an+evidence+review&amp;rft.au=Huth+MM%2C+Zink+KA%2C+Van+Horn+NR&amp;rft.aulast=Huth+MM%2C+Zink+KA%2C+Van+Horn+NR&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F16229132&amp;rft.issue=4&amp;rft.jtitle=Pediatr+Nurs&amp;rft.pages=328-32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=31" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-84">^</a></b></span> <span class="reference-text"><span class="citation journal">Burgess, L; Southern, KW (Aug 5, 2014). "Pneumococcal vaccines for cystic fibrosis.". <i>The Cochrane database of systematic reviews</i> <b>8</b>: CD008865. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008865.pub3">10.1002/14651858.CD008865.pub3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25093421">25093421</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Pneumococcal+vaccines+for+cystic+fibrosis.&amp;rft.au=Burgess%2C+L&amp;rft.aufirst=L&amp;rft.aulast=Burgess&amp;rft.au=Southern%2C+KW&amp;rft.date=Aug+5%2C+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008865.pub3&amp;rft_id=info%3Apmid%2F25093421&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD008865&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-85">^</a></b></span> <span class="reference-text"><span class="citation journal">Fridell JA, Vianna R, Kwo PY, Howenstine M, Sannuti A, Molleston JP, Pescovitz MD, Tector AJ (October 2005). "Simultaneous liver and pancreas transplantation in patients with cystic fibrosis". <i>Transplant. Proc.</i> <b>37</b> (8): 3567–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.transproceed.2005.09.091">10.1016/j.transproceed.2005.09.091</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16298663">16298663</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Simultaneous+liver+and+pancreas+transplantation+in+patients+with+cystic+fibrosis&amp;rft.au=Fridell+JA%2C+Vianna+R%2C+Kwo+PY%2C+Howenstine+M%2C+Sannuti+A%2C+Molleston+JP%2C+Pescovitz+MD%2C+Tector+AJ&amp;rft.aulast=Fridell+JA%2C+Vianna+R%2C+Kwo+PY%2C+Howenstine+M%2C+Sannuti+A%2C+Molleston+JP%2C+Pescovitz+MD%2C+Tector+AJ&amp;rft.date=October+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.transproceed.2005.09.091&amp;rft_id=info%3Apmid%2F16298663&amp;rft.issue=8&amp;rft.jtitle=Transplant.+Proc.&amp;rft.pages=3567-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><span class="citation journal">Belkin RA, Henig NR, Singer LG, Chaparro C, Rubenstein RC, Xie SX, Yee JY, Kotloff RM, Lipson DA, Bunin GR (March 2006). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2662949">"Risk factors for death of patients with cystic fibrosis awaiting lung transplantation"</a>. <i>Am. J. Respir. Crit. Care Med.</i> <b>173</b> (6): 659–66. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1164%2Frccm.200410-1369OC">10.1164/rccm.200410-1369OC</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2662949">2662949</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16387803">16387803</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Risk+factors+for+death+of+patients+with+cystic+fibrosis+awaiting+lung+transplantation&amp;rft.au=Belkin+RA%2C+Henig+NR%2C+Singer+LG%2C+Chaparro+C%2C+Rubenstein+RC%2C+Xie+SX%2C+Yee+JY%2C+Kotloff+RM%2C+Lipson+DA%2C+Bunin+GR&amp;rft.aulast=Belkin+RA%2C+Henig+NR%2C+Singer+LG%2C+Chaparro+C%2C+Rubenstein+RC%2C+Xie+SX%2C+Yee+JY%2C+Kotloff+RM%2C+Lipson+DA%2C+Bunin+GR&amp;rft.date=March+2006&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2662949&amp;rft_id=info%3Adoi%2F10.1164%2Frccm.200410-1369OC&amp;rft_id=info%3Apmc%2F2662949&amp;rft_id=info%3Apmid%2F16387803&amp;rft.issue=6&amp;rft.jtitle=Am.+J.+Respir.+Crit.+Care+Med.&amp;rft.pages=659-66&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=173" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><span class="citation journal">Somaraju, UR; Solis-Moya, A (Oct 13, 2014). "Pancreatic enzyme replacement therapy for people with cystic fibrosis.". <i>The Cochrane database of systematic reviews</i> <b>10</b>: CD008227. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD008227.pub2">10.1002/14651858.CD008227.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25310479">25310479</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Pancreatic+enzyme+replacement+therapy+for+people+with+cystic+fibrosis.&amp;rft.aufirst=UR&amp;rft.aulast=Somaraju&amp;rft.au=Solis-Moya%2C+A&amp;rft.au=Somaraju%2C+UR&amp;rft.date=Oct+13%2C+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD008227.pub2&amp;rft_id=info%3Apmid%2F25310479&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD008227&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zirbes-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-Zirbes_88-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zirbes J, Milla CE (September 2009). "Cystic fibrosis related diabetes". <i>Paediatr Respir Rev</i> <b>10</b> (3): 118–23; quiz 123. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.prrv.2009.04.004">10.1016/j.prrv.2009.04.004</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19651382">19651382</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+related+diabetes&amp;rft.aulast=Zirbes+J%2C+Milla+CE&amp;rft.au=Zirbes+J%2C+Milla+CE&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.prrv.2009.04.004&amp;rft_id=info%3Apmid%2F19651382&amp;rft.issue=3&amp;rft.jtitle=Paediatr+Respir+Rev&amp;rft.pages=118-23%3B+quiz+123&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-89">^</a></b></span> <span class="reference-text"><span class="citation journal">Onady GM, Stolfi A (2005). Onady, Gary M, ed. "Insulin and oral agents for managing cystic fibrosis-related diabetes". <i>Cochrane Database Syst Rev</i> (3): CD004730. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD004730.pub2">10.1002/14651858.CD004730.pub2</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16034943">16034943</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Insulin+and+oral+agents+for+managing+cystic+fibrosis-related+diabetes&amp;rft.aulast=Onady+GM%2C+Stolfi+A&amp;rft.au=Onady+GM%2C+Stolfi+A&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004730.pub2&amp;rft_id=info%3Apmid%2F16034943&amp;rft.issue=3&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD004730&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><span class="citation journal">Conwell LS, Chang AB (2012). Conwell, Louise S, ed. "Bisphosphonates for osteoporosis in people with cystic fibrosis". <i>Cochrane Database Syst Rev</i> <b>4</b> (4): CD002010. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD002010.pub3">10.1002/14651858.CD002010.pub3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22513903">22513903</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Bisphosphonates+for+osteoporosis+in+people+with+cystic+fibrosis&amp;rft.au=Conwell+LS%2C+Chang+AB&amp;rft.aulast=Conwell+LS%2C+Chang+AB&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002010.pub3&amp;rft_id=info%3Apmid%2F22513903&amp;rft.issue=4&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD002010&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><span class="citation journal">Hardin DS, Rice J, Ahn C, Ferkol T, Howenstine M, Spears S, Prestidge C, Seilheimer DK, Shepherd R (March 2005). "Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition". <i>J. Pediatr.</i> <b>146</b> (3): 324–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jpeds.2004.10.037">10.1016/j.jpeds.2004.10.037</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15756212">15756212</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Growth+hormone+treatment+enhances+nutrition+and+growth+in+children+with+cystic+fibrosis+receiving+enteral+nutrition&amp;rft.au=Hardin+DS%2C+Rice+J%2C+Ahn+C%2C+Ferkol+T%2C+Howenstine+M%2C+Spears+S%2C+Prestidge+C%2C+Seilheimer+DK%2C+Shepherd+R&amp;rft.aulast=Hardin+DS%2C+Rice+J%2C+Ahn+C%2C+Ferkol+T%2C+Howenstine+M%2C+Spears+S%2C+Prestidge+C%2C+Seilheimer+DK%2C+Shepherd+R&amp;rft.date=March+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jpeds.2004.10.037&amp;rft_id=info%3Apmid%2F15756212&amp;rft.issue=3&amp;rft.jtitle=J.+Pediatr.&amp;rft.pages=324-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=146" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><span class="citation journal">Marks SC, Kissner DG (1997). "Management of sinusitis in adult cystic fibrosis". <i>Am J Rhinol</i> <b>11</b> (1): 11–4. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2500%2F105065897781446810">10.2500/105065897781446810</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9065342">9065342</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Management+of+sinusitis+in+adult+cystic+fibrosis&amp;rft.aulast=Marks+SC%2C+Kissner+DG&amp;rft.au=Marks+SC%2C+Kissner+DG&amp;rft.date=1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2500%2F105065897781446810&amp;rft_id=info%3Apmid%2F9065342&amp;rft.issue=1&amp;rft.jtitle=Am+J+Rhinol&amp;rft.pages=11-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><span class="citation journal">Phillipson GT, Petrucco OM, Matthews CD (February 2000). "Congenital bilateral absence of the vas deferens, cystic fibrosis mutation analysis and intracytoplasmic sperm injection". <i>Hum. Reprod.</i> <b>15</b> (2): 431–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fhumrep%2F15.2.431">10.1093/humrep/15.2.431</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10655317">10655317</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Congenital+bilateral+absence+of+the+vas+deferens%2C+cystic+fibrosis+mutation+analysis+and+intracytoplasmic+sperm+injection&amp;rft.aulast=Phillipson+GT%2C+Petrucco+OM%2C+Matthews+CD&amp;rft.au=Phillipson+GT%2C+Petrucco+OM%2C+Matthews+CD&amp;rft.date=February+2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fhumrep%2F15.2.431&amp;rft_id=info%3Apmid%2F10655317&amp;rft.issue=2&amp;rft.jtitle=Hum.+Reprod.&amp;rft.pages=431-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><span class="citation journal">Ciofu, O; Lykkesfeldt, J (Aug 7, 2014). "Antioxidant supplementation for lung disease in cystic fibrosis.". <i>The Cochrane database of systematic reviews</i> <b>8</b>: CD007020. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD007020.pub3">10.1002/14651858.CD007020.pub3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25102015">25102015</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Antioxidant+supplementation+for+lung+disease+in+cystic+fibrosis.&amp;rft.au=Ciofu%2C+O&amp;rft.aufirst=O&amp;rft.aulast=Ciofu&amp;rft.au=Lykkesfeldt%2C+J&amp;rft.date=Aug+7%2C+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD007020.pub3&amp;rft_id=info%3Apmid%2F25102015&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD007020&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-median-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-median_95-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cff.org/aboutcf/faqs/#What_is_the_life_expectancy_for_people_who_have_CF_%28in_the_United_States%29?/">"What is the life expectancy for people who have CF (in the United States)?"</a>. <a href="/wiki/Cystic_Fibrosis_Foundation" title="Cystic Fibrosis Foundation">Cystic Fibrosis Foundation</a>. 2008<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-03-14</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=What+is+the+life+expectancy+for+people+who+have+CF+%28in+the+United+States%29%3F&amp;rft.date=2008&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cff.org%2Faboutcf%2Ffaqs%2F%23What_is_the_life_expectancy_for_people_who_have_CF_%2528in_the_United_States%2529%3F%2F&amp;rft.pub=Cystic+Fibrosis+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Mac2014-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mac2014_96-0">^</a></b></span> <span class="reference-text"><span class="citation journal">MacKenzie, T; Gifford, AH; Sabadosa, KA; Quinton, HB; Knapp, EA; Goss, CH; Marshall, BC (Aug 19, 2014). "Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry.". <i>Annals of internal medicine</i> <b>161</b> (4): 233–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2Fm13-0636">10.7326/m13-0636</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25133359">25133359</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Longevity+of+patients+with+cystic+fibrosis+in+2000+to+2010+and+beyond%3A+survival+analysis+of+the+cystic+fibrosis+foundation+patient+registry.&amp;rft.aufirst=T&amp;rft.au=Gifford%2C+AH&amp;rft.au=Goss%2C+CH&amp;rft.au=Knapp%2C+EA&amp;rft.aulast=MacKenzie&amp;rft.au=MacKenzie%2C+T&amp;rft.au=Marshall%2C+BC&amp;rft.au=Quinton%2C+HB&amp;rft.au=Sabadosa%2C+KA&amp;rft.date=Aug+19%2C+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2Fm13-0636&amp;rft_id=info%3Apmid%2F25133359&amp;rft.issue=4&amp;rft.jtitle=Annals+of+internal+medicine&amp;rft.pages=233-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=161" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-97">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cysticfibrosis.ca/assets/files/pdf/CPDR_ReportE.pdf">"Canadian Cystic Fibrosis Patient Data Registry Report"</a> <span style="font-size:85%;">(PDF)</span>. <a href="/wiki/Canadian_Cystic_Fibrosis_Foundation" title="Canadian Cystic Fibrosis Foundation" class="mw-redirect">Canadian Cystic Fibrosis Foundation</a>. 2007<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-03-14</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=Canadian+Cystic+Fibrosis+Patient+Data+Registry+Report&amp;rft.date=2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cysticfibrosis.ca%2Fassets%2Ffiles%2Fpdf%2FCPDR_ReportE.pdf&amp;rft.pub=Canadian+Cystic+Fibrosis+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cff.org/UploadedFiles/research/ClinicalResearch/Patient-Registry-Report-2009.pdf">"Cystic Fibrosis Patient Registry Annual Data Report 2009"</a> <span style="font-size:85%;">(PDF)</span>. <a href="/wiki/Cystic_Fibrosis_Foundation" title="Cystic Fibrosis Foundation">Cystic Fibrosis Foundation</a>. 2009.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=Cystic+Fibrosis+Patient+Registry+Annual+Data+Report+2009&amp;rft.date=2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cff.org%2FUploadedFiles%2Fresearch%2FClinicalResearch%2FPatient-Registry-Report-2009.pdf&amp;rft.pub=Cystic+Fibrosis+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-99">^</a></b></span> <span class="reference-text"><span class="citation journal">Yu H, Nasr SZ, Deretic V (April 2000). <a rel="nofollow" class="external text" href="http://iai.asm.org/cgi/pmidlookup?view=long&amp;pmid=10722612">"Innate lung defenses and compromised <i>Pseudomonas aeruginosa</i> clearance in the malnourished mouse model of respiratory infections in cystic fibrosis"</a>. <i>Infect. Immun.</i> <b>68</b> (4): 2142–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1128%2FIAI.68.4.2142-2147.2000">10.1128/IAI.68.4.2142-2147.2000</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC97396">97396</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10722612">10722612</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Innate+lung+defenses+and+compromised+Pseudomonas+aeruginosa+clearance+in+the+malnourished+mouse+model+of+respiratory+infections+in+cystic+fibrosis&amp;rft.aulast=Yu+H%2C+Nasr+SZ%2C+Deretic+V&amp;rft.au=Yu+H%2C+Nasr+SZ%2C+Deretic+V&amp;rft.date=April+2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fiai.asm.org%2Fcgi%2Fpmidlookup%3Fview%3Dlong%26pmid%3D10722612&amp;rft_id=info%3Adoi%2F10.1128%2FIAI.68.4.2142-2147.2000&amp;rft_id=info%3Apmc%2F97396&amp;rft_id=info%3Apmid%2F10722612&amp;rft.issue=4&amp;rft.jtitle=Infect.+Immun.&amp;rft.pages=2142-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=68" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ratjen03-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ratjen03_100-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ratjen F, Döring G (February 2003). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)12567-6">"Cystic fibrosis"</a>. <i>Lancet</i> <b>361</b> (9358): 681–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2803%2912567-6">10.1016/S0140-6736(03)12567-6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12606185">12606185</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis&amp;rft.aulast=Ratjen+F%2C+D%C3%B6ring+G&amp;rft.au=Ratjen+F%2C+D%C3%B6ring+G&amp;rft.date=February+2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0140-6736%2803%2912567-6&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2803%2912567-6&amp;rft_id=info%3Apmid%2F12606185&amp;rft.issue=9358&amp;rft.jtitle=Lancet&amp;rft.pages=681-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=361" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><span class="citation journal">Rosenstein BJ, Zeitlin PL (January 1998). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(97)09174-5">"Cystic fibrosis"</a>. <i>Lancet</i> <b>351</b> (9098): 277–82. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2897%2909174-5">10.1016/S0140-6736(97)09174-5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9457113">9457113</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis&amp;rft.aulast=Rosenstein+BJ%2C+Zeitlin+PL&amp;rft.au=Rosenstein+BJ%2C+Zeitlin+PL&amp;rft.date=January+1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0140-6736%2897%2909174-5&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2897%2909174-5&amp;rft_id=info%3Apmid%2F9457113&amp;rft.issue=9098&amp;rft.jtitle=Lancet&amp;rft.pages=277-82&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=351" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><span class="citation journal">Schmitz TG, Goldbeck L (2006). <a rel="nofollow" class="external text" href="http://www.hqlo.com/content/4//8">"The effect of inpatient rehabilitation programmes on quality of life in patients with cystic fibrosis: a multi-center study"</a>. <i>Health Qual Life Outcomes</i> <b>4</b>: 8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1477-7525-4-8">10.1186/1477-7525-4-8</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1373610">1373610</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16457728">16457728</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+effect+of+inpatient+rehabilitation+programmes+on+quality+of+life+in+patients+with+cystic+fibrosis%3A+a+multi-center+study&amp;rft.aulast=Schmitz+TG%2C+Goldbeck+L&amp;rft.au=Schmitz+TG%2C+Goldbeck+L&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.hqlo.com%2Fcontent%2F4%2F%2F8&amp;rft_id=info%3Adoi%2F10.1186%2F1477-7525-4-8&amp;rft_id=info%3Apmc%2F1373610&amp;rft_id=info%3Apmid%2F16457728&amp;rft.jtitle=Health+Qual+Life+Outcomes&amp;rft.pages=8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><span class="citation journal">Hegarty M, Macdonald J, Watter P, Wilson C (July 2009). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/resolve/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=0305-1862&amp;date=2009&amp;volume=35&amp;issue=4&amp;spage=462">"Quality of life in young people with cystic fibrosis: effects of hospitalization, age and gender, and differences in parent/child perceptions"</a>. <i>Child Care Health Dev</i> <b>35</b> (4): 462–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2214.2008.00900.x">10.1111/j.1365-2214.2008.00900.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18991968">18991968</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Quality+of+life+in+young+people+with+cystic+fibrosis%3A+effects+of+hospitalization%2C+age+and+gender%2C+and+differences+in+parent%2Fchild+perceptions&amp;rft.au=Hegarty+M%2C+Macdonald+J%2C+Watter+P%2C+Wilson+C&amp;rft.aulast=Hegarty+M%2C+Macdonald+J%2C+Watter+P%2C+Wilson+C&amp;rft.date=July+2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Fopenurl%3Fgenre%3Darticle%26sid%3Dnlm%3Apubmed%26issn%3D0305-1862%26date%3D2009%26volume%3D35%26issue%3D4%26spage%3D462&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2214.2008.00900.x&amp;rft_id=info%3Apmid%2F18991968&amp;rft.issue=4&amp;rft.jtitle=Child+Care+Health+Dev&amp;rft.pages=462-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=35" class="Z3988"><span style="display:none;">&#160;</span></span><br />
<span class="citation journal">Havermans T, Vreys M, Proesmans M, De Boeck C (January 2006). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/resolve/openurl?genre=article&amp;sid=nlm:pubmed&amp;issn=0305-1862&amp;date=2006&amp;volume=32&amp;issue=1&amp;spage=1">"Assessment of agreement between parents and children on health-related quality of life in children with cystic fibrosis"</a>. <i>Child Care Health Dev</i> <b>32</b> (1): 1–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2214.2006.00564.x">10.1111/j.1365-2214.2006.00564.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16398786">16398786</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Assessment+of+agreement+between+parents+and+children+on+health-related+quality+of+life+in+children+with+cystic+fibrosis&amp;rft.au=Havermans+T%2C+Vreys+M%2C+Proesmans+M%2C+De+Boeck+C&amp;rft.aulast=Havermans+T%2C+Vreys+M%2C+Proesmans+M%2C+De+Boeck+C&amp;rft.date=January+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Fopenurl%3Fgenre%3Darticle%26sid%3Dnlm%3Apubmed%26issn%3D0305-1862%26date%3D2006%26volume%3D32%26issue%3D1%26spage%3D1&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2214.2006.00564.x&amp;rft_id=info%3Apmid%2F16398786&amp;rft.issue=1&amp;rft.jtitle=Child+Care+Health+Dev&amp;rft.pages=1-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-104"><span class="mw-cite-backlink"><b><a href="#cite_ref-104">^</a></b></span> <span class="reference-text"><span class="citation journal">Moorcroft AJ, Dodd ME, Webb AK (1998). "Exercise limitations and training for patients with cystic fibrosis". <i>Disabil Rehabil</i> <b>20</b> (6–7): 247–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3109%2F09638289809166735">10.3109/09638289809166735</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9637933">9637933</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Exercise+limitations+and+training+for+patients+with+cystic+fibrosis&amp;rft.aulast=Moorcroft+AJ%2C+Dodd+ME%2C+Webb+AK&amp;rft.au=Moorcroft+AJ%2C+Dodd+ME%2C+Webb+AK&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3109%2F09638289809166735&amp;rft_id=info%3Apmid%2F9637933&amp;rft.issue=6%E2%80%937&amp;rft.jtitle=Disabil+Rehabil&amp;rft.pages=247-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=20" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cysticfibrosis.ca/en/treatment/Medications.php">"Medications"</a>. Cystic Fibrosis Canada. 2011. No. 10684-5100 RR0001.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=Medications&amp;rft.date=2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cysticfibrosis.ca%2Fen%2Ftreatment%2FMedications.php&amp;rft.pub=Cystic+Fibrosis+Canada&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-table-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-table_106-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Araújo FG, Novaes FC, Santos NP, Martins VC, Souza SM, Santos SE, Ribeiro-dos-Santos AK (January 2005). "Prevalence of deltaF508, G551D, G542X, and R553X mutations among cystic fibrosis patients in the North of Brazil". <i>Braz. J. Med. Biol. Res.</i> <b>38</b> (1): 11–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1590%2FS0100-879X2005000100003">10.1590/S0100-879X2005000100003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15665983">15665983</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Prevalence+of+deltaF508%2C+G551D%2C+G542X%2C+and+R553X+mutations+among+cystic+fibrosis+patients+in+the+North+of+Brazil&amp;rft.au=Ara%C3%BAjo+FG%2C+Novaes+FC%2C+Santos+NP%2C+Martins+VC%2C+Souza+SM%2C+Santos+SE%2C+Ribeiro-dos-Santos+AK&amp;rft.aulast=Ara%C3%BAjo+FG%2C+Novaes+FC%2C+Santos+NP%2C+Martins+VC%2C+Souza+SM%2C+Santos+SE%2C+Ribeiro-dos-Santos+AK&amp;rft.date=January+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1590%2FS0100-879X2005000100003&amp;rft_id=info%3Apmid%2F15665983&amp;rft.issue=1&amp;rft.jtitle=Braz.+J.+Med.+Biol.+Res.&amp;rft.pages=11-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><span class="citation book">Tobias, Edward (2011). <a rel="nofollow" class="external text" href="http://books.google.ca/books?id=77Dvq_OoMnYC&amp;pg=PT312"><i>Essential Medical Genetics</i></a>. John Wiley &amp; Sons. p.&#160;312. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-118-29370-3" title="Special:BookSources/1-118-29370-3">1-118-29370-3</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.aufirst=Edward&amp;rft.aulast=Tobias&amp;rft.au=Tobias%2C+Edward&amp;rft.btitle=Essential+Medical+Genetics&amp;rft.date=2011&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3D77Dvq_OoMnYC%26pg%3DPT312&amp;rft.isbn=1-118-29370-3&amp;rft.pages=312&amp;rft.pub=John+Wiley+%26+Sons&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cysticfibrosis.ca/en/aboutCysticFibrosis/CfStatistics.php">"The Canadian Facts &amp; Figures on Cystic Fibrosis"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=The+Canadian+Facts+%26+Figures+on+Cystic+Fibrosis&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cysticfibrosis.ca%2Fen%2FaboutCysticFibrosis%2FCfStatistics.php&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cff.org/aboutcf/testing/geneticcarriertest/">"Genetic Carrier Testing"</a>. Cystic Fibrosis Foundation. 2007.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=Genetic+Carrier+Testing&amp;rft.date=2007&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cff.org%2Faboutcf%2Ftesting%2Fgeneticcarriertest%2F&amp;rft.pub=Cystic+Fibrosis+Foundation&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><span class="citation journal">Rosenstein BJ, Cutting GR (April 1998). "The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel". <i>J. Pediatr.</i> <b>132</b> (4): 589–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-3476%2898%2970344-0">10.1016/S0022-3476(98)70344-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9580754">9580754</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+diagnosis+of+cystic+fibrosis%3A+a+consensus+statement.+Cystic+Fibrosis+Foundation+Consensus+Panel&amp;rft.aulast=Rosenstein+BJ%2C+Cutting+GR&amp;rft.au=Rosenstein+BJ%2C+Cutting+GR&amp;rft.date=April+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-3476%2898%2970344-0&amp;rft_id=info%3Apmid%2F9580754&amp;rft.issue=4&amp;rft.jtitle=J.+Pediatr.&amp;rft.pages=589-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=132" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><span class="citation journal">Hamosh A, FitzSimmons SC, Macek M, Knowles MR, Rosenstein BJ, Cutting GR (February 1998). "Comparison of the clinical manifestations of cystic fibrosis in black and white patients". <i>J. Pediatr.</i> <b>132</b> (2): 255–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0022-3476%2898%2970441-X">10.1016/S0022-3476(98)70441-X</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9506637">9506637</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Comparison+of+the+clinical+manifestations+of+cystic+fibrosis+in+black+and+white+patients&amp;rft.au=Hamosh+A%2C+FitzSimmons+SC%2C+Macek+M%2C+Knowles+MR%2C+Rosenstein+BJ%2C+Cutting+GR&amp;rft.aulast=Hamosh+A%2C+FitzSimmons+SC%2C+Macek+M%2C+Knowles+MR%2C+Rosenstein+BJ%2C+Cutting+GR&amp;rft.date=February+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0022-3476%2898%2970441-X&amp;rft_id=info%3Apmid%2F9506637&amp;rft.issue=2&amp;rft.jtitle=J.+Pediatr.&amp;rft.pages=255-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=132" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><span class="citation journal">Farrell P, Joffe S, Foley L, Canny GJ, Mayne P, Rosenberg M (September 2007). <a rel="nofollow" class="external text" href="http://www.imj.ie//ViewArticleDetails.aspx?ArticleID=2497">"Diagnosis of cystic fibrosis in the Republic of Ireland: epidemiology and costs"</a>. <i>Ir Med J</i> <b>100</b> (8): 557–60. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17955689">17955689</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Diagnosis+of+cystic+fibrosis+in+the+Republic+of+Ireland%3A+epidemiology+and+costs&amp;rft.au=Farrell+P%2C+Joffe+S%2C+Foley+L%2C+Canny+GJ%2C+Mayne+P%2C+Rosenberg+M&amp;rft.aulast=Farrell+P%2C+Joffe+S%2C+Foley+L%2C+Canny+GJ%2C+Mayne+P%2C+Rosenberg+M&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.imj.ie%2F%2FViewArticleDetails.aspx%3FArticleID%3D2497&amp;rft_id=info%3Apmid%2F17955689&amp;rft.issue=8&amp;rft.jtitle=Ir+Med+J&amp;rft.pages=557-60&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11813900-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11813900_113-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hytönen M, Patjas M, Vento SI, Kauppi P, Malmberg H, Ylikoski J, Kere J (December 2001). "Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland". <i>Acta Otolaryngol.</i> <b>121</b> (8): 945–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1080%2F000164801317166835">10.1080/000164801317166835</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11813900">11813900</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+gene+mutations+deltaF508+and+394delTT+in+patients+with+chronic+sinusitis+in+Finland&amp;rft.au=Hyt%C3%B6nen+M%2C+Patjas+M%2C+Vento+SI%2C+Kauppi+P%2C+Malmberg+H%2C+Ylikoski+J%2C+Kere+J&amp;rft.aulast=Hyt%C3%B6nen+M%2C+Patjas+M%2C+Vento+SI%2C+Kauppi+P%2C+Malmberg+H%2C+Ylikoski+J%2C+Kere+J&amp;rft.date=December+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1080%2F000164801317166835&amp;rft_id=info%3Apmid%2F11813900&amp;rft.issue=8&amp;rft.jtitle=Acta+Otolaryngol.&amp;rft.pages=945-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=121" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WHO_.7C_Genes_and_human_disease-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-WHO_.7C_Genes_and_human_disease_114-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.who.int/genomics/public/geneticdiseases/en/index2.html">"WHO | Genes and human disease"</a>. Who.int. 2010-12-07<span class="reference-accessdate">. Retrieved <span class="nowrap">2013-01-23</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.btitle=WHO+%26%23124%3B+Genes+and+human+disease&amp;rft.date=2010-12-07&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.who.int%2Fgenomics%2Fpublic%2Fgeneticdiseases%2Fen%2Findex2.html&amp;rft.pub=Who.int&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><span class="citation book">Russell, Peter (2011). <a rel="nofollow" class="external text" href="http://books.google.ca/books?id=UxkOTD5LNCwC&amp;pg=PT304"><i>Biology&#160;: the dynamic science.</i></a> (2nd ed.). Belmont, CA: Brooks/Cole, Cengage Learning. p.&#160;304. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-538-49372-7" title="Special:BookSources/978-0-538-49372-7">978-0-538-49372-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.aufirst=Peter&amp;rft.aulast=Russell&amp;rft.au=Russell%2C+Peter&amp;rft.btitle=Biology+%3A+the+dynamic+science.&amp;rft.date=2011&amp;rft.edition=2nd&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fbooks.google.ca%2Fbooks%3Fid%3DUxkOTD5LNCwC%26pg%3DPT304&amp;rft.isbn=978-0-538-49372-7&amp;rft.pages=304&amp;rft.place=Belmont%2C+CA&amp;rft.pub=Brooks%2FCole%2C+Cengage+Learning&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://consensus.nih.gov/1997/1997GeneticTestCysticFibrosis106html.htm">"Genetic testing for cystic fibrosis Genetic Testing for Cystic Fibrosis"</a>. <i>Consensus Development Conference Statement</i>. National Institutes of Health. April 14–16, 1997.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Genetic+testing+for+cystic+fibrosis+Genetic+Testing+for+Cystic+Fibrosis&amp;rft.date=April+14-16%2C+1997&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fconsensus.nih.gov%2F1997%2F1997GeneticTestCysticFibrosis106html.htm&amp;rft.jtitle=Consensus+Development+Conference+Statement&amp;rft.pub=National+Institutes+of+Health&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><span class="citation journal">Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B (May 1997). "Gender gap in cystic fibrosis mortality". <i>Am. J. Epidemiol.</i> <b>145</b> (9): 794–803. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Foxfordjournals.aje.a009172">10.1093/oxfordjournals.aje.a009172</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9143209">9143209</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Gender+gap+in+cystic+fibrosis+mortality&amp;rft.aulast=Rosenfeld+M%2C+Davis+R%2C+FitzSimmons+S%2C+Pepe+M%2C+Ramsey+B&amp;rft.au=Rosenfeld+M%2C+Davis+R%2C+FitzSimmons+S%2C+Pepe+M%2C+Ramsey+B&amp;rft.date=May+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Foxfordjournals.aje.a009172&amp;rft_id=info%3Apmid%2F9143209&amp;rft.issue=9&amp;rft.jtitle=Am.+J.+Epidemiol.&amp;rft.pages=794-803&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=145" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><span class="citation journal">Coakley RD, Sun H, Clunes LA, Rasmussen JE, Stackhouse JR, Okada SF, Fricks I, Young SL, Tarran R (December 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2582929">"17beta-Estradiol inhibits <span class="chemf" style="white-space:nowrap;">Ca<span style="display:inline-block;margin-bottom:-0.3em;vertical-align:0.8em;line-height:1.2em;font-size:85%;text-align:left">2+<br /></span></span>-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia"</a>. <i>J. Clin. Invest.</i> <b>118</b> (12): 4025–35. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI33893">10.1172/JCI33893</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2582929">2582929</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19033671">19033671</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=17beta-Estradiol+inhibits+%3Cspan+class%3D%22chemf%22+style%3D%22white-space%3Anowrap%3B%22%3ECa%3Cspan+style%3D%22display%3Ainline-block%3Bmargin-bottom%3A-0.3em%3Bvertical-align%3A0.8em%3Bline-height%3A1.2em%3Bfont-size%3A85%25%3Btext-align%3Aleft%22%3E2%2B%3Cbr+%2F%3E%3C%2Fspan%3E%3C%2Fspan%3E-dependent+homeostasis+of+airway+surface+liquid+volume+in+human+cystic+fibrosis+airway+epithelia&amp;rft.au=Coakley+RD%2C+Sun+H%2C+Clunes+LA%2C+Rasmussen+JE%2C+Stackhouse+JR%2C+Okada+SF%2C+Fricks+I%2C+Young+SL%2C+Tarran+R&amp;rft.aulast=Coakley+RD%2C+Sun+H%2C+Clunes+LA%2C+Rasmussen+JE%2C+Stackhouse+JR%2C+Okada+SF%2C+Fricks+I%2C+Young+SL%2C+Tarran+R&amp;rft.date=December+2008&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2582929&amp;rft_id=info%3Adoi%2F10.1172%2FJCI33893&amp;rft_id=info%3Apmc%2F2582929&amp;rft_id=info%3Apmid%2F19033671&amp;rft.issue=12&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.pages=4025-35&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=118" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-119">^</a></b></span> <span class="reference-text"><span class="citation journal">Verma N, Bush A, Buchdahl R (October 2005). "Is there still a gender gap in cystic fibrosis?". <i>Chest</i> <b>128</b> (4): 2824–34. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1378%2Fchest.128.4.2824">10.1378/chest.128.4.2824</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16236961">16236961</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Is+there+still+a+gender+gap+in+cystic+fibrosis%3F&amp;rft.aulast=Verma+N%2C+Bush+A%2C+Buchdahl+R&amp;rft.au=Verma+N%2C+Bush+A%2C+Buchdahl+R&amp;rft.date=October+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.128.4.2824&amp;rft_id=info%3Apmid%2F16236961&amp;rft.issue=4&amp;rft.jtitle=Chest&amp;rft.pages=2824-34&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=128" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-120">^</a></b></span> <span class="reference-text"><span class="citation journal">Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W (September 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2732133">"Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality"</a>. <i>Diabetes Care</i> <b>32</b> (9): 1626–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2337%2Fdc09-0586">10.2337/dc09-0586</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2732133">2732133</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19542209">19542209</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis-related+diabetes%3A+current+trends+in+prevalence%2C+incidence%2C+and+mortality&amp;rft.aulast=Moran+A%2C+Dunitz+J%2C+Nathan+B%2C+Saeed+A%2C+Holme+B%2C+Thomas+W&amp;rft.au=Moran+A%2C+Dunitz+J%2C+Nathan+B%2C+Saeed+A%2C+Holme+B%2C+Thomas+W&amp;rft.date=September+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2732133&amp;rft_id=info%3Adoi%2F10.2337%2Fdc09-0586&amp;rft_id=info%3Apmc%2F2732133&amp;rft_id=info%3Apmid%2F19542209&amp;rft.issue=9&amp;rft.jtitle=Diabetes+Care&amp;rft.pages=1626-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-121">^</a></b></span> <span class="reference-text"><span class="citation news"><a rel="nofollow" class="external text" href="http://www.irishtimes.com/newspaper/health/2010/0810/1224276467970.html">"CF worse for women 'due to effect of estrogen<span style="padding-right:0.2em;">'</span>"</a>. <i>The Irish Times</i>. August 8, 2010.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=CF+worse+for+women+%27due+to+effect+of+estrogen%27&amp;rft.date=August+8%2C+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.irishtimes.com%2Fnewspaper%2Fhealth%2F2010%2F0810%2F1224276467970.html&amp;rft.jtitle=The+Irish+Times&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid8039801-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid8039801_122-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wennberg C, Kucinskas V (1994). "Low frequency of the delta F508 mutation in Finno-Ugrian and Baltic populations". <i>Hum. Hered.</i> <b>44</b> (3): 169–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000154210">10.1159/000154210</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8039801">8039801</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Low+frequency+of+the+delta+F508+mutation+in+Finno-Ugrian+and+Baltic+populations&amp;rft.aulast=Wennberg+C%2C+Kucinskas+V&amp;rft.au=Wennberg+C%2C+Kucinskas+V&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000154210&amp;rft_id=info%3Apmid%2F8039801&amp;rft.issue=3&amp;rft.jtitle=Hum.+Hered.&amp;rft.pages=169-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid2210753-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid2210753_123-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kere J, Savilahti E, Norio R, Estivill X, de la Chapelle A (September 1990). "Cystic fibrosis mutation delta F508 in Finland: other mutations predominate". <i>Hum. Genet.</i> <b>85</b> (4): 413–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2FBF02428286">10.1007/BF02428286</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2210753">2210753</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+mutation+delta+F508+in+Finland%3A+other+mutations+predominate&amp;rft.au=Kere+J%2C+Savilahti+E%2C+Norio+R%2C+Estivill+X%2C+de+la+Chapelle+A&amp;rft.aulast=Kere+J%2C+Savilahti+E%2C+Norio+R%2C+Estivill+X%2C+de+la+Chapelle+A&amp;rft.date=September+1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2FBF02428286&amp;rft_id=info%3Apmid%2F2210753&amp;rft.issue=4&amp;rft.jtitle=Hum.+Genet.&amp;rft.pages=413-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=85" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-124">^</a></b></span> <span class="reference-text"><span class="citation journal">Wiuf C (August 2001). "Do delta F508 heterozygotes have a selective advantage?". <i>Genet. Res.</i> <b>78</b> (1): 41–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1017%2FS0016672301005195">10.1017/S0016672301005195</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11556136">11556136</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Do+delta+F508+heterozygotes+have+a+selective+advantage%3F&amp;rft.aulast=Wiuf+C&amp;rft.au=Wiuf+C&amp;rft.date=August+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1017%2FS0016672301005195&amp;rft_id=info%3Apmid%2F11556136&amp;rft.issue=1&amp;rft.jtitle=Genet.+Res.&amp;rft.pages=41-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=78" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-125">^</a></b></span> <span class="reference-text"><span class="citation journal">Gabriel SE, Brigman KN, Koller BH, Boucher RC, Stutts MJ (October 1994). "Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model". <i>Science</i> <b>266</b> (5182): 107–9. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1994Sci...266..107G">1994Sci...266..107G</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.7524148">10.1126/science.7524148</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7524148">7524148</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+heterozygote+resistance+to+cholera+toxin+in+the+cystic+fibrosis+mouse+model&amp;rft.au=Gabriel+SE%2C+Brigman+KN%2C+Koller+BH%2C+Boucher+RC%2C+Stutts+MJ&amp;rft.aulast=Gabriel+SE%2C+Brigman+KN%2C+Koller+BH%2C+Boucher+RC%2C+Stutts+MJ&amp;rft.date=October+1994&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F1994Sci...266..107G&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.7524148&amp;rft_id=info%3Apmid%2F7524148&amp;rft.issue=5182&amp;rft.jtitle=Science&amp;rft.pages=107-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=266" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><span class="citation journal">Cuthbert AW, Halstead J, Ratcliff R, Colledge WH, Evans MJ (January 1995). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1157742">"The genetic advantage hypothesis in cystic fibrosis heterozygotes: a murine study"</a>. <i>J. Physiol. (Lond.)</i> <b>482</b> (Pt 2): 449–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1113%2Fjphysiol.1995.sp020531">10.1113/jphysiol.1995.sp020531</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1157742">1157742</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/7714835">7714835</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=The+genetic+advantage+hypothesis+in+cystic+fibrosis+heterozygotes%3A+a+murine+study&amp;rft.au=Cuthbert+AW%2C+Halstead+J%2C+Ratcliff+R%2C+Colledge+WH%2C+Evans+MJ&amp;rft.aulast=Cuthbert+AW%2C+Halstead+J%2C+Ratcliff+R%2C+Colledge+WH%2C+Evans+MJ&amp;rft.date=January+1995&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1157742&amp;rft_id=info%3Adoi%2F10.1113%2Fjphysiol.1995.sp020531&amp;rft_id=info%3Apmc%2F1157742&amp;rft_id=info%3Apmid%2F7714835&amp;rft.issue=Pt+2&amp;rft.jtitle=J.+Physiol.+%28Lond.%29&amp;rft.pages=449-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=482" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><span class="citation journal">Högenauer C, Santa Ana CA, Porter JL, Millard M, Gelfand A, Rosenblatt RL, Prestidge CB, Fordtran JS (December 2000). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1287919">"Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion"</a>. <i>Am. J. Hum. Genet.</i> <b>67</b> (6): 1422–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1086%2F316911">10.1086/316911</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1287919">1287919</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11055897">11055897</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Active+intestinal+chloride+secretion+in+human+carriers+of+cystic+fibrosis+mutations%3A+an+evaluation+of+the+hypothesis+that+heterozygotes+have+subnormal+active+intestinal+chloride+secretion&amp;rft.au=H%C3%B6genauer+C%2C+Santa+Ana+CA%2C+Porter+JL%2C+Millard+M%2C+Gelfand+A%2C+Rosenblatt+RL%2C+Prestidge+CB%2C+Fordtran+JS&amp;rft.aulast=H%C3%B6genauer+C%2C+Santa+Ana+CA%2C+Porter+JL%2C+Millard+M%2C+Gelfand+A%2C+Rosenblatt+RL%2C+Prestidge+CB%2C+Fordtran+JS&amp;rft.date=December+2000&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1287919&amp;rft_id=info%3Adoi%2F10.1086%2F316911&amp;rft_id=info%3Apmc%2F1287919&amp;rft_id=info%3Apmid%2F11055897&amp;rft.issue=6&amp;rft.jtitle=Am.+J.+Hum.+Genet.&amp;rft.pages=1422-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><span class="citation journal">Pier GB, Grout M, Zaidi T, Meluleni G, Mueschenborn SS, Banting G, Ratcliff R, Evans MJ, Colledge WH (May 1998). "<i>Salmonella typhi</i> uses CFTR to enter intestinal epithelial cells". <i>Nature</i> <b>393</b> (6680): 79–82. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1998Natur.393...79P">1998Natur.393...79P</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2F30006">10.1038/30006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9590693">9590693</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Salmonella+typhi+uses+CFTR+to+enter+intestinal+epithelial+cells&amp;rft.aulast=Pier+GB%2C+Grout+M%2C+Zaidi+T%2C+Meluleni+G%2C+Mueschenborn+SS%2C+Banting+G%2C+Ratcliff+R%2C+Evans+MJ%2C+Colledge+WH&amp;rft.au=Pier+GB%2C+Grout+M%2C+Zaidi+T%2C+Meluleni+G%2C+Mueschenborn+SS%2C+Banting+G%2C+Ratcliff+R%2C+Evans+MJ%2C+Colledge+WH&amp;rft.date=May+1998&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F1998Natur.393...79P&amp;rft_id=info%3Adoi%2F10.1038%2F30006&amp;rft_id=info%3Apmid%2F9590693&amp;rft.issue=6680&amp;rft.jtitle=Nature&amp;rft.pages=79-82&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=393" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-129">^</a></b></span> <span class="reference-text"><span class="citation journal">Modiano G, Ciminelli BM, Pignatti PF (March 2007). "Cystic fibrosis and lactase persistence: a possible correlation". <i>Eur. J. Hum. Genet.</i> <b>15</b> (3): 255–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fsj.ejhg.5201749">10.1038/sj.ejhg.5201749</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17180122">17180122</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Cystic+fibrosis+and+lactase+persistence%3A+a+possible+correlation&amp;rft.aulast=Modiano+G%2C+Ciminelli+BM%2C+Pignatti+PF&amp;rft.au=Modiano+G%2C+Ciminelli+BM%2C+Pignatti+PF&amp;rft.date=March+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fsj.ejhg.5201749&amp;rft_id=info%3Apmid%2F17180122&amp;rft.issue=3&amp;rft.jtitle=Eur.+J.+Hum.+Genet.&amp;rft.pages=255-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-130">^</a></b></span> <span class="reference-text"><span class="citation journal">Poolman EM, Galvani AP (February 2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2358959">"Evaluating candidate agents of selective pressure for cystic fibrosis"</a>. <i>Journal of the Royal Society, Interface</i> <b>4</b> (12): 91–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1098%2Frsif.2006.0154">10.1098/rsif.2006.0154</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2358959">2358959</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17015291">17015291</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Evaluating+candidate+agents+of+selective+pressure+for+cystic+fibrosis&amp;rft.aulast=Poolman+EM%2C+Galvani+AP&amp;rft.au=Poolman+EM%2C+Galvani+AP&amp;rft.date=February+2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2358959&amp;rft_id=info%3Adoi%2F10.1098%2Frsif.2006.0154&amp;rft_id=info%3Apmc%2F2358959&amp;rft_id=info%3Apmid%2F17015291&amp;rft.issue=12&amp;rft.jtitle=Journal+of+the+Royal+Society%2C+Interface&amp;rft.pages=91-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><span class="citation journal">Williams, N (2006). "Footprint fears for new TB threat". <i>Current Biology</i> <b>16</b> (19): R821. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.cub.2006.09.009">10.1016/j.cub.2006.09.009</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Footprint+fears+for+new+TB+threat&amp;rft.aufirst=N&amp;rft.aulast=Williams&amp;rft.au=Williams%2C+N&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cub.2006.09.009&amp;rft.issue=19&amp;rft.jtitle=Current+Biology&amp;rft.pages=R821&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bosch-132"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bosch_132-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bosch_132-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Bosch_132-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Busch R (1990). "On the history of cystic fibrosis". <i>Acta Univ Carol Med (Praha)</i> <b>36</b> (1–4): 13–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2130674">2130674</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=On+the+history+of+cystic+fibrosis&amp;rft.au=Busch+R&amp;rft.aulast=Busch+R&amp;rft.date=1990&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2130674&amp;rft.issue=1%E2%80%934&amp;rft.jtitle=Acta+Univ+Carol+Med+%28Praha%29&amp;rft.pages=13-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-133">^</a></b></span> <span class="reference-text"><span class="citation journal">Fanconi, G.; Uehlinger, E.; Knauer, C. (1936). "Das coeliakiesyndrom bei angeborener zysticher pankreasfibromatose und bronchiektasien". <i>Wien. Med. Wschr</i> <b>86</b>: 753–6.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Das+coeliakiesyndrom+bei+angeborener+zysticher+pankreasfibromatose+und+bronchiektasien&amp;rft.au=Fanconi%2C+G.&amp;rft.aufirst=G.&amp;rft.au=Knauer%2C+C.&amp;rft.aulast=Fanconi&amp;rft.au=Uehlinger%2C+E.&amp;rft.date=1936&amp;rft.genre=article&amp;rft.jtitle=Wien.+Med.+Wschr&amp;rft.pages=753-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=86" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-134">^</a></b></span> <span class="reference-text"><span class="citation journal">Di Sant'Agnese PA, Darling RC, Perera GA, Shea E (November 1953). "Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease". <i>Pediatrics</i> <b>12</b> (5): 549–63. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13111855">13111855</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Abnormal+electrolyte+composition+of+sweat+in+cystic+fibrosis+of+the+pancreas%3B+clinical+significance+and+relationship+to+the+disease&amp;rft.au=Di+Sant%27Agnese+PA%2C+Darling+RC%2C+Perera+GA%2C+Shea+E&amp;rft.aulast=Di+Sant%27Agnese+PA%2C+Darling+RC%2C+Perera+GA%2C+Shea+E&amp;rft.date=November+1953&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F13111855&amp;rft.issue=5&amp;rft.jtitle=Pediatrics&amp;rft.pages=549-63&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><span class="citation journal">Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL (September 1989). "Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA". <i>Science</i> <b>245</b> (4922): 1066–73. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1989Sci...245.1066R">1989Sci...245.1066R</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.2475911">10.1126/science.2475911</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2475911">2475911</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Identification+of+the+cystic+fibrosis+gene%3A+cloning+and+characterization+of+complementary+DNA&amp;rft.aulast=Riordan+JR%2C+Rommens+JM%2C+Kerem+B%2C+Alon+N%2C+Rozmahel+R%2C+Grzelczak+Z%2C+Zielenski+J%2C+Lok+S%2C+Plavsic+N%2C+Chou+JL&amp;rft.au=Riordan+JR%2C+Rommens+JM%2C+Kerem+B%2C+Alon+N%2C+Rozmahel+R%2C+Grzelczak+Z%2C+Zielenski+J%2C+Lok+S%2C+Plavsic+N%2C+Chou+JL&amp;rft.date=September+1989&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F1989Sci...245.1066R&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.2475911&amp;rft_id=info%3Apmid%2F2475911&amp;rft.issue=4922&amp;rft.jtitle=Science&amp;rft.pages=1066-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=245" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><span class="citation journal">Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N (September 1989). "Identification of the cystic fibrosis gene: chromosome walking and jumping". <i>Science</i> <b>245</b> (4922): 1059–65. <a href="/wiki/Bibcode" title="Bibcode">Bibcode</a>:<a rel="nofollow" class="external text" href="http://adsabs.harvard.edu/abs/1989Sci...245.1059R">1989Sci...245.1059R</a>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1126%2Fscience.2772657">10.1126/science.2772657</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2772657">2772657</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Identification+of+the+cystic+fibrosis+gene%3A+chromosome+walking+and+jumping&amp;rft.aulast=Rommens+JM%2C+Iannuzzi+MC%2C+Kerem+B%2C+Drumm+ML%2C+Melmer+G%2C+Dean+M%2C+Rozmahel+R%2C+Cole+JL%2C+Kennedy+D%2C+Hidaka+N&amp;rft.au=Rommens+JM%2C+Iannuzzi+MC%2C+Kerem+B%2C+Drumm+ML%2C+Melmer+G%2C+Dean+M%2C+Rozmahel+R%2C+Cole+JL%2C+Kennedy+D%2C+Hidaka+N&amp;rft.date=September+1989&amp;rft.genre=article&amp;rft_id=info%3Abibcode%2F1989Sci...245.1059R&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.2772657&amp;rft_id=info%3Apmid%2F2772657&amp;rft.issue=4922&amp;rft.jtitle=Science&amp;rft.pages=1059-65&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=245" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><span class="citation journal">Lee, Tim WR (26 Nov 2013). <a rel="nofollow" class="external text" href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005599.pub4/abstract">"Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease"</a>. <i>Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease</i> <b>11</b> (11): CD005599. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD005599.pub4">10.1002/14651858.CD005599.pub4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24282073">24282073</a><span class="reference-accessdate">. Retrieved <span class="nowrap">27 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Topical+cystic+fibrosis+transmembrane+conductance+regulator+gene+replacement+for+cystic+fibrosis-related+lung+disease&amp;rft.aufirst=Tim+WR&amp;rft.aulast=Lee&amp;rft.au=Lee%2C+Tim+WR&amp;rft.date=26+Nov+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1002%2F14651858.CD005599.pub4%2Fabstract&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD005599.pub4&amp;rft_id=info%3Apmid%2F24282073&amp;rft.issue=11&amp;rft.jtitle=Topical+cystic+fibrosis+transmembrane+conductance+regulator+gene+replacement+for+cystic+fibrosis-related+lung+disease&amp;rft.pages=CD005599&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><span class="citation journal">Alton, EW; Armstrong, DK (3 July 2015). "Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial.". <i>The Lancet. Respiratory medicine</i>. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS2213-2600%2815%2900245-3">10.1016/S2213-2600(15)00245-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/26149841">26149841</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Repeated+nebulisation+of+non-viral+CFTR+gene+therapy+in+patients+with+cystic+fibrosis%3A+a+randomised%2C+double-blind%2C+placebo-controlled%2C+phase+2b+trial.&amp;rft.au=Alton%2C+EW&amp;rft.au=Armstrong%2C+DK&amp;rft.aufirst=EW&amp;rft.aulast=Alton&amp;rft.date=3+July+2015&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS2213-2600%2815%2900245-3&amp;rft_id=info%3Apmid%2F26149841&amp;rft.jtitle=The+Lancet.+Respiratory+medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><span class="citation journal">Ramalho AS, Beck S, Meyer M, Penque D, Cutting GR, Amaral MD (November 2002). "Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis". <i>Am. J. Respir. Cell Mol. Biol.</i> <b>27</b> (5): 619–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1165%2Frcmb.2001-0004oc">10.1165/rcmb.2001-0004oc</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12397022">12397022</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Five+percent+of+normal+cystic+fibrosis+transmembrane+conductance+regulator+mRNA+ameliorates+the+severity+of+pulmonary+disease+in+cystic+fibrosis&amp;rft.aulast=Ramalho+AS%2C+Beck+S%2C+Meyer+M%2C+Penque+D%2C+Cutting+GR%2C+Amaral+MD&amp;rft.au=Ramalho+AS%2C+Beck+S%2C+Meyer+M%2C+Penque+D%2C+Cutting+GR%2C+Amaral+MD&amp;rft.date=November+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1165%2Frcmb.2001-0004oc&amp;rft_id=info%3Apmid%2F12397022&amp;rft.issue=5&amp;rft.jtitle=Am.+J.+Respir.+Cell+Mol.+Biol.&amp;rft.pages=619-27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><span class="citation journal">Tate S, Elborn S (March 2005). "Progress towards gene therapy for cystic fibrosis". <i>Expert Opin Drug Deliv</i> <b>2</b> (2): 269–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1517%2F17425247.2.2.269">10.1517/17425247.2.2.269</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16296753">16296753</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Progress+towards+gene+therapy+for+cystic+fibrosis&amp;rft.aulast=Tate+S%2C+Elborn+S&amp;rft.au=Tate+S%2C+Elborn+S&amp;rft.date=March+2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1517%2F17425247.2.2.269&amp;rft_id=info%3Apmid%2F16296753&amp;rft.issue=2&amp;rft.jtitle=Expert+Opin+Drug+Deliv&amp;rft.pages=269-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-141">^</a></b></span> <span class="reference-text"><a href="/wiki/Mendelian_Inheritance_in_Man" title="Mendelian Inheritance in Man" class="mw-redirect">Online 'Mendelian Inheritance in Man'</a> (OMIM) <a rel="nofollow" class="external text" href="//omim.org/entry/219700">CYSTIC FIBROSIS; CF -219700</a></span></li>
<li id="cite_note-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-142">^</a></b></span> <span class="reference-text"><span class="citation journal">Schwank G, Koo BK, Sasselli V, Dekkers JF, Heo I, Demircan T, Sasaki N,Boymans S, Cuppen E, van der Ent CK, Nieuwenhuis EE, Beekman JM, Clevers H (Dec 5, 2013). "Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients". <i>Cell Stem Cell</i> <b>13</b> (6): 653–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.stem.2013.11.002">10.1016/j.stem.2013.11.002</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/24315439">24315439</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Functional+repair+of+CFTR+by+CRISPR%2FCas9+in+intestinal+stem+cell+organoids+of+cystic+fibrosis+patients&amp;rft.aulast=Schwank+G%2C+Koo+BK%2C+Sasselli+V%2C+Dekkers+JF%2C+Heo+I%2C+Demircan+T%2C+Sasaki+N%2CBoymans+S%2C+Cuppen+E%2C+van+der+Ent+CK%2C+Nieuwenhuis+EE%2C+Beekman+JM%2C+Clevers+H&amp;rft.au=Schwank+G%2C+Koo+BK%2C+Sasselli+V%2C+Dekkers+JF%2C+Heo+I%2C+Demircan+T%2C+Sasaki+N%2CBoymans+S%2C+Cuppen+E%2C+van+der+Ent+CK%2C+Nieuwenhuis+EE%2C+Beekman+JM%2C+Clevers+H&amp;rft.date=Dec+5%2C+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.stem.2013.11.002&amp;rft_id=info%3Apmid%2F24315439&amp;rft.issue=6&amp;rft.jtitle=Cell+Stem+Cell&amp;rft.pages=653-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=13" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-143">^</a></b></span> <span class="reference-text"><span class="citation journal">Dietz HC (August 2010). <a rel="nofollow" class="external text" href="http://www.nejm.org/doi/full/10.1056/NEJMra0907180">"New therapeutic approaches to Mendelian disorders"</a>. <i>N. Engl. J. Med.</i> <b>363</b> (9): 852–63. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra0907180">10.1056/NEJMra0907180</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20818846">20818846</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=New+therapeutic+approaches+to+Mendelian+disorders&amp;rft.au=Dietz+HC&amp;rft.aulast=Dietz+HC&amp;rft.date=August+2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMra0907180&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra0907180&amp;rft_id=info%3Apmid%2F20818846&amp;rft.issue=9&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=852-63&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=363" class="Z3988"><span style="display:none;">&#160;</span></span> Free full text</span></li>
<li id="cite_note-144"><span class="mw-cite-backlink"><b><a href="#cite_ref-144">^</a></b></span> <span class="reference-text"><span class="citation journal">Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, Aviram M, Bdolah-Abram T, Bebok Z, Shushi L, Kerem B, Kerem E (October 2003). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/349/15/1433">"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations"</a>. <i>N. Engl. J. Med.</i> <b>349</b> (15): 1433–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa022170">10.1056/NEJMoa022170</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14534336">14534336</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Gentamicin-induced+correction+of+CFTR+function+in+patients+with+cystic+fibrosis+and+CFTR+stop+mutations&amp;rft.aulast=Wilschanski+M%2C+Yahav+Y%2C+Yaacov+Y%2C+Blau+H%2C+Bentur+L%2C+Rivlin+J%2C+Aviram+M%2C+Bdolah-Abram+T%2C+Bebok+Z%2C+Shushi+L%2C+Kerem+B%2C+Kerem+E&amp;rft.au=Wilschanski+M%2C+Yahav+Y%2C+Yaacov+Y%2C+Blau+H%2C+Bentur+L%2C+Rivlin+J%2C+Aviram+M%2C+Bdolah-Abram+T%2C+Bebok+Z%2C+Shushi+L%2C+Kerem+B%2C+Kerem+E&amp;rft.date=October+2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F349%2F15%2F1433&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa022170&amp;rft_id=info%3Apmid%2F14534336&amp;rft.issue=15&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1433-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=349" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-145"><span class="mw-cite-backlink"><b><a href="#cite_ref-145">^</a></b></span> <span class="reference-text">Clinical trial number <i><a rel="nofollow" class="external text" href="http://www.clinicaltrials.gov/show/NCT00803205">NCT00803205</a></i> for "Study of Ataluren (PTC124™) in Cystic Fibrosis" at <a href="/wiki/ClinicalTrials.gov" title="ClinicalTrials.gov">ClinicalTrials.gov</a></span></li>
<li id="cite_note-146"><span class="mw-cite-backlink"><b><a href="#cite_ref-146">^</a></b></span> <span class="reference-text"><span class="citation journal">Cheng, K; Ashby, D; Smyth, RL (15 December 2014). "Ursodeoxycholic acid for cystic fibrosis-related liver disease.". <i>The Cochrane database of systematic reviews</i> <b>12</b>: CD000222. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD000222.pub3">10.1002/14651858.CD000222.pub3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25501301">25501301</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACystic+fibrosis&amp;rft.atitle=Ursodeoxycholic+acid+for+cystic+fibrosis-related+liver+disease.&amp;rft.au=Ashby%2C+D&amp;rft.au=Cheng%2C+K&amp;rft.aufirst=K&amp;rft.aulast=Cheng&amp;rft.au=Smyth%2C+RL&amp;rft.date=15+December+2014&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD000222.pub3&amp;rft_id=info%3Apmid%2F25501301&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD000222&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit&amp;section=27" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="mbox-small plainlinks sistersitebox" style="border:1px solid #aaa;background-color:#f9f9f9">
<tr>
<td class="mbox-image"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" width="30" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></td>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="//commons.wikimedia.org/wiki/Category:Cystic_fibrosis" class="extiw" title="commons:Category:Cystic fibrosis">Cystic fibrosis</a></b></i>.</td>
</tr>
</table>
<ul>
<li><a rel="nofollow" class="external text" href="https://www.dmoz.org/Health/Conditions_and_Diseases/Genetic_Disorders/Cystic_Fibrosis/">Cystic fibrosis</a> at <a href="/wiki/DMOZ" title="DMOZ">DMOZ</a></li>
<li><i><a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&amp;part=cf">cf</a></i> at <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">NIH</a>/<a href="/wiki/University_of_Washington" title="University of Washington">UW</a> GeneTests</li>
<li><a rel="nofollow" class="external text" href="http://www.cf-europe.eu/cf-week">CF-europe.eu</a></li>
<li><a rel="nofollow" class="external text" href="http://www.genecards.org/cgi-bin/cardsearch.pl?search=cystic+fibrosis&amp;search_type=kwd&amp;mini=yes&amp;speed=fast#results">Search GeneCards for genes involved in cystic fibrosis</a></li>
<li><a rel="nofollow" class="external text" href="http://www.genet.sickkids.on.ca/app">Cystic Fibrosis Mutation Database</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Cardiopulmonary_therapy" title="Template:Cardiopulmonary therapy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Cardiopulmonary_therapy" title="Template talk:Cardiopulmonary therapy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cardiopulmonary_therapy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Respiratory_therapy" title="Respiratory therapy" class="mw-redirect">Cardiopulmonary therapy</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pulmonary_function_testing" title="Pulmonary function testing">Pulmonary function testing</a></li>
<li><a href="/wiki/Polysomnography" title="Polysomnography">Polysomnography</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Disease" title="Disease">Disease</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Asthma" title="Asthma">Asthma</a></li>
<li><a href="/wiki/Bronchiectasis" title="Bronchiectasis">Bronchiectasis</a></li>
<li><a href="/wiki/COPD" title="COPD" class="mw-redirect">COPD</a></li>
<li><strong class="selflink">Cystic fibrosis</strong></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis</a></li>
<li><a href="/wiki/Pneumonia" title="Pneumonia">Pneumonia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Therapy" title="Therapy">Therapy</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hyperinflation_therapy" title="Hyperinflation therapy">Hyperinflation therapy</a></li>
<li><a href="/wiki/Pulmonary_hygiene" title="Pulmonary hygiene">Pulmonary hygiene</a></li>
<li><a href="/wiki/Mechanical_ventilation" title="Mechanical ventilation">Mechanical ventilation</a></li>
<li><a href="/wiki/Oxygen_therapy" title="Oxygen therapy">Oxygen therapy</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">See also</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Health_care" title="Template:Health care">Health care</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Channelopathy" title="Template:Channelopathy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Channelopathy" title="Template talk:Channelopathy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Channelopathy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Channelopathy" title="Channelopathy">Diseases of ion channels</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Calcium_channel" title="Calcium channel">Calcium channel</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Voltage-dependent_calcium_channel" title="Voltage-dependent calcium channel">Voltage-gated</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Cav2.1" title="Cav2.1">CACNA1A</a></i>
<ul>
<li><a href="/wiki/Familial_hemiplegic_migraine" title="Familial hemiplegic migraine">Familial hemiplegic migraine 1</a></li>
<li><a href="/wiki/Episodic_ataxia" title="Episodic ataxia">Episodic ataxia 2</a></li>
<li><a href="/wiki/Spinocerebellar_ataxia_type-6" title="Spinocerebellar ataxia type-6" class="mw-redirect">Spinocerebellar ataxia type-6</a></li>
</ul>
</li>
<li><i><a href="/wiki/Cav1.2" title="Cav1.2">CACNA1C</a></i>
<ul>
<li><a href="/wiki/Timothy_syndrome" title="Timothy syndrome">Timothy syndrome</a></li>
<li><a href="/wiki/Brugada_syndrome" title="Brugada syndrome">Brugada syndrome 3</a></li>
<li><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome 8</a></li>
</ul>
</li>
<li><i><a href="/wiki/Cav1.4" title="Cav1.4">CACNA1F</a></i>
<ul>
<li><a href="/wiki/Ocular_albinism" title="Ocular albinism">Ocular albinism 2</a></li>
<li><a href="/wiki/X-linked_congenital_stationary_night_blindness" title="X-linked congenital stationary night blindness">CSNB2A</a></li>
</ul>
</li>
<li><i><a href="/wiki/Cav1.1" title="Cav1.1">CACNA1S</a></i>
<ul>
<li><a href="/wiki/Hypokalemic_periodic_paralysis" title="Hypokalemic periodic paralysis">Hypokalemic periodic paralysis 1</a></li>
<li><a href="/wiki/Thyrotoxic_periodic_paralysis" title="Thyrotoxic periodic paralysis">Thyrotoxic periodic paralysis 1</a></li>
</ul>
</li>
<li><i><a href="/wiki/CACNB2" title="CACNB2">CACNB2</a></i>
<ul>
<li><a href="/wiki/Brugada_syndrome" title="Brugada syndrome">Brugada syndrome 4</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Ligand gated</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/RYR1" title="RYR1">RYR1</a></i>
<ul>
<li><a href="/wiki/Malignant_hyperthermia" title="Malignant hyperthermia">Malignant hyperthermia</a></li>
<li><a href="/wiki/Central_core_disease" title="Central core disease">Central core disease</a></li>
</ul>
</li>
<li><i><a href="/wiki/RYR2" title="RYR2" class="mw-redirect">RYR2</a></i>
<ul>
<li><a href="/wiki/Catecholaminergic_polymorphic_ventricular_tachycardia" title="Catecholaminergic polymorphic ventricular tachycardia">CPVT1</a></li>
<li><a href="/wiki/Arrhythmogenic_right_ventricular_dysplasia" title="Arrhythmogenic right ventricular dysplasia">ARVD2</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Sodium_channel" title="Sodium channel">Sodium channel</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Voltage-gated</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/SCN1A" title="SCN1A" class="mw-redirect">SCN1A</a></i>
<ul>
<li><a href="/wiki/Familial_hemiplegic_migraine" title="Familial hemiplegic migraine">Familial hemiplegic migraine 3</a></li>
<li><a href="/wiki/Generalized_epilepsy_with_febrile_seizures_plus" title="Generalized epilepsy with febrile seizures plus">GEFS+ 2</a></li>
<li><a href="/wiki/Febrile_seizure" title="Febrile seizure">Febrile seizure 3A</a></li>
</ul>
</li>
<li><i><a href="/wiki/SCN1B" title="SCN1B">SCN1B</a></i>
<ul>
<li><a href="/wiki/Brugada_syndrome" title="Brugada syndrome">Brugada syndrome 6</a></li>
<li><a href="/wiki/Generalized_epilepsy_with_febrile_seizures_plus" title="Generalized epilepsy with febrile seizures plus">GEFS+ 1</a></li>
</ul>
</li>
<li><i><a href="/wiki/SCN4A" title="SCN4A" class="mw-redirect">SCN4A</a></i>
<ul>
<li><a href="/wiki/Hypokalemic_periodic_paralysis" title="Hypokalemic periodic paralysis">Hypokalemic periodic paralysis 2</a></li>
<li><a href="/wiki/Hyperkalemic_periodic_paralysis" title="Hyperkalemic periodic paralysis">Hyperkalemic periodic paralysis</a></li>
<li><a href="/wiki/Paramyotonia_congenita" title="Paramyotonia congenita">Paramyotonia congenita</a></li>
<li><a href="/wiki/Potassium-aggravated_myotonia" title="Potassium-aggravated myotonia">Potassium-aggravated myotonia</a></li>
</ul>
</li>
<li><i><a href="/wiki/SCN4B" title="SCN4B">SCN4B</a></i>
<ul>
<li><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome 10</a></li>
</ul>
</li>
<li><i><a href="/wiki/SCN5A" title="SCN5A" class="mw-redirect">SCN5A</a></i>
<ul>
<li><a href="/wiki/Brugada_syndrome" title="Brugada syndrome">Brugada syndrome 1</a></li>
<li><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome 3</a></li>
</ul>
</li>
<li><i><a href="/wiki/SCN9A" title="SCN9A" class="mw-redirect">SCN9A</a></i>
<ul>
<li><a href="/wiki/Erythromelalgia" title="Erythromelalgia">Erythromelalgia</a></li>
<li><a href="/wiki/Febrile_seizure" title="Febrile seizure">Febrile seizure 3B</a></li>
<li><a href="/wiki/Paroxysmal_extreme_pain_disorder" title="Paroxysmal extreme pain disorder">Paroxysmal extreme pain disorder</a></li>
<li><a href="/wiki/Congenital_insensitivity_to_pain" title="Congenital insensitivity to pain">Congenital insensitivity to pain</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Epithelial_sodium_channel" title="Epithelial sodium channel">Constitutively active</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/SCNN1B" title="SCNN1B">SCNN1B</a></i>/<i><a href="/wiki/SCNN1G" title="SCNN1G">SCNN1G</a></i>
<ul>
<li><a href="/wiki/Liddle%27s_syndrome" title="Liddle's syndrome">Liddle's syndrome</a></li>
</ul>
</li>
<li><i><a href="/wiki/SCNN1A" title="SCNN1A">SCNN1A</a></i>/<i><a href="/wiki/SCNN1B" title="SCNN1B">SCNN1B</a></i>/<i><a href="/wiki/SCNN1G" title="SCNN1G">SCNN1G</a></i>
<ul>
<li><a href="/wiki/Pseudohypoaldosteronism" title="Pseudohypoaldosteronism">Pseudohypoaldosteronism 1AR</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Potassium_channel" title="Potassium channel">Potassium channel</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Voltage-gated_potassium_channel" title="Voltage-gated potassium channel">Voltage-gated</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/KCNA1" title="KCNA1" class="mw-redirect">KCNA1</a></i>
<ul>
<li><a href="/wiki/Episodic_ataxia" title="Episodic ataxia">Episodic ataxia 1</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNA5" title="KCNA5">KCNA5</a></i>
<ul>
<li><a href="/wiki/Familial_atrial_fibrillation" title="Familial atrial fibrillation">Familial atrial fibrillation 7</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNC3" title="KCNC3">KCNC3</a></i>
<ul>
<li><a href="/wiki/Spinocerebellar_ataxia_type-13" title="Spinocerebellar ataxia type-13">Spinocerebellar ataxia type-13</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNE1" title="KCNE1">KCNE1</a></i>
<ul>
<li><a href="/wiki/Jervell_and_Lange-Nielsen_syndrome" title="Jervell and Lange-Nielsen syndrome">Jervell and Lange-Nielsen syndrome</a></li>
<li><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome 5</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNE2" title="KCNE2">KCNE2</a></i>
<ul>
<li><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome 6</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNE3" title="KCNE3">KCNE3</a></i>
<ul>
<li><a href="/wiki/Brugada_syndrome" title="Brugada syndrome">Brugada syndrome 5</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNH2" title="KCNH2" class="mw-redirect">KCNH2</a></i>
<ul>
<li><a href="/wiki/Short_QT_syndrome" title="Short QT syndrome">Short QT syndrome</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNQ1" title="KCNQ1" class="mw-redirect">KCNQ1</a></i>
<ul>
<li><a href="/wiki/Jervell_and_Lange-Nielsen_syndrome" title="Jervell and Lange-Nielsen syndrome">Jervell and Lange-Nielsen syndrome</a></li>
<li><a href="/wiki/Romano%E2%80%93Ward_syndrome" title="Romano–Ward syndrome">Romano–Ward syndrome</a></li>
<li><a href="/wiki/Short_QT_syndrome" title="Short QT syndrome">Short QT syndrome</a></li>
<li><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome 1</a></li>
<li><a href="/wiki/Familial_atrial_fibrillation" title="Familial atrial fibrillation">Familial atrial fibrillation 3</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNQ2" title="KCNQ2" class="mw-redirect">KCNQ2</a></i>
<ul>
<li><a href="/wiki/Benign_familial_neonatal_epilepsy" title="Benign familial neonatal epilepsy" class="mw-redirect">BFNS1</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Inward-rectifier_potassium_ion_channel" title="Inward-rectifier potassium ion channel">Inward-rectifier</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/ROMK" title="ROMK">KCNJ1</a></i>
<ul>
<li><a href="/wiki/Bartter_syndrome" title="Bartter syndrome">Bartter syndrome 2</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNJ2" title="KCNJ2" class="mw-redirect">KCNJ2</a></i>
<ul>
<li><a href="/wiki/Andersen%E2%80%93Tawil_syndrome" title="Andersen–Tawil syndrome">Andersen–Tawil syndrome</a></li>
<li><a href="/wiki/Long_QT_syndrome" title="Long QT syndrome">Long QT syndrome 7</a></li>
<li><a href="/wiki/Short_QT_syndrome" title="Short QT syndrome">Short QT syndrome</a>)</li>
</ul>
</li>
<li><i><a href="/wiki/Kir6.2" title="Kir6.2">KCNJ11</a></i>
<ul>
<li><a href="/wiki/Transient_neonatal_diabetes_mellitus" title="Transient neonatal diabetes mellitus">TNDM3</a></li>
</ul>
</li>
<li><i><a href="/wiki/KCNJ18" title="KCNJ18" class="mw-redirect">KCNJ18</a></i>
<ul>
<li><a href="/wiki/Thyrotoxic_periodic_paralysis" title="Thyrotoxic periodic paralysis">Thyrotoxic periodic paralysis 2</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Chloride_channel" title="Chloride channel">Chloride channel</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Cystic_fibrosis_transmembrane_conductance_regulator" title="Cystic fibrosis transmembrane conductance regulator">CFTR</a></i>
<ul>
<li><strong class="selflink">Cystic fibrosis</strong></li>
<li><a href="/wiki/Congenital_absence_of_the_vas_deferens" title="Congenital absence of the vas deferens">Congenital absence of the vas deferens</a></li>
</ul>
</li>
<li><i><a href="/wiki/CLCN1" title="CLCN1">CLCN1</a></i>
<ul>
<li><a href="/wiki/Thomsen_disease" title="Thomsen disease" class="mw-redirect">Thomsen disease</a></li>
<li><a href="/wiki/Myotonia_congenita" title="Myotonia congenita">Myotonia congenita</a></li>
</ul>
</li>
<li><i><a href="/wiki/CLCN5" title="CLCN5">CLCN5</a></i>
<ul>
<li><a href="/wiki/Dent%27s_disease" title="Dent's disease">Dent's disease</a></li>
</ul>
</li>
<li><i><a href="/wiki/CLCN7" title="CLCN7">CLCN7</a></i>
<ul>
<li><a href="/wiki/Osteopetrosis" title="Osteopetrosis">Osteopetrosis A2, B4</a></li>
</ul>
</li>
<li><i><a href="/wiki/Bestrophin_1" title="Bestrophin 1">BEST1</a></i>
<ul>
<li><a href="/wiki/Vitelliform_macular_dystrophy" title="Vitelliform macular dystrophy">Vitelliform macular dystrophy</a></li>
</ul>
</li>
<li><i><a href="/wiki/CLCNKB" title="CLCNKB">CLCNKB</a></i>
<ul>
<li><a href="/wiki/Bartter_syndrome" title="Bartter syndrome">Bartter syndrome 3</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Transient_receptor_potential_channel" title="Transient receptor potential channel">TRP channel</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/TRPC6" title="TRPC6">TRPC6</a></i>
<ul>
<li><a href="/wiki/Focal_segmental_glomerulosclerosis" title="Focal segmental glomerulosclerosis">FSGS2</a></li>
</ul>
</li>
<li><i><a href="/wiki/MCOLN1" title="MCOLN1">TRPML1</a></i>
<ul>
<li><a href="/wiki/Mucolipidosis_type_IV" title="Mucolipidosis type IV">Mucolipidosis type IV</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Connexin" title="Connexin">Connexin</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Gap_junction_protein,_alpha_1" title="Gap junction protein, alpha 1" class="mw-redirect">GJA1</a></i>
<ul>
<li><a href="/wiki/Oculodentodigital_dysplasia" title="Oculodentodigital dysplasia">Oculodentodigital dysplasia</a></li>
<li><a href="/wiki/Hallermann%E2%80%93Streiff_syndrome" title="Hallermann–Streiff syndrome">Hallermann–Streiff syndrome</a></li>
<li><a href="/wiki/Hypoplastic_left_heart_syndrome" title="Hypoplastic left heart syndrome">Hypoplastic left heart syndrome</a></li>
</ul>
</li>
<li><i><a href="/wiki/GJB1" title="GJB1">GJB1</a></i>
<ul>
<li><a href="/wiki/Charcot%E2%80%93Marie%E2%80%93Tooth_disease" title="Charcot–Marie–Tooth disease">Charcot–Marie–Tooth disease X1</a></li>
</ul>
</li>
<li><i><a href="/wiki/GJB2" title="GJB2">GJB2</a></i>
<ul>
<li><a href="/wiki/Keratitis%E2%80%93ichthyosis%E2%80%93deafness_syndrome" title="Keratitis–ichthyosis–deafness syndrome">Keratitis–ichthyosis–deafness syndrome</a></li>
<li><a href="/wiki/Ichthyosis_hystrix" title="Ichthyosis hystrix">Ichthyosis hystrix</a></li>
<li><a href="/wiki/Bart%E2%80%93Pumphrey_syndrome" title="Bart–Pumphrey syndrome">Bart–Pumphrey syndrome</a></li>
<li><a href="/wiki/Vohwinkel_syndrome" title="Vohwinkel syndrome" class="mw-redirect">Vohwinkel syndrome</a>)</li>
</ul>
</li>
<li><i><a href="/wiki/GJB3" title="GJB3">GJB3</a>/<a href="/wiki/GJB4" title="GJB4">GJB4</a></i>
<ul>
<li><a href="/wiki/Erythrokeratodermia_variabilis" title="Erythrokeratodermia variabilis">Erythrokeratodermia variabilis</a></li>
<li><a href="/wiki/Progressive_symmetric_erythrokeratodermia" title="Progressive symmetric erythrokeratodermia">Progressive symmetric erythrokeratodermia</a></li>
</ul>
</li>
<li><i><a href="/wiki/GJB6" title="GJB6">GJB6</a></i>
<ul>
<li><a href="/wiki/Clouston%27s_hidrotic_ectodermal_dysplasia" title="Clouston's hidrotic ectodermal dysplasia">Clouston's hidrotic ectodermal dysplasia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Porin_(protein)" title="Porin (protein)">Porin</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/Aquaporin_2" title="Aquaporin 2">AQP2</a></i>
<ul>
<li><a href="/wiki/Nephrogenic_diabetes_insipidus" title="Nephrogenic diabetes insipidus">Nephrogenic diabetes insipidus 2</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2">
<div><i>See also: <a href="/wiki/Template:Ion_channels" title="Template:Ion channels">ion channels</a></i></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Cell_navs" title="Template:Cell navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Cell_navs" title="Template talk:Cell navs" class="mw-redirect"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cell_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of cells</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Cellular_structures" title="Template:Cellular structures">Structure</a>
<ul>
<li><a href="/wiki/Template:Nucleus" title="Template:Nucleus">nucleus</a>
<ul>
<li><a href="/wiki/Template:Chromosome_genetics" title="Template:Chromosome genetics"><i>chromosome genetics</i></a></li>
</ul>
</li>
</ul>
</li>
<li>Organelles
<ul>
<li><a href="/wiki/Template:Peroxisomal_proteins" title="Template:Peroxisomal proteins">peroxisome</a></li>
<li><a href="/wiki/Template:Cytoskeletal_proteins" title="Template:Cytoskeletal proteins">cytoskeleton</a></li>
<li><a href="/wiki/Template:Centrosome" title="Template:Centrosome">centrosome</a></li>
<li><a href="/wiki/Template:Epithelial_proteins" title="Template:Epithelial proteins">epithelia</a></li>
<li><a href="/wiki/Template:Ciliary_proteins" title="Template:Ciliary proteins">cilia</a></li>
<li><a href="/wiki/Template:Mitochondrial_proteins" title="Template:Mitochondrial proteins">mitochondria</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cell_membranes" title="Template:Cell membranes">Membranes</a>
<ul>
<li><a href="/wiki/Template:Cell_membrane_proteins" title="Template:Cell membrane proteins" class="mw-redirect">proteins</a></li>
<li><a href="/wiki/Template:Cell_adhesion_molecules" title="Template:Cell adhesion molecules">cell adhesions</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Membrane_transport" title="Template:Membrane transport">Membrane transport</a>
<ul>
<li><a href="/wiki/Template:Ion_channels" title="Template:Ion channels">ion channels</a></li>
<li><a href="/wiki/Template:Vesicular_transport_proteins" title="Template:Vesicular transport proteins">vesicular transport</a></li>
<li><a href="/wiki/Template:Solute_carrier_family" title="Template:Solute carrier family">solute carrier</a></li>
<li><a href="/wiki/Template:ABC_transporters" title="Template:ABC transporters">ABC transporters</a></li>
<li><a href="/wiki/Template:ATPase" title="Template:ATPase">ATPase</a></li>
<li><a href="/wiki/Template:Oxidoreduction-driven_transporters" title="Template:Oxidoreduction-driven transporters">oxidoreduction-driven</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Structural
<ul>
<li><a href="/wiki/Template:Peroxisomal_disorders" title="Template:Peroxisomal disorders">peroxisome</a></li>
<li><a href="/wiki/Template:Cytoskeletal_defects" title="Template:Cytoskeletal defects">cytoskeleton</a></li>
<li><a href="/wiki/Template:Ciliopathy" title="Template:Ciliopathy">cilia</a></li>
<li><a href="/wiki/Template:Mitochondrial_diseases" title="Template:Mitochondrial diseases">mitochondria</a></li>
<li><a href="/wiki/Template:Nucleus_diseases" title="Template:Nucleus diseases">nucleus</a></li>
<li><a href="/wiki/Template:Scleroprotein_disease" title="Template:Scleroprotein disease">scleroprotein</a></li>
</ul>
</li>
<li>Membrane
<ul>
<li><a href="/wiki/Template:Channelopathy" title="Template:Channelopathy">channelopathy</a></li>
<li><a href="/wiki/Template:Solute_carrier_disorders" title="Template:Solute carrier disorders">solute carrier</a></li>
<li><a href="/wiki/Template:ATPase_disorders" title="Template:ATPase disorders">ATPase</a></li>
<li><a href="/wiki/Template:ABC_transporter_disorders" title="Template:ABC transporter disorders">ABC transporters</a></li>
<li><a href="/wiki/Template:Other_cell_membrane_protein_disorders" title="Template:Other cell membrane protein disorders">other</a></li>
<li><a href="/wiki/Template:Extracellular_ligand_disorders" title="Template:Extracellular ligand disorders">extracellular ligands</a></li>
<li><a href="/wiki/Template:Cell_surface_receptor_deficiencies" title="Template:Cell surface receptor deficiencies">cell surface receptors</a></li>
<li><a href="/wiki/Template:Deficiencies_of_intracellular_signaling_peptides_and_proteins" title="Template:Deficiencies of intracellular signaling peptides and proteins">intracellular signalling</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Vesicular_transport_protein_disorders" title="Template:Vesicular transport protein disorders">Vesicular transport</a></li>
<li><a href="/wiki/Template:Pore-forming_toxins" title="Template:Pore-forming toxins">Pore-forming toxins</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:ABC_transporter_disorders" title="Template:ABC transporter disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:ABC_transporter_disorders" title="Template talk:ABC transporter disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:ABC_transporter_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Genetic_disorder" title="Genetic disorder">Genetic disorder</a>, membrane: <a href="/wiki/ATP-binding_cassette_transporter" title="ATP-binding cassette transporter">ABC-transporter</a> disorders</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">ABCA</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/ABCA1" title="ABCA1">ABCA1</a></i> (<a href="/wiki/Tangier_disease" title="Tangier disease">Tangier disease</a>)</li>
<li><i><a href="/wiki/ABCA3" title="ABCA3">ABCA3</a></i> (<a href="/wiki/Surfactant_metabolism_dysfunction" title="Surfactant metabolism dysfunction">Surfactant metabolism dysfunction 3</a>)</li>
<li><i><a href="/wiki/ABCA4" title="ABCA4">ABCA4</a></i> (<a href="/wiki/Stargardt_disease" title="Stargardt disease">Stargardt disease 1</a>, <a href="/wiki/Retinitis_pigmentosa" title="Retinitis pigmentosa">Retinitis pigmentosa 19</a>)</li>
<li><i><a href="/wiki/ABCA12" title="ABCA12">ABCA12</a></i> (<a href="/wiki/Harlequin-type_ichthyosis" title="Harlequin-type ichthyosis">Harlequin-type ichthyosis</a>, <a href="/wiki/Lamellar_ichthyosis" title="Lamellar ichthyosis">Lamellar ichthyosis 2</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">ABCB</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/ABCB4" title="ABCB4">ABCB4</a></i> (<a href="/wiki/Progressive_familial_intrahepatic_cholestasis" title="Progressive familial intrahepatic cholestasis">Progressive familial intrahepatic cholestasis 3</a>)</li>
<li><i><a href="/wiki/ABCB7" title="ABCB7">ABCB7</a></i> (<a href="/wiki/Sideroblastic_anemia" title="Sideroblastic anemia">ASAT</a>)</li>
<li><i><a href="/wiki/ABCB11" title="ABCB11">ABCB11</a></i> (<a href="/wiki/Progressive_familial_intrahepatic_cholestasis" title="Progressive familial intrahepatic cholestasis">Progressive familial intrahepatic cholestasis 2</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">ABCC</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/ABCC2" title="ABCC2" class="mw-redirect">ABCC2</a></i> (<a href="/wiki/Dubin%E2%80%93Johnson_syndrome" title="Dubin–Johnson syndrome">Dubin–Johnson syndrome</a>)</li>
<li><i><a href="/wiki/ABCC6" title="ABCC6">ABCC6</a></i> (<a href="/wiki/Pseudoxanthoma_elasticum" title="Pseudoxanthoma elasticum">Pseudoxanthoma elasticum</a>)</li>
<li><i><a href="/wiki/ABCC7" title="ABCC7" class="mw-redirect">ABCC7</a></i> (<strong class="selflink">Cystic fibrosis</strong>)</li>
<li><i><a href="/wiki/ABCC8" title="ABCC8">ABCC8</a></i> (<a href="/wiki/Hyperinsulinemic_hypoglycemia" title="Hyperinsulinemic hypoglycemia">HHF1</a>, <a href="/wiki/Transient_neonatal_diabetes_mellitus" title="Transient neonatal diabetes mellitus">TNDM2</a>)</li>
<li><i><a href="/wiki/ABCC9" title="ABCC9">ABCC9</a></i> (<a href="/wiki/Dilated_cardiomyopathy" title="Dilated cardiomyopathy">Dilated cardiomyopathy 1O</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">ABCD</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/ABCD1" title="ABCD1">ABCD1</a></i> (<a href="/wiki/Adrenoleukodystrophy" title="Adrenoleukodystrophy">Adrenoleukodystrophy</a>, <a href="/wiki/Adrenomyeloneuropathy" title="Adrenomyeloneuropathy" class="mw-redirect">Adrenomyeloneuropathy</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">ABCG</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><i><a href="/wiki/ABCG5" title="ABCG5">ABCG5</a></i> (<a href="/wiki/Sitosterolemia" title="Sitosterolemia">Sitosterolemia</a>)</li>
<li><i><a href="/wiki/ABCG8" title="ABCG8">ABCG8</a></i> (<a href="/wiki/Gallbladder_disease" title="Gallbladder disease">Gallbladder disease</a> 4, <a href="/wiki/Sitosterolemia" title="Sitosterolemia">Sitosterolemia</a>)</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2">
<div><i>see also <a href="/wiki/Template:ABC_transporters" title="Template:ABC transporters">ABC transporters</a></i><br /></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Cell_navs" title="Template:Cell navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Cell_navs" title="Template talk:Cell navs" class="mw-redirect"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Cell_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of cells</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Cellular_structures" title="Template:Cellular structures">Structure</a>
<ul>
<li><a href="/wiki/Template:Nucleus" title="Template:Nucleus">nucleus</a>
<ul>
<li><a href="/wiki/Template:Chromosome_genetics" title="Template:Chromosome genetics"><i>chromosome genetics</i></a></li>
</ul>
</li>
</ul>
</li>
<li>Organelles
<ul>
<li><a href="/wiki/Template:Peroxisomal_proteins" title="Template:Peroxisomal proteins">peroxisome</a></li>
<li><a href="/wiki/Template:Cytoskeletal_proteins" title="Template:Cytoskeletal proteins">cytoskeleton</a></li>
<li><a href="/wiki/Template:Centrosome" title="Template:Centrosome">centrosome</a></li>
<li><a href="/wiki/Template:Epithelial_proteins" title="Template:Epithelial proteins">epithelia</a></li>
<li><a href="/wiki/Template:Ciliary_proteins" title="Template:Ciliary proteins">cilia</a></li>
<li><a href="/wiki/Template:Mitochondrial_proteins" title="Template:Mitochondrial proteins">mitochondria</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cell_membranes" title="Template:Cell membranes">Membranes</a>
<ul>
<li><a href="/wiki/Template:Cell_membrane_proteins" title="Template:Cell membrane proteins" class="mw-redirect">proteins</a></li>
<li><a href="/wiki/Template:Cell_adhesion_molecules" title="Template:Cell adhesion molecules">cell adhesions</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Membrane_transport" title="Template:Membrane transport">Membrane transport</a>
<ul>
<li><a href="/wiki/Template:Ion_channels" title="Template:Ion channels">ion channels</a></li>
<li><a href="/wiki/Template:Vesicular_transport_proteins" title="Template:Vesicular transport proteins">vesicular transport</a></li>
<li><a href="/wiki/Template:Solute_carrier_family" title="Template:Solute carrier family">solute carrier</a></li>
<li><a href="/wiki/Template:ABC_transporters" title="Template:ABC transporters">ABC transporters</a></li>
<li><a href="/wiki/Template:ATPase" title="Template:ATPase">ATPase</a></li>
<li><a href="/wiki/Template:Oxidoreduction-driven_transporters" title="Template:Oxidoreduction-driven transporters">oxidoreduction-driven</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Structural
<ul>
<li><a href="/wiki/Template:Peroxisomal_disorders" title="Template:Peroxisomal disorders">peroxisome</a></li>
<li><a href="/wiki/Template:Cytoskeletal_defects" title="Template:Cytoskeletal defects">cytoskeleton</a></li>
<li><a href="/wiki/Template:Ciliopathy" title="Template:Ciliopathy">cilia</a></li>
<li><a href="/wiki/Template:Mitochondrial_diseases" title="Template:Mitochondrial diseases">mitochondria</a></li>
<li><a href="/wiki/Template:Nucleus_diseases" title="Template:Nucleus diseases">nucleus</a></li>
<li><a href="/wiki/Template:Scleroprotein_disease" title="Template:Scleroprotein disease">scleroprotein</a></li>
</ul>
</li>
<li>Membrane
<ul>
<li><a href="/wiki/Template:Channelopathy" title="Template:Channelopathy">channelopathy</a></li>
<li><a href="/wiki/Template:Solute_carrier_disorders" title="Template:Solute carrier disorders">solute carrier</a></li>
<li><a href="/wiki/Template:ATPase_disorders" title="Template:ATPase disorders">ATPase</a></li>
<li><a href="/wiki/Template:ABC_transporter_disorders" title="Template:ABC transporter disorders">ABC transporters</a></li>
<li><a href="/wiki/Template:Other_cell_membrane_protein_disorders" title="Template:Other cell membrane protein disorders">other</a></li>
<li><a href="/wiki/Template:Extracellular_ligand_disorders" title="Template:Extracellular ligand disorders">extracellular ligands</a></li>
<li><a href="/wiki/Template:Cell_surface_receptor_deficiencies" title="Template:Cell surface receptor deficiencies">cell surface receptors</a></li>
<li><a href="/wiki/Template:Deficiencies_of_intracellular_signaling_peptides_and_proteins" title="Template:Deficiencies of intracellular signaling peptides and proteins">intracellular signalling</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Vesicular_transport_protein_disorders" title="Template:Vesicular transport protein disorders">Vesicular transport</a></li>
<li><a href="/wiki/Template:Pore-forming_toxins" title="Template:Pore-forming toxins">Pore-forming toxins</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Arthritis_in_children" title="Template:Arthritis in children"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Arthritis_in_children" title="Template talk:Arthritis in children"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Arthritis_in_children&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Childhood_arthritis" title="Childhood arthritis">Arthritis in children</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Inflammation" title="Inflammation">Inflammatory</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Idiopathic</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Juvenile_idiopathic_arthritis" title="Juvenile idiopathic arthritis">Juvenile idiopathic arthritis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Inflammatory disease</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">Inflammatory bowel disease</a></li>
<li><a href="/wiki/Sarcoidosis" title="Sarcoidosis">Sarcoidosis</a></li>
<li><strong class="selflink">Cystic fibrosis</strong></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Tumors_of_the_hematopoietic_and_lymphoid_tissues" title="Tumors of the hematopoietic and lymphoid tissues">Hematological malignancy</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">Acute lymphoblastic leukemia</a></li>
<li><a href="/wiki/Lymphoma" title="Lymphoma">Lymphoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Cancer" title="Cancer">Malignancy</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Neuroblastoma" title="Neuroblastoma">Neuroblastoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Reactive_arthritis" title="Reactive arthritis">Reactive</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>post-streptococcal</li>
<li><a href="/wiki/Rheumatic_fever" title="Rheumatic fever">Rheumatic fever</a></li>
<li>postenteric, post-viral</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Infection</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Septic_arthritis" title="Septic arthritis">Septic arthritis</a></li>
<li><a href="/wiki/Osteomyelitis" title="Osteomyelitis">Osteomyelitis</a></li>
<li><a href="/wiki/Tuberculosis" title="Tuberculosis">Tuberculosis</a></li>
<li><a href="/wiki/Lyme_disease#Late_disseminated_infection" title="Lyme disease">Lyme arthritis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Mechanical</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Osgood%E2%80%93Schlatter_disease" title="Osgood–Schlatter disease">Osgood–Schlatter disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Tumours of cartilage bone or muscle</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group">Benign</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Osteoid_osteoma" title="Osteoid osteoma">Osteoid osteoma</a></li>
<li><a href="/wiki/Pigmented_villonodular_synovitis" title="Pigmented villonodular synovitis">Pigmented villonodular synovitis</a></li>
<li><a href="/wiki/Hemangioma" title="Hemangioma">Hemangioma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Malignant</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Synovial_sarcoma" title="Synovial sarcoma">Synovial sarcoma</a></li>
<li><a href="/wiki/Rhabdomyosarcoma" title="Rhabdomyosarcoma">Rhabdomyosarcoma</a></li>
<li><a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Central Nervous System</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dd>Idiopathic pain syndromes</dd>
<dt>Local</dt>
<dd><a href="/wiki/Complex_regional_pain_syndrome" title="Complex regional pain syndrome">Complex regional pain syndrome</a>/Reflex sympathetic dystrophy</dd>
<dt>Generalized</dt>
<dd><a href="/wiki/Fibromyalgia" title="Fibromyalgia">Fibromyalgia</a></dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Joint_navs" title="Template:Joint navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Joint_navs" title="Template talk:Joint navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Joint_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Joint" title="Joint">joint</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Joints" title="Template:Joints">Anatomy</a>
<ul>
<li><a href="/wiki/Template:Joints_of_head_and_neck" title="Template:Joints of head and neck">head and neck</a></li>
<li><a href="/wiki/Template:Cranial_fibrous_joints" title="Template:Cranial fibrous joints">cranial</a></li>
<li><a href="/wiki/Template:Joints_of_upper_limbs" title="Template:Joints of upper limbs">arms</a></li>
<li><a href="/wiki/Template:Joints_of_torso_and_pelvis" title="Template:Joints of torso and pelvis">torso and pelvis</a></li>
<li><a href="/wiki/Template:Joints_of_lower_limbs" title="Template:Joints of lower limbs">legs</a></li>
<li><a href="/wiki/Template:Bursae_and_sheaths" title="Template:Bursae and sheaths">bursae and sheathes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Bone_and_cartilage_physiology" title="Template:Bone and cartilage physiology">Physiology</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Arthropathies_and_related_conditions" title="Template:Arthropathies and related conditions">Arthritis</a>
<ul>
<li><a href="/wiki/Template:Acquired_musculoskeletal_deformities" title="Template:Acquired musculoskeletal deformities">acquired</a></li>
<li><a href="/wiki/Template:Spinal_disease" title="Template:Spinal disease">back</a></li>
<li><a href="/wiki/Template:Arthritis_in_children" title="Template:Arthritis in children">childhood</a></li>
<li><a href="/wiki/Template:Soft_tissue_disorders" title="Template:Soft tissue disorders">soft tissue</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_musculoskeletal_system" title="Template:Congenital malformations and deformations of musculoskeletal system">Congenital</a></li>
<li><a href="/wiki/Template:Dislocations,_sprains_and_strains" title="Template:Dislocations, sprains and strains">Injury</a></li>
<li><a href="/wiki/Template:Nervous_and_musculoskeletal_system_symptoms_and_signs" title="Template:Nervous and musculoskeletal system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_skeletal_system_and_joints" title="Template:Eponymous medical signs for skeletal system and joints">eponymous</a></li>
<li><a href="/wiki/Template:Orthopaedic_Eponyms" title="Template:Orthopaedic Eponyms">orthopaedic</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Orthopedic_examination" title="Template:Orthopedic examination">Examination</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Bone,_cartilage,_and_joint_procedures" title="Template:Bone, cartilage, and joint procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antirheumatic_products" title="Template:Antirheumatic products">rheumatoid arthritis</a></li>
<li><a href="/wiki/Template:Antigout_preparations" title="Template:Antigout preparations">gout</a></li>
<li><a href="/wiki/Template:Topical_products_for_joint_and_muscular_pain" title="Template:Topical products for joint and muscular pain">topical analgesics</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Integrated_Authority_File" title="Integrated Authority File">GND</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://d-nb.info/gnd/4040669-6">4040669-6</a></span></li>
<li><a href="/wiki/National_Diet_Library" title="National Diet Library">NDL</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://id.ndl.go.jp/auth/ndlna/00570677">00570677</a></span></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1228
CPU time usage: 1.159 seconds
Real time usage: 1.285 seconds
Preprocessor visited node count: 9199/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 438375/2097152 bytes
Template argument size: 1512/2097152 bytes
Highest expansion depth: 20/40
Expensive parser function count: 1/500
Lua time usage: 0.463/10.000 seconds
Lua memory usage: 3.79 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1041.053      1 - -total
 63.69%  663.086      1 - Template:Reflist
 37.66%  392.059    121 - Template:Cite_journal
 10.41%  108.362     12 - Template:Navbox
  7.18%   74.739      1 - Template:Infobox_disease
  6.33%   65.890      1 - Template:Infobox
  3.59%   37.363      1 - Template:Channelopathy
  2.71%   28.169      9 - Template:Cite_web
  2.58%   26.828      2 - Template:Protein_defects_by_function_navs
  2.34%   24.384      1 - Template:Arthritis_in_children
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:50601-0!*!0!!en!4!* and timestamp 20150709134852 and revision id 670677420
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Cystic_fibrosis&amp;oldid=670677420">https://en.wikipedia.org/w/index.php?title=Cystic_fibrosis&amp;oldid=670677420</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Channelopathy" title="Category:Channelopathy">Channelopathy</a></li><li><a href="/wiki/Category:Autosomal_recessive_disorders" title="Category:Autosomal recessive disorders">Autosomal recessive disorders</a></li><li><a href="/wiki/Category:Pancreas_disorders" title="Category:Pancreas disorders">Pancreas disorders</a></li><li><a href="/wiki/Category:Pediatrics" title="Category:Pediatrics">Pediatrics</a></li><li><a href="/wiki/Category:Lung_disorders" title="Category:Lung disorders">Lung disorders</a></li><li><a href="/wiki/Category:Congenital_disorders" title="Category:Congenital disorders">Congenital disorders</a></li><li><a href="/wiki/Category:Rare_diseases" title="Category:Rare diseases">Rare diseases</a></li><li><a href="/wiki/Category:Steatorrhea-related_diseases" title="Category:Steatorrhea-related diseases">Steatorrhea-related diseases</a></li><li><a href="/wiki/Category:Cystic_fibrosis" title="Category:Cystic fibrosis">Cystic fibrosis</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:CS1_Spanish-language_sources_(es)" title="Category:CS1 Spanish-language sources (es)">CS1 Spanish-language sources (es)</a></li><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_October_2011" title="Category:Articles containing potentially dated statements from October 2011">Articles containing potentially dated statements from October 2011</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Commons_category_template_with_no_category_set" title="Category:Commons category template with no category set">Commons category template with no category set</a></li><li><a href="/wiki/Category:Commons_category_with_page_title_same_as_on_Wikidata" title="Category:Commons category with page title same as on Wikidata">Commons category with page title same as on Wikidata</a></li><li><a href="/wiki/Category:Articles_with_DMOZ_links" title="Category:Articles with DMOZ links">Articles with DMOZ links</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li><li><a href="/wiki/Category:Wikipedia_articles_with_GND_identifiers" title="Category:Wikipedia articles with GND identifiers">Wikipedia articles with GND identifiers</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Cystic+fibrosis&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Cystic+fibrosis" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Cystic_fibrosis"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Cystic_fibrosis"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Cystic_fibrosis" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=edit"  title="You can edit this page. Please use the preview button before saving [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Cystic_fibrosis&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Cystic_fibrosis" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Cystic_fibrosis" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Cystic_fibrosis&amp;oldid=670677420" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Cystic_fibrosis&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q178194" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Cystic_fibrosis&amp;id=670677420" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Cystic+fibrosis">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Cystic+fibrosis&amp;oldid=670677420&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Cystic_fibrosis&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%AA%D9%84%D9%8A%D9%81_%D9%83%D9%8A%D8%B3%D9%8A" title="تليف كيسي – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Fibrosi_qu%C3%ADstica" title="Fibrosi quística – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-cs"><a href="//cs.wikipedia.org/wiki/Cystick%C3%A1_fibr%C3%B3za" title="Cystická fibróza – Czech" lang="cs" hreflang="cs">Čeština</a></li><li class="interlanguage-link interwiki-cy"><a href="//cy.wikipedia.org/wiki/Ffibrosis_systig" title="Ffibrosis systig – Welsh" lang="cy" hreflang="cy">Cymraeg</a></li><li class="interlanguage-link interwiki-da"><a href="//da.wikipedia.org/wiki/Cystisk_fibrose" title="Cystisk fibrose – Danish" lang="da" hreflang="da">Dansk</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Mukoviszidose" title="Mukoviszidose – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-et"><a href="//et.wikipedia.org/wiki/Ts%C3%BCstiline_fibroos" title="Tsüstiline fibroos – Estonian" lang="et" hreflang="et">Eesti</a></li><li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%9A%CF%85%CF%83%CF%84%CE%B9%CE%BA%CE%AE_%CE%AF%CE%BD%CF%89%CF%83%CE%B7" title="Κυστική ίνωση – Greek" lang="el" hreflang="el">Ελληνικά</a></li><li class="interlanguage-link interwiki-es badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//es.wikipedia.org/wiki/Fibrosis_qu%C3%ADstica" title="Fibrosis quística – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-eo"><a href="//eo.wikipedia.org/wiki/Mukoviskozeco" title="Mukoviskozeco – Esperanto" lang="eo" hreflang="eo">Esperanto</a></li><li class="interlanguage-link interwiki-eu"><a href="//eu.wikipedia.org/wiki/Fibrosi_kistiko" title="Fibrosi kistiko – Basque" lang="eu" hreflang="eu">Euskara</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%81%DB%8C%D8%A8%D8%B1%D9%88%D8%B2_%D8%B3%DB%8C%D8%B3%D8%AA%DB%8C%DA%A9" title="فیبروز سیستیک – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//fr.wikipedia.org/wiki/Mucoviscidose" title="Mucoviscidose – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ga"><a href="//ga.wikipedia.org/wiki/Fiobr%C3%B3is_chisteach" title="Fiobróis chisteach – Irish" lang="ga" hreflang="ga">Gaeilge</a></li><li class="interlanguage-link interwiki-gl"><a href="//gl.wikipedia.org/wiki/Fibrose_c%C3%ADstica" title="Fibrose cística – Galician" lang="gl" hreflang="gl">Galego</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EB%82%AD%ED%8F%AC%EC%84%B1_%EC%84%AC%EC%9C%A0%EC%A6%9D" title="낭포성 섬유증 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%B8%E0%A4%BF%E0%A4%B8%E0%A5%8D%E0%A4%9F%E0%A4%BF%E0%A4%95_%E0%A4%AB%E0%A4%BE%E0%A4%87%E0%A4%AC%E0%A5%8D%E0%A4%B0%E0%A5%8B%E0%A4%B8%E0%A4%BF%E0%A4%B8" title="सिस्टिक फाइब्रोसिस – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Fibrosis_sistik" title="Fibrosis sistik – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Fibrosi_cistica" title="Fibrosi cistica – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%A1%D7%99%D7%A1%D7%98%D7%99%D7%A7_%D7%A4%D7%99%D7%91%D7%A8%D7%95%D7%96%D7%99%D7%A1" title="סיסטיק פיברוזיס – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-ka"><a href="//ka.wikipedia.org/wiki/%E1%83%99%E1%83%98%E1%83%A1%E1%83%A2%E1%83%A3%E1%83%A0%E1%83%98_%E1%83%A4%E1%83%98%E1%83%91%E1%83%A0%E1%83%9D%E1%83%96%E1%83%98" title="კისტური ფიბროზი – Georgian" lang="ka" hreflang="ka">ქართული</a></li><li class="interlanguage-link interwiki-kk"><a href="//kk.wikipedia.org/wiki/%D0%9C%D1%83%D0%BA%D0%BE%D0%B2%D0%B8%D1%81%D1%86%D0%B8%D0%B4%D0%BE%D0%B7" title="Муковисцидоз – Kazakh" lang="kk" hreflang="kk">Қазақша</a></li><li class="interlanguage-link interwiki-lv"><a href="//lv.wikipedia.org/wiki/Mukoviscidoze" title="Mukoviscidoze – Latvian" lang="lv" hreflang="lv">Latviešu</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/Cistin%C4%97_fibroz%C4%97" title="Cistinė fibrozė – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-li"><a href="//li.wikipedia.org/wiki/Tejsliemgekrenkdje" title="Tejsliemgekrenkdje – Limburgish" lang="li" hreflang="li">Limburgs</a></li><li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Ciszt%C3%A1s_fibr%C3%B3zis" title="Cisztás fibrózis – Hungarian" lang="hu" hreflang="hu">Magyar</a></li><li class="interlanguage-link interwiki-mk"><a href="//mk.wikipedia.org/wiki/%D0%A6%D0%B8%D1%81%D1%82%D0%B8%D1%87%D0%BD%D0%B0_%D1%84%D0%B8%D0%B1%D1%80%D0%BE%D0%B7%D0%B0" title="Цистична фиброза – Macedonian" lang="mk" hreflang="mk">Македонски</a></li><li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Penyakit_Sistik_Fibrosis" title="Penyakit Sistik Fibrosis – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Taaislijmziekte" title="Taaislijmziekte – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E5%9A%A2%E8%83%9E%E6%80%A7%E7%B7%9A%E7%B6%AD%E7%97%87" title="嚢胞性線維症 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Cystisk_fibrose" title="Cystisk fibrose – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-nn"><a href="//nn.wikipedia.org/wiki/Cystisk_fibrose" title="Cystisk fibrose – Norwegian Nynorsk" lang="nn" hreflang="nn">Norsk nynorsk</a></li><li class="interlanguage-link interwiki-or"><a href="//or.wikipedia.org/wiki/%E0%AC%B8%E0%AC%BF%E0%AC%B8%E0%AD%8D%E0%AC%9F%E0%AC%BF%E0%AC%95%E0%AD%8D_%E0%AC%AB%E0%AC%BE%E0%AC%87%E0%AC%AC%E0%AD%8D%E0%AC%B0%E0%AD%8B%E0%AC%B8%E0%AC%BF%E0%AC%B8%E0%AD%8D" title="ସିସ୍ଟିକ୍ ଫାଇବ୍ରୋସିସ୍ – Oriya" lang="or" hreflang="or">ଓଡ଼ିଆ</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Mukowiscydoza" title="Mukowiscydoza – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Fibrose_c%C3%ADstica" title="Fibrose cística – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ro"><a href="//ro.wikipedia.org/wiki/Fibroz%C4%83_chistic%C4%83" title="Fibroză chistică – Romanian" lang="ro" hreflang="ro">Română</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%9C%D1%83%D0%BA%D0%BE%D0%B2%D0%B8%D1%81%D1%86%D0%B8%D0%B4%D0%BE%D0%B7" title="Муковисцидоз – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-sq"><a href="//sq.wikipedia.org/wiki/Fibroza_kistike" title="Fibroza kistike – Albanian" lang="sq" hreflang="sq">Shqip</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Cystic_fibrosis" title="Cystic fibrosis – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-sk"><a href="//sk.wikipedia.org/wiki/Cystick%C3%A1_fibr%C3%B3za" title="Cystická fibróza – Slovak" lang="sk" hreflang="sk">Slovenčina</a></li><li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Cisti%C4%8Dna_fibroza" title="Cistična fibroza – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/%D0%A6%D0%B8%D1%81%D1%82%D0%B8%D1%87%D0%BD%D0%B0_%D1%84%D0%B8%D0%B1%D1%80%D0%BE%D0%B7%D0%B0" title="Цистична фиброза – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Cisti%C4%8Dna_fibroza" title="Cistična fibroza – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Kystinen_fibroosi" title="Kystinen fibroosi – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Cystisk_fibros" title="Cystisk fibros – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-tl"><a href="//tl.wikipedia.org/wiki/Sistikong_pibrosis" title="Sistikong pibrosis – Tagalog" lang="tl" hreflang="tl">Tagalog</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%8B%E0%B8%B4%E0%B8%AA%E0%B8%95%E0%B8%B4%E0%B8%81_%E0%B9%84%E0%B8%9F%E0%B9%82%E0%B8%9A%E0%B8%A3%E0%B8%8B%E0%B8%B4%E0%B8%AA" title="ซิสติก ไฟโบรซิส – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-tr"><a href="//tr.wikipedia.org/wiki/Kistik_fibrozis" title="Kistik fibrozis – Turkish" lang="tr" hreflang="tr">Türkçe</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%9A%D1%96%D1%81%D1%82%D0%BE%D0%B7%D0%BD%D0%B8%D0%B9_%D1%84%D1%96%D0%B1%D1%80%D0%BE%D0%B7" title="Кістозний фіброз – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-zh badge-Q17437798 badge-goodarticle" title="good article"><a href="//zh.wikipedia.org/wiki/%E5%9B%8A%E8%85%AB%E6%80%A7%E7%BA%96%E7%B6%AD%E5%8C%96" title="囊腫性纖維化 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q178194#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 9 July 2015, at 13:48.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Cystic_fibrosis&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf12/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf12/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf12/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.visualEditor.targetLoader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":128,"wgHostname":"mw1094"});
}</script>
	</body>
</html>
